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C E N E R A I I N T R O D U C T I O N 
General Introduction 
At present, hearing impairment is the most common sensorineural disorder Since 
fast communication becomes more and more important in our society, the value of 
good hearing cannot be overestimated Therefore, hearing impairment can have a 
considerable social and professional impact 
Historical overview of hereditary hearing impairment 
In the second half of the i9 l h century, autosomal dominant and autosomal recessive 
patterns of inheritance of hearing impairment were recognized and named indirect 
and direct transmission ' " It was recognized that an increased rate of consanguinity 
was related to a higher prevalence of the indirect (autosomal recessive) pattern of 
inheritance 
The most frequent syndromes were already reported in the i9 l h century For 
example, Usher syndrome,5 6 Treacher Collins syndrome' and Branchio-Oto-Renal 
syndrome 8 9 Especially in the seventies and eighties of the 20"1 century the number 
of genetic syndromes showing hearing impairment as a feature has been extended 
enormously and this new knowledge was listed in successive encyclopedic 
textbooks on genetic syndromes wi th hearing impairment , a " In total , about 450 
genetic diseases and syndromes have finally been documented 
In the eighties of the 20 ,h century, gene linkage and mutation analysis identified m 
many syndromes the genes involved 'ä For nonsyndromic hearing impairment 
(DFNA, DFNB and DFN) the linkage studies of families became successful m the 
early nineties of the 20,h century Since molecular biology has been added as a 
technique m this field, genotypes were identified and genotype-phenotype 
correlation studies could be started 
General note on hereditary hearing impairment 
Hearing impairment can occur before speech development (prelmgual), but far 
more people are affected by postlingual hearing impairment that arises after the 
first speech development Approximately one in 1000 newborns have profound 
childhood deafness ' 4 , 5 Another one in 1000 individuals wil l develop moderate to 
severe inner ear hearing impairment before reaching adulthood '4 In addition, by 
the age of 65 years a substantial part of the population wil l experience progressive 
sensorineural hearing impairment '4 
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There are numerous causes of hearing impairment, ranging from genetic defects to 
environmental factors such as perinatal infections, cochlear trauma and ototoxic 
drugs. 
In childhood hearing impairment, genetic defects account for at least 50 to 60% of 
the cases in western countries.1 2 , 6 In late-onset hearing impairment, in most of the 
cases a combination of both genetic and environmental factors plays a role." 
Approximately 30% of individuals w i t h hereditary hearing impairment in childhood 
have other associated anomalies (syndromic hearing impairment). However, in the 
majority of cases, hereditary hearing loss is non-syndromic, i.e. not associated wi th 
other distinctive clinical features."1 The mode of inheritance in nonsyndromic 
hereditary hearing impairment can be autosomal recessive (70-80%), autosomal 
dominant (20-30%), X-linked (<i%), or mitochondrial (<1%).,4 Y-linked inheritance 
has been proposed in a Chinese family.17 In general, nonsyndromic autosomal 
dominant hearing impairment is characterized by a postlingual onset and shows 
progression. Nonsyndromic autosomal recessive hearing impairment has a 
prelingual onset in many of the cases and is often non-progressive and more severe 
than the dominant forms. 
Genetic description 
The gene loci for nonsyndromic types of sensorineural hearing impairment have 
been designated DFN (DeaFNess) and are ordered in chronological order of discovery 
(e.g. DFNAi). Autosomal dominant types are referred to as DFNA, autosomal 
recessive types as DFNB, X-linked types as DFNX and Y linked types as DFNY. 
Furthermore, modifier loci (DFNM) and a locus for auditory neuropathy (AUNA) 
have been registered.'8 
Since the early 1990s, genetic linkage and mutation analyses have been applied to 
increase our knowledge of hereditary nonsyndromic hearing impairment. Rapid 
progress has been made and over 100 types of nonsyndromic sensorineural hearing 
impairment have been identified. 
In some families showing a similar phenotype, the (autosomal dominant or 
recessive) sensorineural hearing loss was linked to overlapping chromosomal 
regions and t w o or more different loci were assigned. Subsequently, when the 
underlying gene was identified and appeared to be identical, the t w o loci names 
were combined. This occurred for example in DFNA6/14/38, DFNA8/12, DFNA20/26, 
DFNBS/ioandDFNBy/n.'8 
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Currently, 54 loci and 25 genes have been identified in nonsyndromic autosomal 
dominant types of hearing impairment. In nonsyndromic autosomal recessive 
hearing impairment, 71 loci and 42 genes have been described. For an up-to-date 
overview of known hearing impairment loci see "hereditary hearing loss homepage" 
at http://hereditaryhearingloss.org.'8 On this website the precise anatomical location 
of expression of deafness genes in the cochlea is visible as well. 
Genes involved in nonsyndromic hearing impairment can be divided into different 
classes determined by the function of the protein they encode in the inner ear:'9 
• The fol lowing genes encode proteins associated wi th hair bundle morphogenesis: 
0 cytoskeletal components ACTGi, DIAPH1, ESPN, RDX, TRIOBP, CCDC50 
o adhesion proteins CDH23, PCDHis, TMHS 
o motor proteins MYO3A, MY06, MYO7A MYO15A, MYHg 
o scaffolding proteins WHRN, USHIC 
• Extracellular matrix components (TECTA, C0biA2, OTOA, COCH, STRC) 
• Proteins involved in maintaining ion homeostasis (CJB2, CJB3, CJB6, CJAi, KCNO4, 
SLC26A4, SLC26A5, CLDN14, TRIG, CRYM, WFSi) 
• Genes encoding for transcription factors (POU3F4, POU4F3, EYA4, TFCP2L3, ESRRB) 
• Genes wi th a poorly understood function (TMPRSS3, TMCi, MYO1A, MYH14, DFNA5, 
PJVK, TMIE, OTOF) 
Clinical description 
There is wide variation in the phenotypic presentation of autosomal dominant 
types of hearing loss. These types of hearing impairment especially can be 
characterized by audiometrie configuration, age of onset (congenital, early, late 
onset), degree of progression, and severity of hearing impairment (according to the 
GENDEAF criteria: mild, 20-40 dB; moderate, 41-70 dB; severe, 71-95 dB; profound, 
>95dB). io 
In general, autosomal dominant types of hearing impairment are postlingual and 
progressive wi th variable audiometrie presentations, while in autosomal recessive 
types the hearing is mostly severely impaired and stable wi th a congenital or 
prelingual onset. 
Based on the clinical findings, it is regularly possible to make an initial guess at the 
most probable underlying genetic defect.21 To improve such speculation and to 
learn more about the natural course of these types of genetic hearing loss, geno-
type-phenotype correlation studies on hearing impaired families are useful. 
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The Age-Related-Typical-Audiograms (ARTA) is a method to characterize the natural 
course of hearing impairment in a family. ARTAs of different families with a defect 
in a specific gene can also be compared.2' " This knowledge is helpful for genetic 
counseling purposes. An audioprofile in the form of an ARTA can also be used to 
predict in a specific family which gene might be involved in the hearing impairment 
and guide efficient gene-linkage strategies.23 In addition, the program AudioCene 
can be accessed on the Internet (http://audiogene.eng.uiowa.edu) to perform 
automatic audioprofile analysis of the family's (audiological) phenotype. 
Function of the inner ear 
The cochlea is a f luid filled tube coiled in a spiral shape around the modiolus. This 
tube is longitudinally divided into three compartments: scala media (filled with 
endolymph) and t w o larger perilymphatic filled compartments, the scala vestibuli 
and scala tympani. The organ of Corti resides in the scala media and contains three 
rows of outer hair cells (OHC) and one row of inner hair cells (IHC). The tectorial 
membrane is an extracellular matrix that lies over the stereocilia of the OHCs (fig.i). 
Sound transmission via the eardrum and middle ear to the cochlea generates 
movements of the endo- and perilymphe. This mechanical stimulation deflects the 
basilar membrane and the stereocilia bundle of hair cells. This results in an influx of 
K+ and Ca2* that depolarizes the cell and triggers the release of neurotransmitter at 
the basal pole of the hair cell. IHCs are the major acoustic sensors, the OHCs increase 
the sensitivity and frequency selectivity of the cochlea.24 
This PhD thesis focuses on phenotype descriptions of DFNA2, DFNA8/12, DFNA15, 
DFNA20/26, DFNB7/11 and Nathalie syndrome: four types of nonsyndromic autosomal 
dominant hearing impairment, one type of nonsyndromic autosomal recessive 
hearing impairment and one type of syndromic hearing impairment that probably 
inherits as an autosomal recessive trait. 
An overview of these hearing impairment disorders is given below. 
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Fig. 1 Overview of cochlea and organ of Corti. This figure has been copied by 
courtesy of Nager CT: Pathology of the ear and temporal bone. Baltimore, 
Maryland, USA, Williams&Wilkins.iggj.25 
(Perilymph) 2ona Pedinata 
DFNA2 
Clinical characteristics 
The phenotypic expression of mutations in the KCNO4 gene is a symmetric, 
predominantly high-frequency sensorineural hearing loss (SNHL) that is progressive 
across all frequencies.26"7 At younger ages, hearing loss tends to be mild in the low 
frequencies and moderate in the high frequencies; in older persons, the hearing 
loss is moderate in the low frequencies and severe to profound in the high 
frequencies and the audiogram has typically a down-sloping configuration."· 46'4β 
Congenital onset of DFNA2 hearing loss has been reported in one of the Dutch 
families (family Dutch IV) with the p.Trp276Ser variant3134, but not in other families 
with this mutation. It seems likely that hearing is impaired from birth, especially at 
17 
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high frequencies. Most affected persons initially require hearing aids to assist with 
sound amplification between the ages of ten and 40 years."·4 8 By the age of 70 
years, all persons wi th DFNA2 hearing loss have severe to profound hearing 
impairment. 
Speech recognition scores were relatively good given the pure-tone thresholds 
(Dutch families III and I V ) . ^ 
Vestibular testing was described in 37 members of family Dutch V and in 11 members 
of family Dutch IV and revealed increased vestibulo-ocular reflex activity in 
approximately one third of the cases.32 36 
Genetic aspects 
The DFNA2 locus was identified in 1994 and mapped to chromosome ip34 in 
Indonesian and American families segregating autosomal dominant sensorineural 
hearing loss. Their hearing loss first and mainly affected the high frequencies during 
their teens or 20s and became profound within io years.38 
At least t w o genes responsible for hearing loss have been identified at the DFNA2 
locus: the connexin3i gene (GJB3) which encodes a gap junction protein4 9 and the 
KCNO4 gene which encodes a member of the K+ channel family, KCNO4, a 
voltage-gated potassium channel. , 8 '2 7 
Xia et al. described 2 unrelated Chinese families w i t h autosomal dominant hearing 
loss.49 The deafness was characterized by progressive high frequency hearing loss in 
adulthood, w i t h milder expression in females. Heterozygous mutations in the CJB3 
gene on chromosome ip35 were identified. This hearing loss phenotype caused by 
mutations in GJB3 is now called DFNA2B. 
However, mutations in KCNQ4 on chromosome ip34 are the predominant cause of 
hearing loss at the DFNA2 locus; this phenotype is called DFNA2A. '8 
It has previously been postulated that a third hearing impairment gene resides at 
the DFNA2 locus gene; an Indonesian family was linked to the region but a mutation 
in either known gene could not be found.5 0 Also, an American family wi th 
nonsyndromic, autosomal dominant progressive high-frequency hearing loss was 
linked t o t h e DFNA2 locus, but in both deafness genes no disease-causing mutations 
could be identified.3 9•5 1 
Recently, Jiang et al identified a locus on chromosome 1P34.2-P34.3 in a Chinese 
family segregating dominant, post-lingual, moderate to severe, bilateral hearing 
loss. Although this locus overlaps wi th DFNA2 they could not find a variant in the 
18 
GENERAL INTRODUCTION 
KCNO4 and GJB3 genes up to now and also they suggested there might be another 
deafness gene in this chromosomal region.52 
Up to now, more than 15 DFNA2A/KC/V04 families have been reported worldwide.26 
47
 The families originated from The USA, The Netherlands, Belgium, France, Spain, 
Japan and China (see Table 1). 
15 different mutations in the KCNQ4 gene were reported in association wi th DFNA2A 
hearing loss. These include missense, frameshift, nonsense and splicing mutations. 
Most pathologic allelic variants cluster in exons 5, 6, and 7 of KCNO4. These exons 
encode highly conserved amino acid sequences that form the channel pore. 
The predominant pathologic allelic variants are missense mutations that induce a 
dominant-negative effect. The p.Trp276Ser mutation appears to be most common, 
it has been identified in three of six unrelated Dutch families wi th DFNA2 non-
syndromic hearing loss (see Table 1). 
Three deletions in KCNO4 have been described.26·41 45 Clinically, patients wi th 
deletions have milder hearing loss than patients wi th missense mutations.40 " It is 
characterized by better low frequency hearing but more rapid high frequency 
deterioration when compared wi th the hearing loss phenotype in families in which 
missense mutations segregate wi th the hearing impairment.3''J2•** 
The function of KCNO4 
KCNO4 channels belong to the family of voltage-gated potassium channels and 
KCNO4 forms a potassium channel that consists of six transmembrane domains 
(S1-S6) and a K+ selective pore (P-loop). The protein assembles as a tetramer to form 
a potassium channel made of four subunits which must assemble correctly to form 
a functional channel that is involved in K+ recycling in the inner ear. 
In a person wi th a missense mutation in one allele, half of the total amount of 
encoded protein is defective and consequently only one of every 16 channels 
comprises four normal protein subunits.27 Most missense mutations associated 
with DFNA2 affect amino acids located wi th in or close to the channel pore and 
directly affect the selectivity filter for K+ ions.48 
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T a b l e I O v e r v i e w o f m u t a t i o n s d e s c r i b e d in DFNA2 f a m i l i e s 
( a d a p t e d f r o m S m i t h et al."8) 
DNA Nucleotide Change Protein Amino Acid Change Protein Domain 
c.2ii_223del 
(2ndeli3) 
c.2iidelC 
c.546C>G 
c.667_684del 
(664_68idel) 
c.778G>A 
c.785A>T 
c.725G>A 
c.82iT>A 
p.Gln7iProfsX64 
p.Gln7iSerfsX68 
p.Phei82Leu 
p.Thr223_Gly228del 
p.Glu26oLys 
p.Asp262Val 
p.Trp242X 
p.Leu274Hls 
N-terminal cytoplasmic 
N-terminal cytoplasmic 
S3 transmembrane domain 
Intra-membrane loop (S4-S5) 
S5 transmembrane domain 
S5 transmembrane domain 
S5 transmembrane domain 
P-loop 
c.827G>C p.Trp276Ser P-loop 
c.842T>C 
c.853G>T 
c.853G>A 
c.859G>C 
c.886G>A 
c.96iG>A 
p.Leu28iSer 
p.Gly285Cys 
p.Gly285Ser 
p.Gly287Arg 
p.Gly296Ser 
p.Gly32iSerS6 
P-loop 
P-loop 
P-loop 
P-loop 
Channel pore 
transmembrane domain 
The m u t a t i o n s m i g h t e x e r t s t r o n g d o m i n a n t n e g a t i v e e f f e c t s . 2 6 2 8 · 3 0 ' 3 ' ΐ 4 4 α 4 ' · 4 3 · " 
A n u m b e r o f d e l e t i o n s in KCNQ4 cause f r a m e s h i f t s t h a t resul t in t r u n c a t e d channels 
t h a t are n o n f u n c t i o n a l 2 6 - 4 ' '5 3 a n d resul t in h a p l o i n s u f f i c i e n c y . The p h e n o t y p e 
ref lects a d o s a g e e f f e c t . As a resul t , cells o f t h e i n n e r ear p r o d u c e i n s u f f i c i e n t 
f u n c t i o n a l KCNO4 p r o t e i n a n d over t i m e a u d i t o r y f u n c t i o n is c o m p r o m i s e d . 4 8 
Extensive analysis o f m u r i n e Kcnq4 express ion in t h e i n n e r ear s h o w e d i ts expression 
in b o t h i n n e r a n d o u t e r hair cells. There are l o n g i t u d i n a l g r a d i e n t s a l o n g t h e cochlear 
d u c t , i n v o l v i n g m o s t a b u n d a n t e x p r e s s i o n in i n n e r ear hair cells a t t h e base o f t h e 
cochlea a n d in o u t e r hair cells a t t h e apex. 5 4 Potass ium c h a n n e l s recycle K+ and set 
t h e r e s t i n g m e m b r a n e p o t e n t i a l o f hair cells.5 5 The loss o f KCNO4 channel a c t i v i t y 
20 
GENERAL INTRODUCTION 
Origin 
Belgian 
Japanese 
Taiwanese 
South Korean 
North American 
North American 
North American 
Dutch (family III and VI) 
Dutch (family 1, IV 
North American 
North American 
French 
North American 
Spanish 
Dutch (family II) 
and V); Japanese 
Onset of Symptoms 
Adolescence 
Adolescence 
Childhood 
Childhood 
Childhood 
Childhood 
Childhood 
Childhood 
Childhood 
Childhood 
Childhood 
Childhood 
Childhood 
Childhood 
Childhood 
Reference 
Couckeet al., 1999 
Kamada é ta l , 2006 
Su et a l . , 2007 
Baeketal., 2010 
Hildebrand étal . , 2008 
Hildebrand et al., 2008 
Hildebrand étal . , 2008 
Van Hauwe et al., 2000; 
Ensinketal., 2000; 
de Heer et al., 2011 
Marres et al., 1997; Coucke et al., 
1999; Topsakal et al., 2005; 
Van Campetal . , 2002; 
de Leenheer et al., 2002; 
Akita étal . , 2001 
Talebizadeh et al., 1999 
Couckeet al., 1999 
Kubisch et al., 1999 
Arnett et al., 2011 
Mencia et al., 2008 
Coucke et al., 1999 
may lead to chronic Κ* overload in these cells and ensuing depolarization of outer 
hair cells that impairs sound amplification53,56 as has been studied in mice. There is 
a selective and progressive degeneration of outer hair cells and progressive hearing 
loss. Inner hair cells and their afferent synapses remain mostly intact." 56 
Nevertheless, other processes might contribute to the severe hearing impairment 
in DFNA2 since a complete loss of outer hair cells results in a hearing loss of 
approximately 30-50dB.5ä'57 
KCNQ4 is also expressed in vestibular hair cells58 however neither the Kcnq4 ' mice 
nor the dominant negative line showed vestibular symptoms.56 In two DFNA2 
families (Dutch I and Dutch IV), an increased vestibulo-ocular reflex activity has 
been measured."'6 
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In chapter 2.1 of this thesis an update on relevant DFNA2/KO\/04 audioprofiles is 
provided. In addition, we describe how in a small family (Dutch VI) with 
nonsyndromic autosomal dominant sensorineural hearing loss, for which genetic 
linkage analysis is no option, genetic analysis can be successful when there is a 
match with a specific DFNA audioprofile, in this case DFNA2.46 Alternatively, the 
specially developed program AudioGene can be accessed on the Internet (http:// 
audiogene.eng.uiowa.edu/) to perform automatic audioprofile analysis of the 
family's (audiological) phenotype.i3 
DFNA8/12 
Clinical characteristics 
In the mid 90s of the last century two families were reported with an autosomal 
dominant nonsyndromic sensorineural mid-frequency hearing impairment: an 
Austrian family (DFNA8)« and a Belgian family (DFNA12).60 When in both families 
linkage to chromosome nq22-24 was found and the earlier reported locus in the 
Austrian family on chromosome i jq was abolished59, the locus was designated as 
DFNA8/12 after the causative mutations for both families were shown to be located 
in the same gene (TECTA).6'6! 
Since then, other mutations leading to DFNA8/12 were reported in families 
originating from the UK, Sweden, Spain, France, The Netherlands, Belgium, Turkey, 
Iran, Lebanon, Pakistan, Korea, Japan and the USA.62 76 
DFNA8/12 is characterized by two distinct types of hearing impairment. It can present 
as a typical prelingual, mid-frequency ('cookie-bite') hearing impairment or it can 
primarily affect high frequencies. Both progressive and stable impairment have been 
described.6276 Speech recognition scores are almost normal in the families with a 
cookie-bite configuration audiogram and a mutation in the ZP domain of TECTA59 67 70 
or a mutation that is predicted to affect a region adjacent to this domain.72 " 
Vestibular dysfunction does not seem to be a feature in DFNA8/12. Sporadic 
dizziness (Spanish family66; Dutch family73) and/or a late walking onset (French 
family65) were mentioned in 3 families and could suggest vestibular dysfunction. 
Nevertheless, in two DFNA8/12 families vestibular testing, that comprised caloric 
and rotatory tests, did not reveal any vestibular abnormality.67·70 To find a possible 
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otolith dysfunction, more extensive vestibular function examination, including 
otolith reflex tests are required. 
The function of TECTA 
DFNA8/12 is caused by mutations in TECTA61 " which has been mapped to the 
chromosomal locus iiq22-24.59-60 
TECTA encodes a-tectorin, which is the most important non-collagenous component 
of the tectorial membrane in the cochlea and in the otoconial membrane in the 
maculae of the vestibular labyrinth. The tectorial membrane consists of an 
extracellular matrix that lies over and is connected to the stereocilia of the OHCs of 
the organ of Corti. It is critical for the mechanical intracochlear sound transmission 
and amplification by ensuring optimal cochlear feedback.6 '78 
The a-tectorin protein comprises three distinct modules linked by disulfide bridges: 
the entactin Ci domain, the Zonadhesin (ZA) domain (with von Willebrand factor 
(vWF) type C and type D repeats), and the zona pellucida (ZP) domain.79 
Missense mutations of TECTA cause autosomal dominant nonsyndromic hearing 
impairment (DFNA8/12), whereas nonsense (inactivating) mutations cause 
autosomal recessive nonsyndromic hearing impairment (DFNBzi).6276 
The clinical presentation of a mutation in the TECTA gene is influenced by the 
precise location of the affected residue in the a-tectorin protein. 
Until recently, 13 TECTA mutations associated wi th DFNA8/12 were documented and 
the established genotype-phenotype correlations indicated that missense 
mutations in the ZA domain are associated wi th hearing impairment that primarily 
affects the high frequencies.65 7C7 ' '80 In addition, missense mutations that affect 
the ZP domain of the protein are associated wi th a prelingual, stable, mid-frequency 
("cookie-bite") hearing impairment, if cysteine residues are replaced the loss is 
progressive.59·6'67'69 '' Prior to the publication of Hildebrand et al.,76 only missense 
mutations in the ZP domain of TECTA were known to cause typical mid-frequency 
hearing loss. However, Hildebrand et al identified 20 novel TECTA mutations in 
DFNA8/12, including the first mutation in the entactin domain.76 Moreover, they 
described that mutations in the entactin domain, and in the Zonadhesin (ZA) 
domain (i.e. vWFDi and vWFDi) can lead to a mid-frequency hearing loss as well. 
Consequently, mid-frequency hearing impairment in DFNA8/12 is not only 
associated wi th mutations in the ZP domain anymore. 
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Genetic and functional aspects 
In human, functional null mutations and missense mutations in TECTA are 
responsible for a variety of hearing impairment phenotypes. 
Mouse models have been studied to understand the function of the tectorial 
membrane in hearing.78·8,•82 Several roles for this membrane have been suggested: 
it may act as a stiff layer that slides over the epithelium as the basilar membrane 
vibrates,as it may function as a second resonator that amplifies the input to the hair 
cells,84 or it may behave as an inertial mass.85·86 
A potential role for the recessive mutations, that are predicted to be inactivating 
and to cause moderate-to-severe hearing impairment in humans, is demonstrated 
in mice that are homozygous for a deletion that removes the entactin Gi-like 
domain of a-tectorin (ΔΕΝΤ). These functional null mice (TectaA£N7/ACNT) have 
tectorial membranes that are detached from the cochlear sensory epithelium and 
lack all tectorin-based features (non-collagenous matrix). Heterozygous mice 
(TectaAENTU) have intact tectorial membranes and normal hearing.78 8 6 In humans, 
homozygosity for recessive, predicted null alleles of a-tectorin might have a 
comparable effect on the tectorial membrane.6 8 
The Tectd',S7oC'* mouse serves as a model for a dominant missense mutation in 
TECTA associated wi th DFNA8/12 (prelingual, moderate-severe stable hearing loss). 
Mice heterozygous for this mutation have a disrupted structure of the tectorial 
membrane, a reduction in thickness caused by delamination of the lower layer that 
normally lies in close contact wi th the hair cells.8' These abnormalities do not 
influence the sensory transduction by OHCs, however, the OHCs are the source of 
amplification in the cochlea. The tectorial membrane is critical in shaping the 
frequency tuning of the cochlea's neural responses through its interaction with the 
inner hair cells. The tectorial membrane also ensures that feedback from the OHCs 
is delivered to the basilar membrane at the correct t ime and wi th optimal gain and 
the IHCs are stimulated at their best frequency. When the tectorial membrane does 
not function optimally, the sensitivity and frequency tuning of the cochlea becomes 
impaired.8' 
Mice homozygous for a Y1870C mutation (Tecta*'8701- ' '''S7oC) show a completely 
detached tectorial membrane.8' In humans, homozygosity has been found in 
DFNA8/12.76 The homozygous family members had more severe hearing loss than 
the older heterozygous family members. This suggests a dosage effect on tectorial 
membrane function.7 6 
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Tecta0*090'* mice have partial hearing loss secondary to a shortened tectorial 
membrane that only contacts the first row of OHC's.87 The Turkish DFNA8/12 family 
wi th this mutation (ZA domain) showed a prelingual, mild-to-severe progressive 
high frequency hearing loss.69 Based on studies in the Tectac'S09C/~' mice, it has been 
suggested that uncoupling the tectorial membrane from the OHCs leads to partial 
hearing loss but also places the remaining coupled OHCs at higher risk for 
susceptibility to chronic acoustic trauma since less OHCs are able to share the load 
of applied force created by noise. Higher levels of OHC loss were found in the middle 
region.87 This is consistent wi th the mid-frequency hearing loss that can be found 
in patients wi th TECTA mutations.59-63'66·67'70'7274·77 
Vestibular dysfunction does not seem to be a feature in DFNA8/12, although in 
mice, a-tectorin is expressed in the vestibular organ (utricular and saccular maculae) 
and it is a component of the otoconial membrane.78 
Chapter 2.2 of this thesis describes a new mutation in a Dutch DFNA8/12 family, 
which was shown to affect splicing of the TECTA transcripts. Although the novel 
mutation did not affect amino acids within the ZP domain of a-tectorin, the 
phenotype was fairly similar to the phenotypes previously described for mutations 
that affect the ZP domain.7 2" 
DFNA15 
Clinical characteristics 
The autosomal dominant nonsyndromic sensorineural hearing impairment DFNAis 
is characterized by a bilateral progressive sensorineural hearing impairment, w i th 
an onset in early adulthood to midlife.8892 Most often a high-frequency type of 
hearing impairment is observed, however, mid-frequency and flat audiometrie 
configurations also occur.8892 The hearing impairment progresses rapidly at high 
frequencies.9' 
Up to now, four DFNA15 families have been reported.88 9092 The first description is 
on an Israeli family. The affected family members presented wi th bilateral 
progressive high-frequency sensorineural hearing impairment starting from young 
adulthood.88 8 9 · 9 3 A second family has been identified in the Netherlands. The 
phenotype was variable, but overall, the audiograms showed a flat to down-sloping 
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configuration, an early-adult to mid-life onset of hearing loss and significant 
progression.90 In a third DFNA15 family9', also from the Netherlands (chapter 2.3), 
the clinical symptoms were less severe, but quite similar to those described in the 
Israeli and first Dutch reports.8890 9ï Most often, the affected family members of 
the third DFNA15 family showed a high-frequency hearing loss and an early-adult to 
mid-life onset. Remarkably, the low and mid frequencies are less affected in this 
third family.9' In both Dutch families, some individuals reported an onset of the 
hearing impairment in childhood.9C· 9'The most recent report on DFNA15 originates 
from Korea. In 42 unrelated Koreans with autosomal dominant nonsyndromic 
hearing loss mutation analysis was performed on the POU4F3 gene and a novel 
deletion was identified in one person. The hearing impairment was noticed since 
the age of 20, the audiogram had a down-sloping configuration with residual 
hearing in the low frequencies. Speech recognition scores could not be obtained. In 
this family, another four individuals suffered from hearing loss; they were not 
investigated.92 
Speech recognition scores in DFNA15 are generally fairly good.889' 9ì In the two 
Dutch families, vestibular symptoms were reported.90 9 '94 Vestibular function tests 
in the mutation carriers revealed hypofunction of the labyrinth in the majority of 
the individuals of the first Dutch family.90 94 
Hence, DFNA15 has been assigned the third cochleovestibular disorder besides 
DFNAgandDFNAn.94'00 
Genetic aspects 
The DFNA15 locus has been mapped to human chromosome 5q3i. Here the POU4F3 
gene resides that encodes the transcription factor POU4F3. This protein is composed 
of 2 highly conserved DNA-binding domains: the POU-specific DNA-binding domain 
and the POU-homeodomain. 
In the Israeli family, an 8 base-pair deletion was found in the POU4F3 gene (884del8). 
This mutation causes a frameshift that results m premature termination of POU4F3 
protein synthesis which is predicted to result m a protein that lacks part of the POU 
homeodomain.88 '0' 
In the first Dutch family, a missense mutation (L289F) was found in the POU4F1 
gene which is predicted to affect the POU-homeodomain and the DNA-binding 
capacity of the POU4F3 protein.102. In the second Dutch family a novel mutation in 
POU4F3 was found (L223P) that alters the POU-specific domain, (chapter 2.3)9' '02 
It has been predicted that the missense mutations affect the tertiary structure of 
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these domains in the protein.'02 All mutant proteins were found to be less capable 
of activating reporter genes than the wild-type protein and were partially 
mislocalized outside the nucleus."5,io2 These findings indicate that these mutations 
affect proper functioning of the POU4F3 protein."" 
Collin et al predicted that the L289F mutat ion (Dutch I) causes a more pronounced 
deleterious effect than the L223P mutat ion (Dutch II) on the ability of the POU4F3 
transcription factor to bind target DNA, resulting in lack or decrease of reporter 
gene expression, respectively.'02 The variation in severity of the clinical presentation 
in the two Dutch families might be explained by the differences in reporter gene 
expression. 
In the Korean study, mutation analysis of the POU4F3 gene revealed a deletion 
(c.662deh4) in exon 2 (POD specific domain). This is predicted to result in a truncated 
protein that lacks both functional POD domains. In vitro, the mutation has a 
detrimental effect on nuclear localization and transcriptional activity, it fails to 
activate reported gene expression.92 
The function of POU4F3 
The POU4F3 gene encodes a member of the POD family of transcription factors that 
have an important function in tissue-specific gene regulation.'01 POU4F3 plays a 
central role in the development, differentiation and survival of hair cells in the 
human and murine inner ear sensory epithelia.103 '05 
In mice, Pou4f3 (also called Brns.i or Brnjc) is expressed in the inner and outer hair 
cells of the cochlea and labyrinth. In Pou4f3 knock-out mice {Brnjc') auditory and 
vestibular hair cells are completely absent, which results in profound deafness and 
impaired balance. Heterozygous Brnsc*' mice show no obvious hearing problems.'06 
107
 In humans the vestibular dysfunction is less prominent than in mice. Possibly, 
heterozygous mutat ion carriers might still have a sufficient amount of functional 
POU4F3 protein to maintain vestibular function to a certain degree. 
In chapter 2.3 of this thesis the cochleovestibular characteristics in a Dutch DFNA15 
family that carries the missense mutat ion L223P are described.9' 
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DFNA2O/26 
Clinical characteristics 
The autosomal dominant type of nonsyndromic hearing impairment DFNA20/26 is 
characterized by progressive sensorineural hearing impairment at all frequencies, 
w i t h predominant involvement of the mid and high frequencies. The onset age is 
between the first and third decade. Hearing deteriorates severely over a few 
decades of life, w i t h annual threshold deterioration (ATD) values of 2-6 dB eventually 
leading to residual hearing.108 "7 
Speech recognition scores remain good at given pure tone averages,"2 "' however, it 
can become problematically low (maximum phoneme recognition score of less 
than 50%) from the age of 25 to 45 years onwards."2 The combination of the 
postlingual onset of the hearing impairment and low speech recognition scores have 
resulted in implantation of a cochlear device in several DFNA20/26 individuals.'0 9"7 
Vestibular examination revealed no significant vestibular involvement, although 
vestibular symptoms have been reported in DFNA20/26."2 "7 
The first clinical report on a DFNA20/26 family came from Norway in 1968. The 
affected family members displayed a progressive hearing impairment that begins 
in the high frequencies and starts in the first or second decade, and by the age of 20 
years most of the affected family members needed a hearing aid.'0 8 The causative 
genetic defect in this family was identified in 2006.1 0 9 
In the beginning of this century, in three families the autosomal dominant 
postlingual progressive sensorineural hearing loss was linked to overlapping regions 
of chromosome i7q25. Two different loci were assigned: DFNA20 and DFNA26."3 "s 
"
8
 Zhu et al."0 and van Wijk et al.'" identified the underlying ACTGi gene simultaneously 
in 2003 and the locus was designated as DFNA20/26."3 Up to now, twelve DFNA20/26 
families have been described. They originate from Norway, The Netherlands, Spain, 
The USA and China.'08 , , 0 " ! "5"7 "' 
Genetic aspects 
The DFNA20/26 locus has been mapped to human chromosome ^ 2 5 . 3 . The gene 
responsible for hearing loss identified at this locus is the gamma-actin gene (ACTCi). 
Various mutations in the ACTGi gene have been described. There is a wide variation 
in DFNA20/26 phenotype associated w i t h these different mutations.'0 8 "7 
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The ACTCi gene consists of 6 exons'" and it encodes the protein γ-actin. Y-actin, a 
cytoskeletal protein, consists of two domains which can be divided in four 
subdomains: the outer domain comprises subdomaini and 2, the inner larger 
domain contains subdomains 3 and 4. Actin filaments are formed through the 
polymerization of actin monomers. The actin filament is a polar structure with a 
'barbed' end (subdomains 1 and 3), which is the preferred site for monomer addition 
during filament elongation and has been implicated in interactions with a number 
of proteins regulating actin polymerization in the cell. The 'pointed' end (subdomains 
2 and 4) is the preferred site of monomer release."' '23 
At present, eight missense mutations in ACTCi have been identified causing 
autosomal dominant sensorineural hearing impairment. These mutations are 
located in various subdomains of γ-actin: subdomain ι (I122V; T98I; Kn8M; K118N)"0 
114,1.5.12012._ subdomain 2 (ΟςιΝ),"7 subdomain 3 (T278I; P332A) "0 "2 and subdomain 4 
(P264L; E241K).,,0·,,3',2, The V370A mutation resides in the C-terminal.'08,09 
Functional analyses on yeast showed that mutations in ACTCi restrict cell growth.'09 
119.123 Severe growth inhibition was found in four γ-actin mutations (K118M, T278I, 
P332A, V370A) and mild growth impairment in two (T89I, P264L).'!3 No clear 
correlation was observed between the results of these functional growth assays 
and threshold deterioration in the corresponding ARTA of the DFNA20/26 families 
with the same mutation."7 
Morin et al. engineered two γ-actin mutations in yeast (K118N and E241K) and 
reported that the one with the stronger inhibitory effect on γ-actin function was 
associated with an earlier onset of hearing impairment."9'21 
The function of ACTGi 
In the cochlea hair cells are the most prominent structures containing γ-actin.'24 
Actin filaments are essential for the shape and function of the stereocilia of the hair 
cells. The stereocilia are anchored in the cuticular plate, which consists of a gel-like 
meshwork of actin filaments.'09 '23-124 It has been suggested that mutations in γ-actin 
cause hearing loss mainly by impairing the function and/or viability of hair cells.'09 '" 
All mutations in γ-actin reported to cause deafness are missense mutations.109 '" "3 
"4, «ι However, it has been predicted that these mutations only modestly affect 
structure and function of γ-actin. Hearing was found to be normal in juvenile γ-actin 
mutation carriers, which suggests that hair cells are fully functional. However, hair 
cells may be more susceptible to age-related degeneration.'09 The mutations may 
have an adverse effect on actin polymerization that leads to malformed or 
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structurally unstable stereocilia and/or disturbed interactions between actin and 
other proteins.'2' This may reduce the stability and impede repair of the cochlear cell 
structures (stereocilia) after noise damage or ageing."0 '2 , , 2 S 
Actgi knockout mice (Actgi') form functional, morphologically normal stereocilia 
and have normal hearing at young ages. However, they develop progressive hearing 
loss together wi th stereocilia degradation. Y-actin seems to have a critical role in 
maintenance of stereocilia.'2 5'2 6 
In chapter 2.4 of this thesis the audiological and vestibular findings in the second 
Dutch DFNA20/26 family w i t h a novel mutation in ACTGi (c.i5iG>A)"7 are described 
and compared to previously reported clinical data on other DFNA20/26 families. 
DFNB7/II 
Clinical characteristics 
The autosomal recessive nonsyndromic sensorineural hearing impairment DFNBy/n 
is characterized by a congenital or prelingual severe to profound hearing loss,'27'36 
affecting all frequencies.'3' It is caused by mutations in the transmembrane 
channel-like 1 gene (T/WCTJ.'32 
Worldwide, more than 50 DFNBy/n families have been reported that originated 
from Pakistan, Sudan, Turkey, Iran, Lebanon/Jordan, Tunisia, India, Greece and the 
Netherlands.'27'« 
The sensorineural hearing impairment in the Dutch DFNB7/11 family (chapter 3)'" 
had a postlingual onset and was progressive in contrast to the previously reported 
DFNB7/11 families and was more similar to phenotypes described for dominant 
TMO mutations (DFNA36). The hearing impairment started at high frequencies and 
rapidly progressed to residual hearing ('corner audiogram') in the second decade. 
The phoneme recognition scores probably started to deteriorate in the first decade, 
and the score deteriorated thereafter by about 2-3% per year up to the age of 30 
years. The phoneme recognition scores were very similar to those in presbyacusis 
patients at the same pure tone average (PTA) level. From the second decade hearing 
aids were necessary for proper communication.'3 7 No vestibular symptoms have 
been reported.'3 6 '3 7 
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Genetic aspects 
The DFNB7/11 locus has been mapped to human chromosome 9qi3-q2i. The gene 
responsible for hearing loss identified at the DFNB7/11 locus is the transmembrane 
channel-like 1 gene (TMO). The TMCi protein is predicted to contain 6 transmembrane 
domains.''2 Mutations in the TMO gene are associated wi th prelingual autosomal 
recessive profound deafness (DFNB7/11) and with postlingual progressive autosomal 
dominant (DFNA36) sensorineural hearing loss.1'2 
More than 30 different mutations in the TMCi gene have been reported.'27 '". Some 
of the mutations recurred in different families, suggesting a founder effect. ,2B, Î2 ,36 
A postlingual onset and progression of the hearing impairment was reported in the 
Dutch family. As an explanation for this different phenotype it has been suggested 
that in individuals carrying this mutation there is still a certain amount of normal 
TMCi protein sufficient for hearing at young age or that the mutant TMCi transcript 
is not completely degraded and that the resulting protein has some residual 
function.1" 
A milder hearing impairment was found in an Iranian DFNB7/11 family, in the 
moderate-to-severe range and preserving the higher frequencies and a possible 
genetic modifier effect was proposed.'36 
The function of TMCi 
Tma is expressed in the IHCs and OHCs of the murine cochlea and the hair cells in 
the vestibular labyrinth. The precise function of TMCi remains to be determined, 
but the transmembrane proteins encoded by the TMC gene family are thought to 
act as ion channels, ion pumps or transporters.'38,39 
Two mouse models for hearing impairment caused by a defect in Tma have been 
studied.''2"10 The Beethoven (Bth) mouse mutant carries a heterozygous mutation 
in Tma (P.M412K). Tma8'h/* mice are considered to be a model for progressive 
hearing loss (DFNA36). They showed progressive hair cell degeneration, mainly 
affecting inner hair cells, starting from postnatal day 20 onwards. Before 
degeneration initiated, hair cells seemed to function normally."10 
The deafness {dn) mice are considered to be a model for recessive hearing 
impairment DFNB7/n (deletion in the Tma gene which is predicted to result in a 
frameshift and premature termination of the Tmci protein).''2 In homozygous 
jmadn/dn r n j c e c o chlear hair cells develop normally, but cochlear responses are 
completely lacking.'4''43 Besides early hair cell degeneration of the organ of Corti, 
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occasionally degeneration of the vestibular saccular maculae is observed ten days 
after birth." 1 ' · '^ Despite this observation, the phenotype of both mutant mice 
(Tma""'"" and Tmcf""*) does not seem to be associated wi th vestibular deficits.'3 1'4 0' 
143
 Taken together, the studies performed in the Beethoven and deafness mice 
support a role for Tma in the inner and outer hair cells, either in proper trafficking 
of other membrane proteins in these cells, or in regulating the differentiation of 
immature hair cells into fully functional auditory receptors.'44 
Chapter 3 of this thesis describes a Dutch DFNB7/11 family whose hearing impairment 
is caused by a novel mutat ion in the known deafness gene TMCi (c.i763+3A>G). 
Although the novel mutat ion was inherited in an autosomal recessive pattern, the 
phenotype was more similar to the phenotypes described for dominant TMCi 
mutations (DFNAje).'37 
Nathalie syndrome 
Nathalie syndrome was first described in 1975 by Cremers et al. Four sibs in a family 
of Dutch and Ukrainian descent were reported.'4 5 The assumed pattern of inheritance 
is autosomal recessive. At that time, the oldest one of the four individuals described 
was 20 years old. The affected family members presented w i t h sensorineural 
hearing loss (SNHL), cataract formation, muscular atrophy, skeletal abnormalities, 
retardation of growth, underdeveloped secondary gender characteristics and elec­
trocardiographic abnormalities. This condition was called "Nathalie syndrome" 
after the oldest affected child.'45 The syndrome is rare and exhibits autosomal 
recessive inheritance.12·'45 It comprises a combination of features that does not 
resemble any other known syndrome and is as such an independent, rare entity. To 
our knowledge this is the only family wi th this specific combination of symptoms.12 
The underlying genotype that causes Nathalie syndrome is not yet known. The 
rarity of this syndrome and the small size of the family w i t h only 4 affected 
individuals restricted in the past the identification of the mutant gene involved. 
Only recently, blood samples for a DNA extraction have been taken from the only 
surviving affected member of the family, a healthy sister and the mother. 
In Chapter 4 of this thesis we provide a clinical follow-up on the affected siblings in 
this family. An update of the family history reveals that 3 out of the 4 affected 
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children in this sibship passed away. Follow up shows they are at risk to develop 
cardiomyopathy and have a risk of sudden death or death from heart failure. 
An extensive cardiologie evaluation of the youngest affected sister is given. 
In addition, one of the deceased affected individuals had donated her body for 
medical research. The outcome of the autopsy and especially the histopathological 
findings of the temporal bone are described. These findings are related to the 
clinical presentation of her hearing impairment. 
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CHAPTER 2 ι 
Abstract 
We undertook this study to show that in a family w i t h nonsyndromic autosomal 
dominant sensorineural hearing loss, genetic analysis can be successful when there 
is a match w i t h a specific DFNA audioprofile. We also provide an update of relevant 
DFNA2/KCNO4 audioprofiles and report the results of automatic audioprofile analysis 
using the Internet program AudioGene. 
Audiometrie data and blood samples were obtained from the family W08-0384. 
Based on the audiograms of the affected participants, mutation analysis of KCNO4 
was started. Original audiometrie threshold data were collected for all identified 
KCNQ4-related DFNA2 families The Internet computer program AudioGene, recently 
developed for automatic audioprofile analysis, was accessed. 
The family's audioprofile and the program AudioGene predicted the DFNA2/KCNO4 
locus. Mutat ion analysis of KCNQ4 revealed a c.82iT>A (p.Leu274His) mutation of 
the KCNO4 gene. This mutat ion has been previously identified in a Dutch family. 
Genetic analysis revealed a common haplotype in these t w o families over a region 
including the KCNO4 gene. 
Familiarity w i t h the audioprofiles of DFNA traits may lead to successful mutation 
analysis of the gene involved, even in a small family in which genetic linkage 
analysis is not an option. Alternatively, the specially developed program AudioGene 
can be accessed on the Internet to perform automatic audioprofile analysis of a 
family's (audiological) phenotype. 
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Introduction 
The causes of nonsyndromic autosomal dominant sensorineural hearing loss are 
very heterogeneous Based on gene linkage studies, more than 50 types of DFNA 
have been identified To date, 24 genes for DFNA loci have been identified ' 2 
Successful gene linkage analysis usually requires the participation of about 7 to 15 
affected family members Linkage analysis is not sufficiently informative if a smaller 
number of participants is available However, this type of analysis maybe skipped if 
there is reason to believe that a particular candidate gene is involved This can be 
the case if the phenotype is characteristic for a common type of mutation in the 
underlying gene The key phenotype feature for DFNA loci is the audiogram The 
audioprofile3, or Age Related Typical Audiograms (ARTA)" 5 covers either the typical 
average audiogram m a stable type of hearing impairment or a set of audiograms 
that characterizes progression in hearing impairment with advancing age, in case 
the latter is substantial Familiarity with the audioprofiles of various DFNA types is 
needed to be able to select a suitable candidate for successful mutation analysis 
This report shows that the strategy of audioprofile-directed mutation analysis 
succeeded in a new, small DFNA2 family An updated survey of genotype-pheno-
type correlations m DFNA2/KC/VO4 is therefore included The present approach is 
not unlike the one followed in a previous study on a KC/V04-related DFNA2 trait 
reported by Topsakal et al6 A different approach underlies the identification by 
Hildebrand et al of 3/CCWO -^related DFNA2 traits'These authors used audioprofile 
analysis performed by a prototype of the program AudioCene The program 
performs cluster analysis on audiogram data and does not require the user to be 
familiar with the details of documented audioprofile data For the sake of 
comparison we used the presently accessible Internet version of this computer 
program (AudioCene V3 o)8 
Patients and methods 
The hearing impaired father (proband) and his hearing impaired son from the 
present family were referred by a general otolaryngologist m an attempt to trace the 
genetic cause of their sensorineural hearing impairment The family history 
(W08-0384) revealed that the mother of the proband, a brother of this mother and 
the only brother of the proband were also hearing-impaired Together with the 
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other, normal-hearing family members, they were included in a detailed family 
study. The study was approved by the local medical ethics committee (Commissie 
Wetenschappelijk Onderzoek bij Mensen, project number 9504-052i).The medical 
history of this family covered 4 generations, including a deceased hearing-impaired 
grandparent in the oldest generation. Previous audiograms were requested where 
available. Pure tone audiograms were obtained in a sound-treated room under 
standard conditions. Genomic DNA was isolated from peripheral blood samples by 
standard techniques. The coding exons 1, 5, 6 and 7 (containing all of the published 
mutations) of the KCNO4 gene (NM_oo4700.2 NCBI) and their flanking intron 
sequences were amplified by polymerase chain reaction (PCR). A DNA sequence 
analysis was performed wi th a 3730 automated sequencer and the BigDye Terminator 
kit according to the specifications of the manufacturer (Life Sciences, Foster City, 
California). Primer information and PCR conditions are available on request. 
Microsatellite markers flanking the KCNQ4 gene, more specifically 0152743, D1S2706, 
DiSii88 and D1S2722, were genotyped under standard PCR conditions, separated on 
an ABI Prism 3730 Genetic Analyzer and analyzed wi th the GeneMapper program 
according to the manufacturer's protocol. (Life Sciences). 
Threshold data 
Original threshold data (binaural average at the frequencies 0.25, 0.5,1, 2, 4 and 8 
kHz) were collected for all identified and retrievable DFNA2/KCNQ4 families 
documented so far. These included our own original data, original data obtained 
from others by personal communication as specified in previous publications, or 
data from published papers using table entries or plotted data points. 
Age Related Typical Audiograms (ARTA) 
Age classes were defined wi th attempted center ages of 5,10, 20, 30,40, 50, 60 and 
70 years. All of the threshold data that were available for a given family were 
collected and distributed across the intended age classes. Each individual was 
represented with in each age class by one audiogram at the most. For each age class 
in each family, the mean (binaural average) threshold and SD were calculated. These 
were used for linear regression analysis (age and threshold) to establish ARTA.4 
AudioCene audioprofile analysis 
The computer program AudioGene V3.0 that was recently developed for automatic 
audioprofile analysis8 was accessed at the website: http://audiogram.eng.uiowa. 
46 
AUDIOfROFllF DIRECTED MUTATION ANALYSIS iN DF\A2 
edu. For the sake of comparison, the same last-visit threshold data that were 
available for the individuals 11.1,11.3,111.5, and II 1.6, which had prompted us to perform 
mutation analysis of KCNO4, were used as input to this program (now separately for 
right and left ears). 
It should be noted that person IV.14, 2 years of age, was omitted, because the 
program AudioCene has not been trained w i t h data pertaining to such very young 
ages. For each individual, the program returns the most likely DFNA locus predicted 
in the first round. In the second and third rounds, the locus is shown that is most 
likely predicted for each individual, separately, after exclusion of the previously 
predicted locus or loci. 
Results 
In Figure 1, the pedigree of the family is shown. In Figure 2, all pure tone audiograms 
retrieved for the 5 affected family members are presented separately. In Figure 3, 
the ARTA for this family (family Dutch VI) is shown and ARTAs are presented for 
Fig. 1 Pedigree of Dutch family W08-0384 w i t h KCNO4 mutation (c.82iT>A; 
p.Leu274His). 
+T0 
ί~ϊ D-
rVrn 
<n 
Pedigree has been modified for privacy reasons 
Square — male, circle — female, solid symbol — clinically affected; open symbol — clinically unaffected, 
slash — deceased Generation is indicated m symbol legend 
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Fig. 2 Binaural mean pure tone thresholds measured in 5 carriers of KCNQ4 
p.Leu274His mutation in family Dutch VI (W08-0384). 
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Age is indicated in years in key to each audiogram panel Dotted line represents free field measurement 
families with the same mutation (top right panel) and other mutations in KCNQ4.6 
9 20
 Some of the reported mutations7 2'!3 have not been included, because we were 
unable to derive reliable ARTAs. 
As previously described, all families have symmetric, predominantly high-frequency 
sensorineural hearing impairment that is progressive at all frequencies. The Belgian 
family'2 ,8 and the Japanese family20 with the truncating mutations caused by a 
frame shift at position 71 both have a rather atypical phenotype sparing the low 
frequencies and more progressively and severely affecting the high frequencies. 
This might be because these two families both have a truncating mutation early in 
the protein. There was a striking similarity (Figure 3) between the audioprofile of 
the present family Dutch VI and the audioprofiles of the other traits caused by 
various KCNO4 mutations affecting the channel pore region. These KCNO4 
mutations are p.Leu274His (family Dutch III)'4 '5, the hotspot mutation p.Trp276Ser 
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Fig· 3 Age-related typical audio-gram (ARTA) for present family Dutch VI 
with KCNQ4 p.Leu274. His mutation (left upper panel) shown together with 
other ARTAs that could be obtained for families with same mutation 
(right upper panel) or other mutations in KCNO4. 
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Data of single famil ies are used in ARTAs of panels for mutat ions p.Leu274His (family Dutch ΜΙ"1), 
p.Leu28iSer (family USA 11," original data communicated by Zoreh Talebizadeh t o Els De Leenheer'9), 
p.Gly-285Cys (family USA I, or iginal data communicated by Shelley Smith to Els De Leenheer"), and 
p.Cly32iSer (family Dutch II"). Panel for hotspot mutat ion p.Trp276Ser pertains to 4 famil ies 6 '0 " " '9 whose 
ARTAs were averaged." ARTAs were also averaged for 2 famil ies harboring delet ion m u t a t i o n causing 
f rame shi f t w i t h protein t runcat ion at residue posit ion 71 (Belgian family,'1 original data communicated by 
Margr iet Verstreken t o Els De Leenheer"; and Japanese fami ly 2'°). 
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(the mean ARTA for 4 different traits is shown 6 , c '6 "> - see Van Camp et al. 2002),'7 
p.Leu28iSer (family USAII),'3 p.Gly285Cys (family USAI, data derived from Shelley 
Smith, personal communication from Els De Leenheer),16 and p.Gly32iSer (family 
Dutch II)." 
The program AudioGene V3.0 returned the results as shown in Table i. DFNA2 was 
the predicted locus in the first round. 
Table 1 Results of Audiogene V3.0. 
Patient ID First predicted locus 
(Pedigree code 
and age at last visit 
in years) 
11.3,59 DFNA2 DFNA9 DFNA10 
111.6.38 DFNA2 DFNA10 DFNA13 
111.5.39 DFNA2 DFNA9 DFNA10 
11.1,62 DFNA2 DFNAio DFNA9 
In all affected family members, the c.82iT>A (p.Leu274His) mutation was detected. 
The sequence chromatogram is shown in Figure 4. This mutation is believed to be 
pathogenic because it occurs in the P-loop of the protein and therefore probably 
interferes wi th pore formation in the final protein complex. The c.82iT>A (p. 
Leu274His) mutation has been previously identified in another Dutch family, family 
Dutch III. The present family is living in the eastern central part of The Netherlands. 
It was previously reported that family Dutch III travelled through The Netherlands 
as merchandisers. Most of the family members therefore had no fixed place of 
residence and were living in caravans in nonpermanent trailer camps.'4 
STS marker analysis revealed a common haplotype of at least 2 cM including the 
KCNO4 gene, indicating that the mutation is derived from a common ancestor. 
Second predicted Third predicted locus 
locus 
SO 
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Fig. 4 Electropherograms obtained for heterozygous mutation in KCNO4 gene 
and corresponding wild-type allele. GenBank Ref. ID NM_oo4700.2. 
A) Base change from Τ to A at position 821 (arrow) leads to substitution of 
Leucine 274 by Histidine. B) Wild-type sequence for comparison. 
Β 
Discussion 
Studies of genetically hearing-impaired families with an autosomal dominant 
pattern of inheritance (DFNA1-60) have found that the causes show unparalleled 
heterogeneity.24·25 To date, 24 genes for autosomal dominant deafness (DFNA) have 
been identified.' Some loci, such as DFNA8 and DFNA12, as well as DFNA6, DFNA14 
and DFNA38, later turned out to be identical and have the same gene involved. This 
outcome was the result of the policy of providing a DFNA ranking number even 
before the gene involved was identified. 
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Some traits show distinctive types of DFNA, such as low-frequency hearing 
impairment (DFNAi/ DIAPHi ; DFNA6/14/38 / WFSi) and mid-frequency hearing 
impairment (DFNA8/12 / TECTA; DFNA13 / COLnA2). The age of onset might also be 
helpful, as is the case in the midlife onset of the type of cochleovestibular 
impairment that progresses to severe deafness and vestibular areflexia (DFNAg / 
COCH). 
Autosomal dominant high-frequency hearing loss represents one of the most 
prevalent genetic audioprofiles and can be the consequence of mutations in several 
different genes, such as KCNO4 (DFNA2), DFNA5 (DFNA5), EYA4 (DFNA10) and 
POU4F3 (DFNAis). KCNO4 and POU4F3 hearing loss often start wi th substantial 
hearing impairment in the first and second decades of life.'8 For this reason, we first 
performed mutation analysis of KCNO4. 
In the fifth Dutch DFNA2 family (Dutch V), the audioprofile already suggested 
conducting mutation analysis for KCNO4 right away. In fact, a gene linkage study 
was still performed in that family, and it indicated linkage to the DFNA2 locus.6 This 
already showed that the audioprofile approach can lead to successful early 
engagement of mutation analysis. That some type of audioprofile approach is 
helpful in diagnosing DFNA2 in small DFNA2 families was most recently shown in 
some American families. These were in a group of 48 families whose DFNA2 profile 
had been recognized by the AudioGene program and were shown to have 2 novel 
missense mutations and a stop mutation in KCNQ4.ia Entering the present family's 
audiogram data into this program (V3.0) also resulted in prediction of the DFNA2/ 
KCNQ4 locus. 
In the present DFNA2 family, designated Dutch VI, the P.L274H mutation in KCNO4 
was found. This mutation was already disclosed before the AudioGene program 
became available on the Internet, in the first 3 of 5 affected family members, by the 
direct mutation analysis of KCNO4, which had been requested because of the 
clinical picture. The mutation was later confirmed for the 2 additional affected 
family members who were wil l ing to participate in our family study. 
Previous reports mentioned substantial intrafamilial variation in onset age or offset 
level, but annual threshold deterioration was almost uniformly calculated at around 
τ dB.10-1"'"' 
Extensive analysis of murine kcnq4 expression in the inner ear showed that it is 
expressed in both inner and outer hair cells. There are longitudinal gradients along 
the cochlear duct involving the most abundant expression in inner ear hair cells at 
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the base of the cochlea and in outer hair cells at the apex.26 These findings correlate 
with the human audioprofile for /CCWQi-related hearing loss.27 
Speech recognition scores have been analyzed in 45 affected members of families 
Dutch III and Dutch IV.'4 's Given the level of pure tone impairment, they presented 
with relatively good scores. Moreover, the scores did not deteriorate substantially 
before a hearing impairment of about 60 dB.28 
Vestibular testing was described in 37 members of family Dutch V and in 11 members 
of family Dutch IV and revealed increased vestibulo-ocular reflex activity in 
approximately 30% of the cases.'0'8 Family Dutch V6 and families Dutch I and Dutch 
IV have the W276S mutation in common.'0'7·'8 
Van Camp et al.'7 examined whether these three families were related by analyzing 
flanking microsatellite markers and intragenic single nucleotide polymorphisms. 
Because they identified differences between the families in both the flanking 
markers and the intragenic polymorphisms, they concluded that tryptophan at 
position 276 is a hotspot for mutation.'7 
Identifying the cause of hearing loss is valuable to families with autosomal 
dominant non-syndromic hearing loss (DFNA). Therefore, there is a need to publish 
detailed audiometrie data for each responsible gene to learn about the specific 
audioprofile, the variations, and the natural course of the disease. The method of 
producing ARTA has been developed for that purpose.5 29 It is noteworthy that for a 
clinician or research worker who is not familiar with detailed knowledge of 
audioprofiles, it is nevertheless possible to obtain reliable results by use of the 
dedicated program AudioCene. However, the development of such a program is 
impossible without an extensive pool of reliable audiogram data bearing on known 
genotypes that can be used to train that program, which is based on neural network 
methods.7,8 As a result of the use of audioprofiles, either by the clinician or research 
worker himself or herself, or by use of a dedicated public access program such as 
AudioCene, it has now become an option to ask for direct mutation analysis in 
those families that are too small for successful gene linkage analysis.8 
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Abstract 
A novel TECTA mutation (C.5331GM) was identified affecting a-tectorin just 
N-terminally of the zona pellucida domain in a Dutch family with nonsyndromic 
autosomal dominant sensorineural hearing impairment. The present mutation is 
clearly associated with a flat-threshold type of hearing impairment. Intriguingly, 
our results demonstrated that the present TECTA mutation had a significant 
protective effect against presbyacusis. Substantial protection against presbyacusis 
is a novel finding in a family with autosomal dominant hearing impairment. 
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Introduction 
Awareness of the familial occurrence of mid-frequency / flat-threshold types of 
sensorineural hearing loss with autosomal dominant inheritance has been present 
for several decades,'5 although it remains a relatively infrequent audiometrie 
finding6. Genotyping such traits succeeded within the decade around the past turn 
of the century. 
Hereditary mid-frequency hearing impairment has been diagnosed in families with 
DFNA8/12, DFNA13, DFNA21, DFNA31, DFNA44, DFNA497'7 and more recently in 
some cases of DFNAis,'8 as well as in a family that carries a mutation in the Wolfram 
syndrome type 1 gene (WFSi). The latter gene is involved in DFNA6/14/38'9 and in 
the Wolfram syndrome. 
Mutations in TECTA are known to cause the autosomal dominant type of 
non-syndromic hearing impairment DFNA8/12'6 20 that has been mapped to the 
chromosomal locus iiq22-24.9 '5 
TECTA encodes a-tectorin, which is the most important noncollagenous component 
of the tectorial membrane in the cochlea and in the otolith membrane in the 
maculae of the vestibular labyrinth. The tectorial membrane consists of an 
extracellular matrix that covers the organ of Corti. It is connected to the stereocilia 
of the outer cochlear hair cells and plays an important role in intracochlear sound 
transmission by ensuring optimal cochlear feedback.2' 
The clinical presentation of a mutation in the TECTA gene is influenced by the 
precise location of the affected residue in the a-tectorin protein. Mutations that 
affect the zona pellucida (ZP) domain of the protein are associated with a prelingual, 
stable, mid-frequency type of hearing impairment, except when they cause cyste-
ine-replacing substitutions. In the latter case postlingual, progressive hearing 
impairment results. Mutations in the zonadhesin (ZA) domain are reported to 
primarily affect the high frequencies."2S 
In the present family, nonprogressive flat or midfrequency hearing impairment was 
observed. Genetic analysis revealed a novel synonymous mutation in the TECTA 
gene (c.533iG>A). This mutation was shown to affect splicing, resulting in the 
deletion of 37 amino acids (p.SiysSY/GiysgNiygsdel) just N-terminally of the ZP 
domain of the a-tectorin protein.26 
We obtained detailed audiometrie data and compared them to findings published 
previously on families with a mutation in the ZP domain. 
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Patients and methods 
Patients 
A four-generation pedigree was constructed on this DFNA8/12 family (W04-096) 
and 17 family members participated in the present study. Signed informed consent 
was obtained and a questionnaire was filled out to exclude other possible causes of 
acquired hearing impairment. Medical history was taken from all the participants, 
and it also covered vestibular function. Micro-otoscopy was performed as well. 
All the participants underwent pure tone audiometry. Speech audiometry was only 
performed on the clinically affected persons. Previous medical records and 
audiograms were retrieved to enable individual longitudinal evaluation. 
Blood samples for genetic analysis were taken from 16 family members (some were 
affected and some were not) and ι spouse. Whole-genome SNP genotyping mapped 
the genetic defect underlying the hearing loss in this family to the DFNA8/12 locus. 
Sequence analysis of the corresponding TECTA gene revealed a heterozygous 
synonymous mutation in exon 16 (c.533iG>A; p.LiyyyL) which results in aberrant 
splicing and was found to segregate with the hearing loss. The aberrant splicing is 
predicted to result in the deletion of 37 amino acids of the a-tectorin protein (p. 
Si758Y/Ci759_Ni795del)just N-terminally of the ZP domain.'6 
Audiometrie data analysis was performed on the mutation carriers identified in the 
present family. 
Audiometry and data analysis 
Pure tone and speech audiometry was performed in a sound-treated room, 
according to the International Organization for Standardization (ISO) norms.27 i 8 
Thresholds were fixed at an arbitrary value of 130 dB hearing level in the case of out 
of scale measurements. Individual 95,h percentile thresholds of presbyacusis (P95) 
were derived at each frequency in relation to the participant's gender and age by 
using the ISO 7029 method.29 Individuals were considered to be clinically affected 
when the best ear showed air conduction thresholds that were beyond the P95 at at 
least two frequencies. Bone conduction thresholds were also measured to exclude 
conductive or mixed hearing impairment. 
Binaural mean pure-tone thresholds (air conduction levels in decibels of hearing 
level) were calculated at each frequency and used to perform cross-sectional linear 
regression analysis (threshold on age) at each frequency. The regression coefficient 
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(slope) was called the annual threshold deterioration (ATD), expressed in dB per 
year. Progression was significant if the 95% confidence interval of the ATD did not 
include zero. 
In clinically affected persons with 3 or more consecutive measurements and an 
overall follow-up of at least 3 years, we performed individual longitudinal regression 
analysis of binaural mean thresholds on age. Individual progression was considered 
to be significant (p < 0.05 in binomial distribution) when significant progression 
was observed on at least 3 out of the 6 frequencies. Protection against presbyacusis 
was tested for significance using the method previously described by Plantinga et 
al..25 The individual thresholds at each frequency were 'corrected' for presbyacusis 
by subtracting the median (P50) threshold indicated by the ISO 702929; the resulting 
value was 'excess' loss with reference to median presbyacusis. A similar linear 
regression analysis (corrected threshold on age), produced plots that had 
significantly negative slopes when significant age-related overcorrection of excess 
loss took place at the higher frequencies. The level of significance used in all the 
tests was ρ = 0.05. 
Speech audiometry was performed in a quiet environment using standard mono­
syllabic Dutch word lists. Maximum monaural phoneme recognition scores were 
derived from individual performance versus intensity plots. These scores were used 
to produce binaural mean scores, and binaural mean PTA,
 2 4 ^ levels were also 
obtained. Comparisons were made with maximum recognition scores, obtained in a 
group of previously described presbyacusis patients at matching PTA,i2i4 ^ levels.50 
Results 
The pedigree (fig. 1) comprised 4 generations and included 12 affected family 
members, 11 of whom were alive and willing to participate in this study; person 1:2 
had also been affected according to his history. The pattern of inheritance was 
autosomal dominant. Genetic analysis of the blood samples from 16 family 
members revealed a total of 11 carriers of the c.533iG>A mutation in the TECTA gene. 
Due to aberrant splicing events, the mutation is predicted to result in the deletion 
of 37 amino acids (p.Si758Y/Gi759_Ni795del), just N-terminally of the ZP domain of 
the a-tectorin protein.26 
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There was no evidence of any other cause of the hearing impairment. However, 
person 111:3 reported substantial noise exposure in his working environment. The 
first symptoms of hearing impairment were reported in the age ranges from < ι to 
30 years. Otoscopy did not reveal any irregularities. Pure tone audiometry was 
performed in 17 individuals and indicated that η individuals were affected. These η 
individuals all carried the c.533iC>A mutation. 
Fig. 1 Part of the pedigree of Dutch family W04-096 with the novel TECTA 
mutation (c.533iC>A). 
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The pedigree has been modified for privacy reasons. Squares represent men, circles women. Solid symbol, 
clinically affected. Open symbol, clinically unaffected, slash, deceased individual, Horizontal line, 
individual participated m this study, plus, mutation carrier, minus, mutation absent. The proband is 
marked with an arrow The generation is indicated m the symbol legend 
Last-visit pure tone audiograms of all the mutation carriers are shown in figure 2. 
These revealed a symmetrical but variable configuration. A so-called cookie-bite 
audiogram, which indicates that the mid-frequencies are predominantly affected, 
was only present in a few cases. A fairly flat audiometrie configuration that also 
involved the low and high frequencies was seen in most cases. The highest threshold 
in each case could be found at any frequency in the range from 0.25 - 8 kHz (fig. 2). 
It was usually in the range of 40-70 dB and apparently independent of age. 
Audiograms were also obtained from the 7 noncarriers, of whom only 2 (11:5 and 11:7) 
were old enough to possibly show (beginning) presbyacusis. However, their 
thresholds were not unusual for their age (49 and 54 years, respectively). 
Tinnitus was mentioned by only 3 affected individuals and occurred occasionally 
(11:2, ll:io and llhs). 
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Fig. 2 Last-visit audiograms of the 11 mutation carriers alive. 
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Fig. 3 Cross-sectional regression analysis of the participants' binaural mean air 
conduction thresholds at 0.25-8 kHz, obtained at the most recent complete 
audiological examination. 
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Vestibular symptoms ('dizziness') were reported by two mutation carriers (ll:2 and 
lll:2). Real vertigo was not mentioned. Vestibular function was not evaluated 
because the family members were not willing to undergo the tests. The affected 
family members also did not wish to undergo further hearing tests, such as acoustic 
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reflex thresholds, loudness discomfort levels, distortion product otoacoustic 
emissions to test outer hair cell functionality, frequency-modulated pure tones to 
assess frequency discrimination and speech perception in noise, as described before.31 
Audiometrie analysis 
Pure tone thresholds versus age 
In fig. 3, the cross-sectional binaural mean threshold data of the mutation carriers 
are plotted against age at each frequency separately, based on last-visit measurements. 
We found only shallow positive or negative slopes. Linear regression analysis did 
not show any significant progression wi th increasing age at any frequency. ATD 
values ranged from -o.i to 0.4 dB/year. Thus, it appeared that the thresholds did not 
depend on age. Age could therefore be ignored and mean thresholds were calculated 
that applied to all ages (fig.4). 
Fig. 4 shows the mean threshold in the present family and includes the mean 
évaluable thresholds previously reported in other DFNA8/12 families that carry a 
mutation in the ZP domain of the TECTA gene and have nonprogressive hearing 
impairment. Our mean threshold was remarkably flat, but still close to the median 
threshold of the combined data of the other families. 
Fig. 4 Mean threshold ± ι across-subject SD in the present family (open circles 
and thick solid line). 
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Individual longitudinal data analysis that included regression analysis covering a 
meaningful age range was only possible in individual Ihg, who only showed 
significant progression, by about 1.3 dB/year, at 0.25 kHz (fig.5). 
Fig. 5 Longitudinal binaural mean air conduction threshold data of the affected 
family members. 
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Speech recognition scores 
All 8 mutation carriers understood speech remarkably well, with maximum phoneme 
recognition scores of 90 to ioo% (mean 97%) at a PTAV 4 kHz of < 60 dB hearing 
level. In the study of De Leenheer et al., which described subjects with presbyacusis, 
only η of the 19 subjects selected on matching PTA levels, had maximum scores 
within this range at this threshold level, which is significantly different (p = 0.03 in 
Fisher's exact test); the other 8 subjects with presbyacusis had maximum scores in 
the range of 65-85 dB hearing level.J0 
Discussion 
In the present family, a novel mutation was detected in the TECTA gene, which 
caused aberrant splicing and an abnormal TECTA transcript. It has been predicted to 
result in the deletion of 37 amino acids, located just N-terminally of the ZP domain 
of the a-tectorin protein.26 
The a-tectorin protein comprises three distinct modules: the entactin Gì domain, 
the ZA domain and the ZP domain.33 Mutations in the ZA domain are associated 
with hearing impairment that primarily affects the high frequencies. Mutations in 
the ZP domain are associated with mid-frequency hearing impairment.9,6" 24·25 32 
"
3 6
 Until now, only missense mutations in the ZP domain of TECTA are known to 
cause typical mid-frequency hearing loss. In the present DFNA8/12 family, for the 
first time a mutation affecting splicing of TECTA mRNA was detected. As a result, 37 
amino acids adjacent to the ZP domain are predicted to be deleted, thereby causing 
a phenotypethat is fairly similar to that found for the missense mutations in theZP 
domain. To verify this, we compared the audiometrie configuration of the present 
family to the configurations described for previously published families with a 
mutation in the ZP domain (table 1). Most of these studies reported prelingual 
nonprogressive hearing impairment that mainly affected the mid frequencies. 
Hearing impairment in these other families was categorized as moderately severe 
(from about 40 to 80 dB).9· ' 5 ' 2 C ' 2 4 · 2 5 - î 2 ' î 5 Their threshold configurations were 
somewhat different from our findings. In the present family, there was on average 
a fairly flat configuration over the whole frequency range. The hearing loss caused 
by this novel TECTA mutation has a nonprogressive course and presumably a 
prelingual onset. Cross-sectional regression analysis of the participants' last-visit 
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audiograms did not reveal any substantial significant deterioration in hearing 
impairment. The history of most of the mutation carriers suggested a prelingual 
onset (at birth or in the first few years of life) and no progression over the subsequent 
decades, which is in accordance wi th these findings. There were 3 exceptions: 
individuals 11:2 , 11:4 and Ihg reported hearing impairment wi th progression after 
the age of io years. Unfortunately, no audiograms were available to substantiate 
their self-reported progression. However, two other individuals (IV:i and 111:5) had 
been followed-up between the age of about 5 and 13 years and they did not show 
any tangible progression (fig. 5). Audiograms obtained from the 7 nonmutation 
carriers of this family showed hearing thresholds that were normal for their age. 
The virtually normal speech recognition scores in the present family were 
comparable to those in previously described families wi th a mutation in the ZP 
domaino fTECTA.^ ' 2 
In contrast wi th the above-described ZP domain mutations in a-tectorin, the 
postlingual onset mid-frequency hearing impairment in two families, Spanish and 
American, showed gradual deterioration into moderate-severe hearing loss at all 
frequencies.2455 In the American family, the thresholds deteriorated mainly at the 
high frequencies. The mutation found in both families involved the replacement of 
a cysteine residue. Their divergent phenotype can be explained by this substitution 
of a cysteine residue as a significant association has recently been reported between 
this feature and age-related progression.25 
In the present family (W04-096), tinnitus was mentioned by 3 affected individuals, 
but it only occurred occasionally. Members of the Belgian and Spanish families also 
reported infrequent episodes of tinnitus.'5 2°'35 
Kirschhofer et al suggested that patients with mid-frequency hearing impairment 
due to a mutation in TECTA might be less vulnerable than usual to so-called 
presbyacusis or damage caused by noise exposure.9 The TECTA mutation might 
impair the proper transmission of intracochlear sound and therefore attenuate the 
level of sound that reaches the organ of Corti. 
Unaided phoneme recognition scores were all > 90 % and significantly higher than 
the scores found in presbyacusis patients at matching PTA,
 2 4 ^Hz levels in the range 
of 40-60 dB hearing level. These findings are fairly similar to those reported by 
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Table I TECTA mutations affecting the zona pellucida domain described in DFNA8/12 families 
Origin Mutation 
Protein 
Mutation Exon Onset 
Nucleotide 
Phenotype' Frequency Course Reference 
Dutch p.Si758Y/Ci759_ c.533iG>A 16 
present Ni795del 
Belgian L1820F c.5458C>T 17 
Gi824D c.547iG>A 
Spanish 08370 
American C1837R 
Austrian Y1870C 
Dutch R1890C 
Japanese R2021H 
Prelingual Mild-moderate (30-50 dB) Flat 
Prelingual Moderate (21-80 dB, mean 51 dB) Mid 
Stable-
Stable 
c.5509T>G 
C
-55°9T>C 
c.5609A>G 
c.5668C>T 
c.6o62G>A 
17 
17 
18 
18 
20 
Postlingual 
Postlingual 
Prelingual 
Prelingual 
Prelingual 
Mild-moderately severe (40-100 
dB) 
Mild-moderate (23-69 dB) 
Moderate-severe (60-80 dB) 
Mild-moderate (40-60 dB) 
Mild-moderate (36-47 dB) 
Mid 
Mid-High 
Mid 
Mid 
Mid 
Progressive 
Progressive 
Stable 
Stable 
Stable 
Present study 
Verhoeven et al. 1997; 
Govaertsetal . 1998 
Moreno Pelayoet al. 
2001 
Meyer et al. 2007 
Kirschhofer et al. 1998 
Plantinga et al. 2006 
Iwasaki et al. 2002 
" According to the CENDEAF criteria: mild, 20-40 dB; moderate, 41-70 dB; severe, 71-95 dB; 
profound, > 95 dB" 
" Significant protection against presbyacusis 
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Plantinga et al.25 It should be realized that when presbyacusis patients have about 
40-60 dB PTA, 2,4 kHz, their thresholds are much better at the lower frequencies 
than those in the present patients wi th TECTA mutations and a flat audiometrie 
threshold configuration (fig. 4). This makes it even more remarkable that the 
significant difference in maximum speech recognition scores was in favor of the 
latter patients. 
The study of De Leenheer et. al. shows the trend in the maximum speech recognition 
scores at decreasing PTA levels in presbyacusis patients.30 It is possible that subjects 
in the initial stages of presbyacusis, whose PTA,
 2 4 kHz levels are still in the range of 
0-20 dB hearing loss, have similar scores to those in the present patients with TECTA 
mutations that affect the ZP domain, whose mean thresholds were close to about 
45 dB hearing loss at 1-4 kHz (Fig. 4). This would underscore the notion of a protective 
effect of the TECTA mutation against presbyacusis. It should also be noted that the 
PTA level in the present patients can indeed be matched with that in the presbyacusis 
patients. However, there is a difference in the nature of the impairment between 
the two groups of patients. In presbyacusis, the impairment implies sensorineural 
hearing loss, whereas in the present patients, it mainly implies intracochlear conductive 
hearing loss.31 
In an attempt to substantiate the presence of a protective effect against presbyacusis, 
we corrected the individual thresholds at each frequency using the median (P50) 
threshold indicated by the ISO 1984.29 Linear regression analysis (threshold on age) 
was performed on the corrected thresholds. This produced plots with regression lines 
that showed negative slopes at the frequencies 2-8 kHz (fig. 6). The slope at 8 kHz 
was significant, which supports the hypothesis that the mutation provided protection 
against presbyacusis. Thus, application of the P50 presbyacusis value led to 
overcorrection that increased significantly with age. In contrast with our results, 
Plantinga et al. could not demonstrate such a protective effect.!S Our distinct finding 
in the present family with a mutation just outside of the ZP domain might be 
explained by higher hearing thresholds overall, but especially at the low (0.25-0.5 
kHz) and high (4-8 kHz) frequencies (fig. 4). Particularly intracochlear conductive 
hearing loss at the high frequencies might protect the organ of Corti against the 
'wear and tear' that is generally assumed to be associated wi th presbyacusis. 
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Fig. 6 Cross-sectional regression analysis of the participants' binaural mean air 
conduction thresholds at 0.25-8 kHz obtained at the most recent complete 
audiological examination, corrected for median presbyacusis. 
120 
100-
80-
60-
40-
20-
0-
0 
0 
0.25 kHz 
8 
- 0 
0 
0.3 
0 
0 
0 10 20 30 40 50 60 
1 kHz 
12U-
100 
80-
60-
40 
20· 
(Ι­
Ο 
Ο 
o o 
ο 
ο 8 
ο 
0.1 
% 
100-
80-
60-
40-
20-
0 -
β 
0.5 kHz 
θ 
ο 
ο 
0.2 
CO 
10 20 30 40 50 60 
2 kHz 
0 10 20 30 40 50 60 
4 kHz 
100-
60-
60-
40 
20-
0-
^ j O 
^ 
8 kHz 
0 o 
ο ο 
-0.6 
ο 
0 10 20 30 40 50 60 
Age (years) 
ATD (dB per year) in bold italics. Bold regression line has significant negative slope. 
71 
CHAPTER 2 2 
Vestibular dysfunction does not seem to be a feature in DFNA8/12, although in 
mice, a-tectorin is expressed in the vestibular organ (utricular and saccular maculae) 
and is a component of the otoconial membrane.21 In the Spanish family35 and the 
current family, sporadic dizziness was mentioned by a number of affected 
individuals. In the French family (ZA domain mutation), walking onset was reported 
to be late in some members, which might suggest vestibular dysfunction." 
However, in two DFNA8/12 families, vestibular testing that comprised caloric and 
rotatory tests did not reveal any vestibular abnormality in any of the 8 affected 
individuals.25- 32 More extensive vestibular function examination, including 
otolith-reflex tests, may provide better information about the possible involvement 
of the vestibular labyrinth in DFNA8/12. Late walking onset may indicate otolith 
dysfunction in the form of impaired righting reflexes. 
In summary, we studied a family wi th a novel mutat ion in TECTA that has been 
predicted to result in deletion of part of a-tectorin. The hearing impairment started 
prelingually, was mild to moderate and clearly nonprogressive. Audiometrie analysis 
showed a fairly flat threshold configuration. 
Although the novel mutation was not located wi th in the ZP domain of a-tectorin, 
the phenotype was fairly similar to the phenotypes previously described in TECTA 
mutations that affect the ZP domain. Therefore, we suggest that this novel 
mutation also affects the ZP domain and, as a result, shows a comparable 
phenotype. In the present family, the audiograms were flat on average, which may 
be a typical feature. 
Intriguingly, our findings demonstrated that the mutat ion in TECTA provided 
significant protection against presbyacusis. The substantiation of this protective 
effect against presbyacusis is a novel finding in a family wi th autosomal dominant 
hearing impairment and seems to have its mechanical basis in attenuated 
intracochlear sound transmission. 
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Abstract 
Objectives: cochleovestibular characteristics were investigated in a Dutch DFNA15 
family with a novel POU4F3 mutation, L223P. 
Methods: A 4-generation pedigree was constructed of the Dutch family with the 
novel L223P POU4F3 mutation. Pure tone audiometrie data were collected and 
analysed cross-sectionally in mutation carriers. Age-related typical audiograms were 
derived. Vestibular examination was performed in most of the mutation carriers. The 
results were compared to those obtained from previously identified 884del8 and 
L289F POU4F3 mutation carriers. 
Results: A novel mutation (L223P) in POU4F3 segregated with hearing impairment in 
the present family. Audiometrie analysis generally showed an early-adult to midlife 
onset of hearing impairment. High-frequency hearing impairment was observed 
most frequently. Age-related typical audiograms showed a down-sloping configuration 
at ages of more than 30 years, with the fastest rate of progression at the high frequencies. 
Vestibular function tests revealed hy pof unction of the vestibular labyrinth in 2 mutation 
carriers (not statistically significant). 
Conclusions: The clinical features in the present family with a POU4F3 mutation 
were fairly similar to those in the 2 previously described DFNA15 families, but the 
level of hearing impairment was milder, and there was no substantial vestibular 
dysfunction. 
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Introduction 
Hearing impairment is the most common sensorineural disorder. Approximately ι in 
10OO newborns have profound childhood deafness ' 2 Another ι in 1000 individuals will 
develop moderate to severe inner ear hearing impairment before reaching adulthood.' 
Genetic defects account for at least 50% to 60% of childhood hearing impairment in 
Western countries.3 4 In the majority of cases (approximately 70%), hereditary hearing 
loss is nonsyndromic, i.e. not associated with other distinctive clinical features.' The 
mode of inheritance in nonsyndromic hereditary hearing impairment can be autosomal 
recessive (70% to 80%), autosomal dominant (20% to 30%), X-linked (less than 1%), or 
mitochondrial (less than 1%).' 
At present, 46 different loci have been described for autosomal dominant non­
syndromic hearing impairment (DFNAi-57).The causative gene has been identified for 
22 of these loci.5 
In order to understand the clinical significance of a specific genetic defect and to gain 
insight into the natural course of the disease, it is necessary to make a detailed description 
of the phenotype that corresponds with each novel locus and mutation.6 Until now, 
vestibular involvement has only been described as present in DFNA9 and 11.7 "1 
Only 2 DFNA15 families have been clinically described in the literature. The first is an 
Israeli family, who presented with bilateral progressive high-frequency sensorineural 
hearing impairment starting in young adulthood.'5'7 Recently, a second family has 
been identified in the Netherlands. The audiograms showed a flat to down-sloping 
configuration, an early-adult to midlife onset and significant progression of hearing 
loss.'8 In the 2 families, speech recognition scores were fairly good. In the Dutch family, 
vestibular symptoms were observed. Vestibular function tests were performed in only 
2 affected individuals with vestibular complaints.These studies revealed hypofunction 
of the labyrinth.'8 
The DFNA15 locus has been mapped to human chromosome 5q3i. In the Israeli family, 
an 8 base pair deletion was found in the POU4F3 gene (884del8).This mutation causes 
a frameshift that results in premature termination of the POU4F3 protein.'5 In the 
previously identified Dutch family, a missense mutation (L289F) was found in the 
POL/4F3 gene that is predicted to affect the DNA-binding capacity of the POU4F3 
protein.'9 
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The POU4F3 gene encodes a member of the POU family of transcription factors that 
have an important function in tissue-specific gene regulation.20 POU4F3 plays a 
central role in the development, differentiation, and survival of hair cells in the 
human and mouse inner ear sensory epithelia.212S In Pou4fs knock-out mice, auditory 
and vestibular hair cells are completely absent, wi th the result of profound deafness 
and impaired balance.24 25 
We studied the clinical characteristics of a third DFNA15 family with a novel 
mutation in POU4F3 (L223P). The molecular characteristics of this mutation have 
been described by Collin et al.'9 Audiometrie and vestibular results were analysed 
and compared to those obtained from the 2 previously described DFNA15 families.'5 '8 
Patients and methods 
Patients 
The proband in this study was identified when a panel of 30 index patients from 
small families wi th autosomal dominant hearing impairment underwent genetic 
screening for mutations in POU4F3. '9 She was found to carry a novel missense 
mutation in this gene. The proband and her family were then invited to participate 
in a study on the segregation of this mutation in the family. Written informed 
consent was obtained from 40 family members and a 4-generation pedigree was 
constructed (W02-096). A medical history was taken from all of the participants, 
and a micro-otoscopic examination was performed. Attention was paid to the 
presence of vestibular symptoms and other possible causes of acquired hearing 
impairment. 
All of the participants underwent pure tone audiometry, except for person Ill:i8, 
who did not participate; speech audiometry was performed only in the clinically 
affected persons. Vestibular function was tested in 8 affected family members. 
Blood or saliva samples from 32 family members (some affected, and some not) and 
8 spouses were obtained for linkage analysis. Based on the clinical findings, POU4F3 
mutation analysis was performed in almost all of them, to determine the presence 
of the L223P mutation. The saliva samples from children wi th mutation-negative 
parents were not tested. To enable individual longitudinal analysis, we retrieved 
previous medical records and audiograms. Audiometrie data analysis was performed 
on the mutation carriers identified in the present family. 
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Audiometrie analysis 
Pu re tone and speech audiometry was performed in a sound treated room, according 
to the International Organization for Standardization (ISO) norms.26 27The threshold 
was fixed at an arbitrary value of 130 dB hearing level when measurements were 
out of scale. The individual 95'h percentile threshold values of presbyacusis (P95) 
were derived in relation to the participant's gender and age at each frequency, by 
using the ISO 7029 method.2 8 Individuals were considered to be clinically affected 
when the best ear showed air conduction thresholds beyond the P95 on at least 2 
frequencies. Bone conduction thresholds were also measured to exclude conductive 
or mixed hearing impairment. 
Binaural mean pure tone thresholds (air-conduction level in decibels hearing level) 
were calculated at each frequency and used to perform cross-sectional linear 
regression analysis (threshold on age) at each frequency.The regression coefficient 
(slope) was called the annual threshold deterioration (ATD) and was expressed in 
decibels per year. Progression was significant when the 95% confidence interval of 
the ATD did not include zero. If significant progression was found, age-related 
typical audiograms (ARTAs) were constructed fol lowing a previously described 
method.2 9 
In clinically affected persons w i t h 3 or more consecutive measurements and an 
overal I fol low-up of at least 3 years, we performed individual longitudinal regression 
analysis of binaural mean threshold on age. Individual progression was significant 
(according to binomial distribution statistics) when significant progression was 
observed on at least 2 of the 6 frequencies. The level of significance used in all the 
tests was a ρ value of 0.05. 
Speech audiometry was performed in a quiet environment wi th standard 
monosyllabic Dutch word lists. Maximum monaural phoneme recognition scores 
were derived from individual performance-versus-intensity plots. Cross-sectional 
speech recognition scores (averaged over both ears) were plotted against age or the 
binaural pure tone average at the frequencies of 1,2 and 4 kHz (PTAi,2,4 kHz).30 
A previously described group of subjects w i t h presbyacusis alone served as a 
reference group.3' 
Vestibular analysis 
Vestibulo-ocular responses were evaluated and recorded in 8 of the affected 
individuals; person Ill:i8 did not wish to undergo the tests.The horizontal vestibulo-
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ocular reflex (VOR), was evaluated in the dark w i t h the eyes open by means of elect-
ronystagmography and computer analysis. Saccades, smooth pursuit eye 
movements, and optokinetic nystagmus responses were evaluated, as well as 
gaze-evoked and spontaneous nystagmus. Vestibular stimulation included velocity 
steps of goVs and caloric tests as described previously.32 " 
The dominant VOR t ime constant Τ (in seconds) was taken to characterize the VOR. 
This parameter shows a lognormal distribution, so the geometric mean in both 
nystagmus directions was used in the further analyses. The 90% (P5 to P95) 
confidence interval was 13 to 23 seconds.'2 Table 1 shows the classification according 
to Τ value of the VOR findings obtained wi th the velocity-step test. 
Table 1 Classification of Vestibulo-Ocular reflex findings in velocity step test 
according to bidirectional mean value of t ime constant. 
Τ (s) classification 
>23 Hyperreflexia 
13-13 Normal 
5-12 Hyporeflexia 
<5 Severe hyporeflexia, close to areflexia 
ο Areflexia 
Results 
The pedigree (Fig.i) comprised 4 generations wi th 9 affected family members; those 
alive participated in this study. Person 1:2 was affected, according to history. The 
pattern of inheritance was autosomal dominant. Blood samples for genetic analysis 
were obtained from 40 family members. They revealed a total of 9 carriers of the 
missense mutation L223P in the POU4F3 gene.'9 One mutation carrier, a 12-year-old 
boy (IV:i5), was not found to be clinically affected. 
There was no indication of any other cause for the hearing impairment. Persons 11:5 
and Ill:i6 reported substantial noise exposure in their working environment. The 
first symptoms of hearing impairment were reported in an age range from 4 to 44 
years. Otoscopie findings were normal in almost all of the family members. In a few 
unaffected children, some scarring of the tympanic membrane was seen. Pure tone 
audiometry was performed in 39 individuals and indicated that 7 were affected. Five 
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of them reported that they had hearing loss. Tinnitus was mentioned by only 2 
affected individuals (Ill:i6 and llhig). 
Fig. 1 Part of pedigree of Dutch family (W02-096) with novel L223P mutation in 
POU4F3. 
Pedigree has been modif ied for privacy reasons Squares represent men, circles women Solid symbol, 
clinically affected, Open symbol, clinically unaffected, slash, deceased individual, Horizontal line, individual 
participated in this study, plus, mutat ion carrier, minus, mutat ion absent The proband is marked w i th 
arrow Generation number is indicated in symbol legend. Nonpart ic ipatmg family members have been 
omit ted 
Audiometrie analysis 
Pure tone thresholds versus age 
Fig. 2 shows the last-visit audiograms of all mutation carriers who participated in 
the study. The audiograms were symmetric. In Fig. 3, the cross-sectional binaural 
threshold data from the mutation carriers are plotted against age at each frequency 
separately. Thus, single-shot measurements are combined with last-visit 
measurements. Linear regression analysis showed significant progression with 
increasing age at the frequencies of 2,4 and 8 kHz (bold regression lines). The ATD 
values ranged from 0.3 to 1.7 dB/y. 
The ARTAs were constructed based on the results of the cross-sectional linear 
regression analysis (Fig. 4).These showed a flat to gently downsloping audiometrie 
configuration at the age of 30 years or younger, with the most rapid progression at 
the high frequencies. At the age of more than 30 years, the threshold configuration 
became more steeply downsloping, with the most rapid progression at the high 
frequencies. To compare these results to the other 2 DFNA15 families described in 
the literature, we show their ARTAs in figure 4;'7'6 ARTAs for presbyacusis are also 
included.28 Individual longitudinal data analysis that included regression analysis 
was only possible in individual 11:5, who showed significant progression by about 
0.8 to 2.2 dB/y at the frequencies of 1 to 4 kHz (Fig. 5). 
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Fig. 2 Last-visit audiograms of 8 participating mutat ion carriers. 
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Dotted Ime represents International Organization for Standardization P95 presbyacusis threshold at 
specified ages (P95 is 95"' percentile air conduction threshold level of presbyacusis for given age according 
to ISO 7029.) M = male; F = female, o = right ear; χ = left ear, y = years (age). Mutation carrier IV15 showed 
no audiometrie abnormalities 
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Fig. 3 Cross-sectional regression analysis of participants' binaural mean air 
conduction thresholds at 0.25 to 8 kHz on age, obtained at most recent 
complete audiological examination. 
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Annual threshold deterioration (decibels peryear) is in bold italics. Bold lines indicate significant progression. 
Speech recognition scores 
The speech recognition score data were unsuitable for regression analysis. Of the 5 
participants who were younger than 50 years and had a binaural mean PTA,
 2 4 k H z 
of less than 60 dB, 4 had word recognition scores of 100% and 1 had a score of 90%. 
Patient 11:5,74 years of age, had a score of 60% at 90 dB P T A , ^ ^ 
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Fig. 4 Age-related typical audiograms (ARTA) derived from cross-sectional 
regression analysis of mean air conduction threshold levels from first to 
seventh decades for the present DFNA15 family wi th L223P mutation in 
POU4F3. 
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Table 2 Data on eight examined mutation carriers of present family. 
Person 
Nr. 
IV:7 
IV:15 
IV:l6 
IILig 
111:16 
111:10 
11:7 
11:5 
Age 
(years) 
10 
η 
15 
38 
4o 
44 
73 
74 
Gender 
F 
M 
F 
M 
M 
F 
M 
M 
Vestibularfunction: 
VOR 
Hyperreflexia + asymmetry 
Normal 
Normal 
Hyperreflexia 
Normal 
Hyporeflexia + asymmetry 
Normal 
Hyporeflexia 
ΡΤΑ,,ι^
 kHz 
(dB HL) 
27 
9 
19 
2 0 
44 
53 
48 
89 
Tinnitus 
-
-
-
+ 
+ 
-
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Fig. 5 Longitudinal binaural mean air conduction threshold data of affected 
family members. 
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M = male; F = female. Age (years) is shown w i th symbol key. 
Vestibular analysis 
Two of the affected family members reported vestibular symptoms that included 
vertigo and a tendency to fall. Eight of the 9 mutation carriers underwent vestibular 
examination. The velocity step test disclosed normal results in 4 cases (Table 2), 
hyporeflexia in 2 cases, and hyperreflexia (long Τ value) in 2 cases.Two persons were 
found to have significant directional asymmetry combined with hyporeflexia and 
hyperreflexia, respectively. Binomial distribution statistics did not show a 
significantly high frequency of any of the abnormal VOR parameter values. Caloric 
testing was not performed in person 11:5 (age, 74 years), but the responses in all 7 of 
the other cases were normal. 
Discussion 
This report describes the third family known worldwide who has a hearing 
impairment linked to DFNA15 and carries a mutation in POU4F3.'9 We made a 
detailed analysis of the cochleovestibular findings. 
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Collin et al. have predicted that the novel mutation L223P in POU4F3 in this family 
affects proper functioning of the POU4F3 protein, similar to the mutation described 
in the Israeli family and the L289F mutation in the previously described Dutch 
family.'5 " '9 '9 20 The clinical symptoms in the present family were less severe, but 
were more or less consistent wi th those described in the Israeli and Dutch reports 
on the first and second DFNA15 family.'5 '8 
All 3 DFNA15 families showed bilateral progressive sensorineural hearing 
impairment, and the reported subjective onset age varied from early adulthood to 
midlife. However, when the ARTAs are compared (Fig.4), the hearing impairment in 
the 2 Dutch families seems to start at a younger age. Pertaining to the affected 
frequencies, l itt le consistency was reported in the shape of the audiograms between 
affected individuals in the Israeli family, ranging from a flat configuration to a 
sloping curve.'6 Pauw et al. reported most frequently a high-frequency type of 
hearing impairment wi th a downsloping configuration, but mid-frequency and flat 
audiometrie configurations also occurred. 's In the present study, high-frequency 
hearing impairment was observed most often. Remarkably, the low and mid-fre­
quencies are less affected in the present family than in the other 2 DFNA15 families 
(figs.2 and 4). In all families, most progression was found in the mid and high 
frequencies, w i t h an annual deterioration rate (ATD) of 2.1 dB/y at 2 to 8 kHz in the 
Israeli family, an ATD of 1.4 dB/y at 4 to 8 kHz in the previously described Dutch 
family, and an ATD ranging from 0.3 to 1.7 dB/y at 2 to 8 kHz in the present family. In 
the low frequencies, an ATD of 1.1 dB/y at 0.25 to ι kHz in the Israeli family and an 
ATD of 0.8 dB/y at 0.25 to 2kHz in the Dutch family was reported. We found an ATD 
of 0.4dB/y at 0.25 t o i kHz.'5'8 
As reported by Collin et al., the L289F mutation causes a more pronounced 
deleterious effect than the L223P mutation on the ability of the POU4F3 transcription 
factor to bind target DNA, resulting in a lack or a decrease of reporter gene 
expression, respectively.'9 This difference in reporter gene expression might explain 
the phenotypic difference in severity of the clinical presentations of the 2 genotypes. 
Audiometrie analysis showed an early-adult to midlife onset of noticeable hearing 
impairment. Most commonly, high-frequency hearing impairment was observed 
(Fig. 2). Linear regression analysis of cross-sectional audiometrie data revealed 
significant progression at the frequencies of 2, 4 and 8 kHz. The ARTAs (Fig. 4) 
showed flat to gently downsloping configurations at the age of 30 years and 
younger. At the age of more than 30 years, a more steeply downsloping configuration 
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was seen, with the most rapid progression at the high frequencies. When comparing 
the ARTAs of the 3 DFNA15 families, all of which showed rapid progression at the 
high frequencies, it is remarkable that the present family with the L223P mutation 
was least affected at speech frequencies (0.5 to 2 kHz). (Fig.4) 
Although we found that 9 family members were carriers of the novel POU4F3 
mutation, only 5 of them reported the presence of hearing impairment and only 3 of 
them were using conventional hearing aids.They all had noticed some (mild) degree 
of hearing loss for the first time between 30 and 40 years of age. Individual IV:7 was 
an exception, because her hearing loss had already been recognized at the age of 4 
years. The early onset of the hearing impairment in this person might be due to the 
phenotypic variation in severity and onset age seen in all DFNA15 families. 
Contributions of sequence variants in target genes of POU4F3 or genes encoding 
inner ear proteins are likely but unknown. Also, improvements in diagnosis of 
hearing loss might have contributed to the earlier recognition of hearing 
impairment. However, her hearing was probably more severely impaired at a 
younger age, and because the impairment mainly affected the speech frequencies, 
it would have been noticed earlier. 
Speech recognition scores were generally good, and this fact may explain why the 
hearing impairment may have gone unnoticed fora long period of time. 
There is a striking similarity between the ARTA for the present family and that for 
presbyacusis (Fig.4). Given the fact that most of the present patients were men, we 
used the ISO 7029 coefficient a for men28 to outline a model predicting the threshold 
in men from the present family: threshold = a (age - 4)' + 25, i.e., including a flat 
congenital offset of 25 dB hearing loss. Compared with the ISO 7029 median 
thresholds, this equation covers presbyacusis starting 14 years earlier than 'usual' 
(18-14 = 4 years; data not shown). Prediction was accurate for this model, within 
about 10 dB, 90% of the time. Presbyacusis thus can be said to have occurred 
precociously by about 14years. 
Based on the mild degree of hearing loss and the similar configurations of the 
DFNA15/L223P ARTA and the ARTA for presbyacusis (Fig. 4), with progression mainly 
at the high frequencies, we propose that POU4F3 is an excellent candidate for 
identification of genes involved in presbyacusis. Further support for this idea is 
provided by the recent identification of the first presbyacusis gene. It has been 
recognized as one of the DFNA genes that also encodes a transcription factor." 
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Until now, concomitant vestibular impairment has only been reported in 2 types of 
nonsyndromic autosomal dominant hearing impairment: DFNA9 and DFNA11."2 In 
DFNAg, the type of COCH mutation determines the level of vestibular impairment. 
Deterioration can precede hearing impairment and progress rapidly to vestibular 
areflexia, or have a milder course in which vestibular impairment starts at a more 
advanced age.7·9 " In the DFNAn families, the clinical vestibular findings vary from 
asymptomatic to complete vestibular areflexia.8'1 "' 
In mice, Pou4fs (also called Bm^.i or Brnjc) is expressed in the inner and outer hair 
cells of the cochlea and labyrinth. Targeted disruption of this gene results in the 
absence of sensory hair cells, which causes deafness and vestibular dysfunction.i4'!î 
Two downstream targets of Pou4f3 have been identified in mice: the transcription 
factor growth factor independence ι (Οβή and the LIM domain transcription factor 
Lhxj. These transcription factors bind to DNA to activate or suppress transcription.55 
Lhx3 is a hair cell-specific gene. It is regulated by Pou4f3 specifically in the cochlea, 
but not in the vestibular system. Cfii is regulated by Pou4fs in the auditory and 
vestibular hair cells. In Gfii mutant mice (Cfii ' ), loss of expression of Cfii resulted 
in degeneration of the outer hair cells alone.21 J5 This phenotypic change may be 
caused by other downstream molecules of Pou4fs that are essential for the survival 
and/or differentiation of inner hair cells in the cochlea and hair cells in the 
vestibulum.2' 
Brn-^c' mice have not only hearing deficits, but also vestibular deficits.2" In humans, 
the family with the L289F mutation also showed substantial vestibular 
hypofunction.36 However, in the Israeli DFNA15 family, no vestibular involvement 
was reported, and in the present family that carries the L223P mutation only 2 
affected family members were found to have vestibular hyporeflexia. In humans, 
the vestibular deficits are less dominant than in mice. Possibly, heterozygous 
mutation carriers might still have a sufficient amount of functional POU4F3 protein 
to maintain vestibular function to a certain degree. 
Two mutation carriers in this family (11:5 and lll:io) reported impaired balance. 
Vestibular examination revealed hyporeflexia in these 2 affected individuals. It is 
not clear whether there is vestibular involvement in the Israeli DFNA15 family, 
because to our knowledge this has not been investigated. Pauw et al. reported 
vestibular hyporeflexia in 2 DFNA15 mutation carriers with vestibular symptoms in 
their medical history.'9 In our study, the 2 mutation carriers who showed vestibular 
hyporeflexia were among the 3 oldest and most severely hearing-impaired family 
9 0 
AUDIOMETRIC AND VESTIBULAR FINDINGS IN DFNAls 
members. Quite intriguingly, in the Dutch DFNA15 family wi th the L289F mutat ion, 
a significant number of mutation carriers were recently found to have vestibular 
hyporeflexia; 1 of them even showed complete vestibular areflexia.36 It may be 
relevant to note that this family wi th the L289F missense mutation also showed the 
highest degree of age-related hearing impairment in the low frequency range in 
the DFNA15 families described in the literature (Fig. 4). The apparent difference in 
the degree of vestibular impairment between the present L223P-associated trait 
and the L289F-associated trait might well be explained by a difference in degree of 
target gene expression by the POU4F3 protein wi th the 2 different mutations, as 
mentioned before. 
In summary, the present study describes the cochleovestibular characteristics in a 
Dutch DFNA15 family that carries the missense mutation L223P. Compared to the 
previously reported Dutch an Israeli DFNA15 families, this family has a milder level 
of hearing impairment and no substantial vestibular dysfunction. 
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Abstract 
We analyzed the phenotype in a 5-generation DFNA20/26 family with a novel 
missense mutation in the ACTCi gene (c.i5iG>A) and compared the findings to 
previous reports on DFNA20/26 families. 
Audiometrie data were collected from the family members of a Dutch kindred with 
the novel ACTCi mutation. Cross-sectional and/or longitudinal analyses were 
performed on pure tone and speech audiometry data of the mutation carriers. 
Age-related typical audiograms were constructed. Vestibular examination was 
performed in all mutation carriers. 
Overall, high-frequency hearing impairment, most prominent at ages over 30 years, 
was observed with a progression rate of 1.1 to 2.1 dB/y, increasing with frequency. It 
ultimately resulted in residual hearing. Speech recognition scores remained good at 
given pure tone average (1,2, and 4 kHz) levels, but were slightly poorer than those at 
similar levels in a group of patients with presbycusis. Vestibular examination did not 
reveal any consistent, statistically significant abnormalities. 
The audiometrie phenotype of the Dutch DFNA20/26 family with a novel mutation in 
ACTCi was largely consistent with previous reports on DFNA20/26. Considerable 
variations were found in audiogram configurations within the family. This is the first 
known DFNA20/26 family that has experienced tinnitus. 
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Introduction 
Since the early 1990s, genetic linkage and mutation analyses have been applied to 
increase our knowledge of hereditary nonsyndromic hearing impairment. At present, 
54 genetically different types of autosomal dominant nonsyndromic hearing 
impairment have been identified.' 
There is wide variation in the phenotypic presentation of autosomal dominant types 
of hearing loss. On the basis of the clinical findings, it is often possible to make an 
initial guess at the most probable underlying genetic defect.2 To improve such 
speculation and to learn more about the natural course of these types of genetic 
hearing loss, genotype-phenotype correlation studies on hearing-impaired families 
are useful. 
Initially, the autosomal dominant postlingual progressive sensorineural hearing loss 
in 3 families was found to be linked to overlapping regions of chromosome I7q25.3 6 
Two different loci were assigned: DFNA20 and DFNA26. Zhu et al7 and van Wijk et al8 
identified the underlying ACTGi gene simultaneously in 2003. The first clinical report 
on a DFNA20/26 family came from Norway in 19689; the causative genetic defect in 
this family has only recently been identified.'0 Up to now, 9 DFNA20/26 families have 
been described.3 7-913 
The ACTGi gene encodes Y-actin, a cytoskeletal protein abundantly present in the 
sensory hair cells of the cochlea.'" Actm filaments are essential for the shape and 
function of the stereocilia of the hair cells. The stereocilia are anchored to the cuticular 
plate, which consists of a gel-like meshwork of actin filaments.10,14,15 It has been 
suggested that mutations in Y-actin cause hearing loss mainly by impairing the 
function and/or viability of hair cells.'8'"These mutations may have an adverse effect 
on actin polymerization that leads to malformed or structurally unstable stereocilia 
and/or disturbed interactions between actin and other proteins.'5 This may reduce the 
stability and impede repair of the cochlear cell structures (stereocilia) after noise 
damage or aging.7 
Patients and methods 
We performed audiological and vestibular tests on a second Dutch DFNA20/26 family 
with a novel mutation in ACTGi (c.i5iG>A) and compared the results to previously 
reported clinical data from other DFNA20/26 families. 
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Fig. 1 Part of pedigree of Dutch family W07-265 with novel D51N mutation inACTCi. 
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Pedigree has been modified for privacy reasons. Squares represent men, circles women. Solid symbol - clinically 
affected; open symbol - clinically unaffected; slash - deceased individual; horizontal line - individual 
participated in this study; plus - mutation carrier. Proband is indicated with arrow. 
Patients 
A 5-generation pedigree was constructed on this family (W07-265; Fig. 1), and 33 
individuals participated in the study. Signed informed consent was obtained, and a 
questionnaire was filled out to exclude other possible causes of acquired hearing 
impairment. The study was approved by the local medical ethics committee 
(Commissie Wetenschappelijk Onderzoek bij Mensen, project number 9504 0521). 
A medical history was taken from all of the participants, and included information on 
vestibular function. Micro-otoscopy was also performed. 
All of the participants underwent pure tone audiometry. Speech audiometry was only 
performed in the clinically affected persons. Blood samples, or in the case of young 
children, saliva samples, were obtained for DNA isolation from 29 family members 
(some affected and some not) and 4 spouses. In view of the clinical findings, ACTCi 
mutation analysis was performed on the individuals.To enable individual longitudinal 
analysis, we retrieved previous medical records and audiograms. Audiometrie data 
analysis was performed on the mutation carriers identified in the present family. 
Audiometrie Analysis 
Pure tone and speech audiometry was performed in a sound-treated room, according 
to the International Organization for Standardization (ISO) norms.'6'7 The threshold 
was fixed at an arbitrary value of 130 dB hearing level (HL) when measurements were 
out of scale. The individual 95th percentile threshold values of presbycusis (P95) were 
derived in relation to the participant's gender and age at each frequency by use of the 
ISO 7029 method.'8 Individuals were considered to be clinically affected when the 
best ear showed air conduction thresholds beyond the P95 on at least 2 frequencies. 
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Bone conduction thresholds were also measured to exclude conductive or mixed 
hearing impairment. To describe the level of hearing impairment, we used the 
CENDEAF criteria: mild, 20 to 40 dB; moderate, 41 to 70 dB; severe, 71 to 95 dB; and 
profound, more than 95 dB.'9 
Binaural mean pure tone thresholds (air conduction level in decibels hearing level) 
were calculated at each frequency and were used to perform cross-sectional linear 
regression analysis (threshold on age) at each frequency. The regression coefficient 
(slope) was called the annual threshold deterioration (ATD) and was expressed in 
decibels per year. Progression was considered significant if the 95% confidence 
interval of the ATD did not include zero. Age-related typical audiograms (ARTAs) were 
derived for the present family and for previously described DFNA20/26 families by an 
existing method.20 
In clinically affected persons with 3 or more consecutive measurements and an overall 
follow-up of at least 3 years, individual longitudinal regression analysis was performed 
on the binaural mean threshold values on age. Individual progression was considered 
significant (according to binomial distribution statistics) when significant progression 
was observed on at least 3 of the 6 frequencies.The level of significance used in all the 
tests was a ρ value of 0.05. 
Speech audiometry was performed in a quiet environment with standard monosyllabic 
Dutch word lists. Maximum monaural phoneme recognition scores were derived from 
individual performance versus-intensity plots. Cross-sectional speech recognition 
scores (binaural means) were plotted against age and the binaural mean pure tone 
average at the frequencies of 1,2, and 4 kHz (PTAi,2,4kHz). Regression lines were fitted, 
as well as sigmoidal dose- response curves with variable slope.2' 
Vestibular Analysis 
Vestibulo-ocular responses were examined in 8 affected persons. The horizontal ves-
tibulo-ocular reflex was evaluated in the dark with the eyes open, by means of 
electronystagmography and computer analysis. Saccades, smooth pursuit eye 
movements, and optokinetic nystagmus responses were evaluated, as well as 
gaze-evoked and spontaneous nystagmus. Vestibular stimulation included velocity 
steps of 9o7s and caloric tests, as described previously." ^ 
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Results 
The pedigree (Fig. i) comprised 5 generations with 11 clinically affected family 
members. Eight of them were alive and participated in this study. Persons ll:i, 11:3, and 
111:7 were affected by history. All 8 individuals reported that they were suffering from 
hearing loss. Pure tone audiometry was performed in 33 individuals, including the 8 
affected individuals. There was no evidence of any other, nongenetic causes for the 
hearing impairment. Affected persons 111:3,111:6, and IV:5 reported substantial noise 
exposure in their working environment (in the case of person 111:6, sharpening ice 
skates). The first symptoms of hearing impairment were reported in the age range 
from birth to 34 years. Otoscopy did not reveal any anomalies. All of the individuals 
made use of a conventional hearing aid. Two individuals (111:6 and IV:4) have been 
preselected for a cochlear implant and are currently participating in the selection and 
testing procedures. Person IV:4 has been scheduled to receive a cochlear implant in 
combination with a conventional hearing aid. Tinnitus was mentioned by 6 of the 8 
affected individuals (111:2,111:3,111:5, IV:i, IV:4, and IV:5). 
The pattern of inheritance of the hearing impairment was autosomal dominant. 
Blood or saliva samples for genetic analysis were obtained from 33 family members. 
On the basis of the type of hearing loss, the ACTCi gene was tested for the presence 
of mutations.The c.i5iG>A mutation was detected; it co-segregated with the hearing 
loss in the family and was absent in 100 control individuals (Collin et al, in preparation). 
This mutation is predicted to result in the substitution of an asparaginefor an aspartic 
acid. The present family revealed a total of 8 carriers of the missense mutation D51N 
in the ACTCi gene. 
Audiometrie Analysis 
Fig. 2 shows the last-visit audiograms of all of the mutation carriers. The audiograms 
were generally symmetric. 
In Fig. 3, the last-visit cross-sectional binaural threshold data from the mutation 
carriers are plotted against age at each frequency separately. Linear regression 
analysis showed significant progression with increasing age at the frequencies 0.25 
kHz.i kHz, and 4 kHz (bold regression lines).The ATD values ranged from 1.1 to 2.1 dB/y. 
The youngest person, the proband (IV:4), was excluded from the analysis, because her 
thresholds showed outlier behavior (Fig 2): at 1 to 4 kHz, her binaural mean threshold 
was outside the 95% prediction interval for the extrapolated regression line of the 
other mutation carriers (38 to 66 years of age; Fig. 3). 
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Fig. 2 Last-visit audiograms of 8 mutation carriers. 
IV:4F21y IV:1M3By IV:S M 41 y lll:2 M 46 y 
Frequency (kHz) Frequency (kHz) Frequency (kHz) Frequency (kHz) 
Dotted line represents International Organization for Standardization P95 presbycusis threshold at specified 
ages. M - male; F - female; 0 - right ear; χ - left ear. 
The ARTAs were constructed from the results of the cross-sectional linear regression 
analysis. Figure 4 shows the ARTAs in the present family that harbors the D51N 
mutation, together with the ARTAs that were constructed from previously published 
audiogram data on the other families with ACTGi mutations.4 " " The Discussion gives 
a detailed comparison among the families. 
Only persons 111:3 and IV:i had longitudinal data (Fig. 5) that were suitable for 
regression analysis (Fig. 3); individual 111:3 did not show significant progression, but 
individual IV:i did. The longitudinal data from individuals 111:3 and IV:i (at 4 to 8 kHz) 
were fairly close to the (extrapolated) cross-sectional regression lines and showed 
similar trends of progression (Fig. 3). 
Regression analysis was performed on the speech recognition scores (Fig. 6). The 
onset age (90% score) was about 40 years, and the speech recognition score 
deteriorated by about 2.4%/y thereafter (Fig. 6A). The onset level (90% score) was 
about PTAi,2,4kHz 60 dB HL and deteriorated by about 1.2%/dB HL (Fig. 6B). 
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Fig. 3 Cross-sectional regression analysis of participants' binaural mean air 
conduction thresholds (open circles) at 0.25 to 8 kHz on age, obtained at 
most recent complete audiological examination. 
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Vestibular Analysis 
Vestibular symptoms were reported by 3 of the 8 affected individuals. These included 
dizziness and a tendency to fall when looking backward (111:3,111:5, and IV:i). Person 
111:6 used to suffer from episodes of vertigo, but had not experienced any for many 
years. All 8 mutation carriers underwent vestibular examination. The velocity-step 
test disclosed abnormal findings in some individuals (Table 1). Person 111:2 was 
excluded from the analysis because of manifest latent fixation nystagmus. 
Significant directional asymmetry was found in 4 individuals. In 2 of them (111:5 and 
llhio), it was combined with unidirectional hyper-reflexia, which was possibly due to 
release from contralateral inhibition. Binomial distribution statistics did not show a 
significantly high frequency of any of the abnormal velocity-step findings. Caloric 
testing was performed in all 8 of the clinically affected persons; 3 of them (persons 
111:3,111:5, and llhio) showed unilateral caloric hyporeflexia (left). All 3 persons were 
more than 50 years of age. None of the velocity-step parameter values showed any 
age-related trend (data not shown). 
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Fig. 4 Age-related typical audiograms derived from cross-sectional regression 
analysis on mean air conduction thresholds from first to seventh decades. 
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Fig. 6 Binaural mean phoneme recognition scores (percent correct) plotted against 
A) age and B) binaural mean pure tone average (PTA) atfrequenciesof i, 2, 
and 4 kHz. Small symbols indicate outliers. 
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Table ι Vestibular findings, age, binaural mean hearing level, and presence or 
absence of tinnitus in eight mutation carries. 
Person 
IV:4 
IV:! 
IV:5 
111:2 
111:5 
111:6 
111:3 
111:10 
Age (y) 
20 
38 
40 
45 
54 
62 
64 
65 
Sex 
F 
M 
M 
M 
M 
M 
M 
F 
Vestibular Function 
(Vestibulo-ocular Reflex) 
Asymmetry 
Asymmetry 
Normal 
(Latent fixation 
nystagmus) 
Hyper-reflexiat + 
asymmetry 
Normal 
Hyporeflexia 
Hyper-reflexiat + 
asymmetry 
Caloric Test 
Normal 
Normal 
Normal 
Normal 
Hyporeflexia L 
Normal 
Hyporeflexia L 
Hyporeflexia L 
Pure Tone 
Average* (dB HL) 
106 
57 
57 
77 
80 
"5 
82 
118 
Tinnitus 
+ 
+ 
+ 
+ 
+ 
-
+ 
-
'At frequencies i, 2, and 4 kHz. 
tPossible release from contralateral inhibit ion. 
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Discussion 
This study was a detailed analysis of the cochleovestibular features in the second 
Dutch DFNA20/26 family with a novel missense mutation (D51N) in the ACTCi gene. 
Previously,7 DFNA20/26 families3 7·9 "13 have been described,and 2 families" have been 
reported in abstracts (Table 2,3 " "•"J. 
Our data analysis revealed autosomal dominant hearing impairment at all of the 
frequencies, but especially in the middle- and high-frequency range. The thresholds 
deteriorated rapidly with advancing age, wi th ATD values that ranged from 1.1 to 2.1 
dB/y. The hearing impairment progressed to (overall) severe-to-profound hearing 
levels, and ultimately resulted in residual hearing (Fig. 2). 
A typical finding in the present family, and in all of the families with the DFNA20/26 
phenotype, was that the hearing impairment started at the high frequencies and 
showed a down-sloping audiogram (Fig. 4). This then progressed to residual hearing 
levels (corner audiogram). 
The ARTAs of the DFNA20/26 families showed that there was wide variation in 
phenotype between the different mutations in the Y-actin gene. In particular, the 
differences in progression in the first 3 decades were striking (Fig. 4). In the first 
decade,the K118M mutation7 showed substantial high-frequency hearing impairment, 
whereas the T89I mutation4 and the T278I mutation" had hardly any appreciable 
effect on hearing. Nevertheless, all of the mutations eventually led to residual hearing 
at specific ages, ie, in the fourth (P264L, T278I) to seventh decades (present DsiN 
mutation, T89I). 
Wide variation was seen in age at onset, degree of hearing impairment, and frequency 
range across the carriers of the different mutations (Fig. 4 and Table 2). The rate of 
deterioration, indicated by the ATD, also varied across the different mutations (Table 
2).The P264L mutation57 showed moderate high-frequency hearing impairment by 10 
years of age (Fig. 4). The V370A mutation9·10 caused moderate high-frequency hearing 
impairment that was probably congenital. The P332A mutation7 seemed to show less 
severe impairment at the lower frequencies into the fourth decade. For the most 
recently described DFNA20/26 family wi th the I122V mutation in sub-domain i,'3 there 
were not enough audiometrie data available to allow a meaningful comparison. 
However, the hearing loss in the Chinese family first affected the high frequencies, 
and after the second decade, progression may lead to profound hearing impairment 
across all frequencies.'3 
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Table 2 ACTGi mutations described in DFNA 20/26 families showing progressive 
hearing impairment in MF to HF range. 
Threshold (dB HL) Maximum ATD 
by Age 30-40 y (dB/y) 
Origin (Family) Mutation Subdomain Onset Age 0.25 kHz 4 kHz LF MF HF 
2-5 
2-5 
2-4 
6$ 
3 
ΐ·5 
Dutch present 
(W07-265) 
Chinese'!' 
American î47 
(MSUDFi) 
American'(1250) 
American5·7 
(kindred 6) 
Dutch8" (W99-
060) 
American7 (1320) 
Norwegiang.io 
D51N 
I122V 
T89I 
K118M 
P264L 
T278I 
P332A 
V370A 
2 
1 
1 
1 
4 
3 
3 
C-terminal 
ist decade 
3rd decade 
ist or 2nd 
decade 
ist or 2nd 
decade 
ist or 2nd 
decade 
2nd decade 
ist or 2nd 
-35 
~35 
-50 
-55 
-65 
-35§ 
-45 
-50 
-50 
-100 
-120t 
-100 
-8o§ 
-100 
decade 
MF - middle-frequency; HF - high-frequency; HL - hearing level; ATD - annual threshold deterioration; LF -
low-frequency. "Lack of clinical data to make comparisons. tExceptionally high (out of line) when ordered by 
mutation position or subdomain. $ln second decade. §Exceptionally low (out of line) when ordered by 
mutation position or subdomain. 
By estimating the thresholds in steps of 10 years, we derived ATD values from the 
ARTAs (Fig. 4 and Table 2). The highest values, of about 6 dB/y, were found in the 
second decade at 2 to 4 kHz, as indicated by the longitudinal data from the Dutch 
T278I family." In the American P264L family," the ATD was about 4 dB/y at the high 
frequencies in the first decade. It decreased to about 2 dB/y in the third decade. In the 
American P332A family,7 the ATD was about 3 dB/y at the high frequencies in the 
fourth decade. In the American T89I7 and KiiSM3"7 families, the ATD was about 2.5 
dB/y at the high frequencies and lowfrequencies, respectively. An ATD of approximately 
2 dB/y at the high frequencies was seen in the D51N mutation carriers in the present 
Dutch family, whereas the lowest ATD at the high frequencies, of 1.5 dB/y, was seen in 
the Norwegian V370A mutation carriers.9'0 
Approximate threshold levels by age 30 to 40 years at 0.25 kHz and 4 kHz were derived 
from the ARTAs, ordered by the position of the mutation relative to the protein (Fig. 4) 
or the protein subdomain (as listed in Table 2; data not shown).These threshold levels 
generally increased with the relative position of the mutation or the subdomain 
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number - wi th, however, some noticeable exceptions. The threshold at 4 kHz was 
exceptionally high (approximately 120 dB), given the relative position of the mutation 
or the affected proteinsubdomain, in the American P264L trait (Fig. 4 and Table 2).The 
threshold was relatively low at both 0.25 kHz (35 dB) and 4 kHz (80 dB) in the American 
P322A trait (Fig. 4 and Table 2). 
Modulation in ATD values at each frequency may well indicate nonlinearity in 
deterioration. This was clearly demonstrated in the Dutch family wi th the T278I 
mutation: the highest rate of deterioration was seen in the second decade at 2 to 4 
kHz (Fig 4 and Table 2). Nonlinear threshold deterioration at the same frequencies was 
predominant in the second to third decades in the original longitudinal threshold data." 
We replotted the original cross-sectional data from the American P264L family 
(threshold versus age). An ATD modulation, i.e., nonlinear threshold deterioration, was 
visible in these plots (not shown) in the first 3 decades of life. The thresholds at decade 
steps in age constituting the ARTAs for the other families, depicted in Fig. 4, are fairly 
equally spaced at each frequency, reflecting fairly linear deterioration with increasing 
age. Unfortunately, we do not have sufficient knowledge to correlate the variation in 
DFNA20/26 phenotypes to specific protein domains affected by the mutation. 
The speech recognition scores in the present family, when we controlled for the 
PTAi,2,4kHz level, were slightly better than those in the Dutch family with the T278I 
mutation" and only slightly poorer than those in patients with presbycusis.25 The 2 
families showed wide intersubject variation, but speech recognition became prob­
lematically low (maximum phoneme score of less than 50%) in the present family 
from about 60 years of age onward, in contrast with the age of 25 to 45 years in the 
family described by Kemperman et al." The ARTAs indicate that in the 2 families, the 
PTAi,2,4kHz was about 90 to 95 dB by that age. The presbycusis data reported by De 
Leenheer et al.25 also predicted about 50% word recognition at the same level of 
hearing impairment - however, at a much more advanced age of about 90 years. 
In the cochlea, the hair cells are the most prominent structures that contain actin. 
They include the stereocilia, with a rigid dense core of actin filaments and the cuticular 
plate that anchors the stereocilia.'4 All of the mutations in Y-actin that are reported to 
cause deafness are missense mutations.i«-8-'0 it has been predicted that these 
mutations only modestly affect the structure and function of Y-actin. The fact that 
hearing was found to be normal in juvenile Y-actin mutation carriers suggests that 
the hair cells are fully functional. However, the hair cells may be more susceptible to 
age-related degeneration.10 
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Functional analyses on yeast showed that mutations in ACTGi restrict cell growth."'•'2,5 
Bryan et al.'5 engineered 6 of the previously reported Y-actin mutations into yeast 
(T89I, P264L, K118M, 1278!, P332A, V370A) and found severe growth inhibition in 4 
(Kii8M,T278l, P332A, V370A) and mild growth impairment in 2 (T89I, P264L). When the 
results of these functional growth assays were compared to the corresponding ARTAs 
of the DFNA20/26 families wi th the same mutation (Fig.4) and the derived ATD values 
(Table 2), we did not observe any clear difference in threshold deterioration between 
mutations that caused mild growth impairment and those that caused stunting of 
growth. Morin et al'2 engineered 2 Y-actin mutations into yeast and reported that the 
one wi th the stronger inhibitory effect on Y-actin function was associated with an 
earlier onset of hearing impairment. 
The postlingual onset of hearing impairment and the risk of hair cell degeneration 
suggest that certain individuals from affected families are suitable candidates for 
cochlear implantation. In the present family, 2 individuals (111:6 and IV:4) have entered 
the preselection phase of this procedure. Person IV:4 is scheduled to receive a cochlear 
implant in combination wi th a conventional hearing aid. Rendtorff et al'0 reported 
that 3 DFNA20/26 individuals had received a cochlear implant, but they did not 
mention any results after implantation. It will be interesting to evaluate the hearing 
ability of ACTGi mutation carriers after cochlear implantation. 
An interesting point of phenotypic difference between this family and the previously 
reported DFNA20/26 families is the occurrence of t innitus. In this study, 6 of the 8 
affected individuals have experienced tinnitus. In the previously reported DFNA20/26 
families,4·57" tinnitus was not a feature.Teig9 did mention tinnitus, but did not specify 
how many individuals had it. The D51N mutation is predicted to result in the 
substitution of an asparagine for an aspartic acid in subdomain 2. Notably, this is the 
only ACTCi mutation in subdomain 2. It might be that this family experiences tinnitus 
because their mutation resides in another domain of actin and disturbs a special 
function. Since the exact cause of tinnitus is not known in detail, it is difficult to 
speculate why this specific mutation would induce it. 
In the present family, 3 mutation carriers reported having impaired balance, and 1 
mentioned vertigo. In agreement with the results of the previously reported Dutch 
family," vestibular examination did not reveal any consistent or substantially 
significant abnormalities in the present carriers with a novel mutation in ACTCi, 
either. 
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Of the unaffected family members, no one reported balance problems It is interesting 
that individual III 10 had experienced vertigo attacks wi th nausea and vomiting that 
lasted for several hours, diagnosed as Meniere's disease In the past 10 years she had 
not experienced any further vestibular symptoms 
Elfenbein et a l 4 reported that the affected family members did not experience any 
vestibular symptoms, and neurologic tests did not show vestibular dysfunction 
Kemperman et al" reported vestibular hyporeflexia m 2 individuals, but no 
abnormalities on caloric testing Liu et al'3 reported that none of the family members 
mentioned any abnormalities of vestibular function, however, they did not undergo 
formal vestibular testing 
In hair cells, β- and Y-actms are found Y-Actm is the predominant actm in the auditory 
hair cells of the cochlea 26 However, it is unknown whether Y-actm is also the 
predominant actm in the vestibular hair cells Therefore, it is difficult to predict 
whether vestibular symptoms are to be expected in DFNA20/26 Still, it remains 
remarkable that balance problems have been reported in our family, m contrast with 
the other DFNA20/26 families A possible explanation might bethatonly in our family 
does the mutation reside m subdomam 2 of the actm molecule, which might affect 
the binding of other proteins m the vestibulum that are important for normal 
function 
In our family, hyper-reflexia and hyporeflexia were measured in the 3 affected 
individuals who reported balance problems, however.the results were not statistically 
significant This does not exclude the possibility that special vestibular tests might 
reveal dysfunction of the otolith organs 
In summary, the clinical features of the second Dutch family wi th a novel mutation in 
ACTCi, D51N, were largely consistent wi th previous reports on DFNA20/26 
down-sloping audiograms at all of the frequencies, wi th predominant involvement of 
the middle and high frequencies However, the current family had somewhat milder 
initial hearing impairment, although it also ultimately resulted m residual hearing 
Considerable variations were found in audiogram configuration and m type (linear 
and nonlinear) and rate of threshold deterioration m the present series of threshold 
data and in the literature on families with different ACTCi mutations 
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CHAPTER 3 ι 
Abstract 
In a Dutch family with autosomal recessive hearing loss, genome-wide single 
nucleotide polymorphism analysis mapped the genetic defect to the DFNB7/11 
locus. A novel homozygous A-to-G change in the TMCi gene was detected near 
the splice donor site of intron 19 (c.i763+3A>C) segregating with the hearing loss 
in this family. One of the 6 transmembrane domains and the actual TMC channel 
domain are predicted to be absent in the mutant protein. The sensorineural hearing 
impairment in this DFNB7/11 family has a postlingual onset. Audiometrie analysis 
initially showed a steeply downward-sloping threshold configuration. The progressive 
phenotype in this family resembles the phenotype previously described for families 
with dominant 7WIC; mutations (DFNA36) ratherthan that of families with recessive 
TMO mutations (DFNB7/11) which invariably cause severe-to-profound, prelingual 
hearing impairment. 
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Introduction 
Approximately ι in 1000 children are affected by severe-to-profound hearing loss at 
birth or will develop this during childhood.' At least 50% of childhood hearing 
impairment in developed countries is attributed to genetic defects.2 Approximately 
70% of these cases are nonsyndromic, i.e. not associated with other distinctive 
clinical features. Autosomal recessive inheritance is the most prevalent pattern of 
inheritance (70-80%) in cases with nonsyndromic hearing loss.' 
The autosomal recessive nonsyndromic forms of hearing impairment (DFNB) are 
generally severe with a congenital or prelingual onset. Many of the autosomal 
dominant nonsyndromic forms (DFNA) are postlingual, exhibit a variable age of 
onset, variable audiometrie presentations, severity, and rate of progression. 
Nonsyndromic hearing impairment is genetically extremely heterogeneous; already 
more than 60 DFNB loci and 30 of the causative genes have been identified.3 5 
Different mutations in the transmembrane channel-like 1 gene (TMCi) can cause 
prelingual autosomal recessive profound deafness (DFNB7/11) as well as postlingual 
progressive autosomal dominant (DFNA36) sensorineural hearing loss.6 Tma is 
expressed in the inner and outer hair cells of the murine cochlea and in the hair cells 
in the vestibular labyrinth. The precise function of TMCi remains to be determined, 
but the transmembrane proteins encoded by the TMC gene family are thought to 
act as ion channels, ion pumps or transporters.7 8 
This report provides a detailed audiometrie and vestibular phenotype description 
of affected members of a Dutch family with autosomal recessive hearing loss 
(DFNB7/11). Remarkably, the nonsyndromic sensorineural hearing impairment in 
this family starts as a moderate impairment and shows progression. The affected 
persons have been ascertained during childhood and their audiometrie characteris­
tics until young adulthood have been previously described.9· '° Genome-wide 
homozygosity mapping, as part of a project to trace genes involved in autosomal 
recessive sensorineural hearing loss in the Dutch population, followed by sequence 
analysis of TMCi, revealed a novel mutation (c.i763+3A>G) to be causative of the 
hearing loss in this family. After identification of the underlying genetic defect, we 
performed a detailed clinical follow-up study to improve genotype-phenotype 
correlations. 
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Patients and methods 
Patients 
In 1979, we reported on a family w i t h 11 siblings including 3 individuals who suffered 
from a remarkable type of nonsyndromic, progressive sensorineural hearing 
impairment. An autosomal recessive pattern of inheritance was shown.9 We 
updated the clinical characteristics and follow-up of these 3 affected family 
members as part of a project in which we unravel the causes of autosomal recessive 
nonsyndromic hearing loss in the Dutch population. The pedigree of this family 
(W06-792)9 was extended (figure i ) . Informed consent was obtained from all 
participating individuals. The study was approved by the local medical ethics 
committee (Commissie Wetenschappelijk Onderzoek bij Mensen, project number 
9504-0521). 
Most of the participating family members underwent pure tone audiometry. In the 
affected individuals, speech audiometry and vestibular testing was carried out as 
well. Also, micro-otoscopy was performed again. Peripheral blood samples were 
obtained for DNA and RNA isolation. To allow individual longitudinal analysis, 
previous medical records and audiograms were retrieved. Computerized tomography 
of the temporal bone was performed as part of the cochlear implant procedures. 
Genotyping 
Genomic DNA from peripheral blood lymphocytes of all participating individuals 
was extracted as described by Miller et al." After exclusion of the involvement of 
CJB2 via linkage analysis w i t h variable number tandem repeat (VNTR) markers, 
genotyping was performed for the 3 affected individuals by using Affymetrix 250K 
single-nucleotide polymorphism (SNP) arrays (Nspl array, Affymetrix, Santa Clara, 
Calif, USA) and homozygous regions determined by the CNAG software program'2 
Chromosomal segments were accepted t o be homozygous if the loss-of-heterozy-
gosity (LOH) score was ffl 8. The LOH-score is a measure of the likelihood of a stretch 
of SNPs to be homozygous based on the population SNP allele frequencies. 
Confirmation of homozygosity of the candidate region was achieved by VNTR 
markers (D9S1822, D9S1837 and D9S1876). The genomic localization of the markers 
was derived from the UCSC (University of California, Santa Cruz) human genome 
database (http://genome.ucsc.edu/). 
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Fig. 1 Pedigree of Dutch family W06-792 with the novel TMO mutation 
(c.i763+3A>G). 
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The pedigree has been modif ied for privacy reasons. Squares = males, circles = females. Solid symbol = 
clinically af fected; Open symbol - clinically unaffected; slash - deceased individual; arrow = proband. The 
generation is indicated in the symbol legend. 
Mutation analysis 
Primers for all coding exons and the intron-exon boundaries of MIO were designed 
and the exons of this gene amplified under standard PCR conditions. Primer sequences 
are listed in supplemental table 1. Sequence analysis was performed as described 
before13 using the same primers that were used for PCR. Primer sequences are listed 
in supplemental table 1. The occurrence of the observed mutation (c.i763+3A>G) in 
family W06-792, as well as in a panel of 80 Dutch probands with (presumably) 
recessive hearing loss and in 177 Dutch normally hearing individuals, was tested 
with S0U96I restriction digestion. 
RNA analysis 
RNA of 1 of the affected individuals of family W06-792 was isolated from peripheral 
blood collected and isolated using the Paxgene Blood RNA Kit (Qiagen Benelux BV, 
Venlo, The Netherlands). Subsequently, RNA was reverse transcribed into cDNA 
according to standard procedures using random hexamer primers. 
119 
CHAPTER 3 ι 
A nested PCR approach to cDNA was used to amplify part of the TMCi transcript 
containing exons 18 to 20, by using forward primer 5'-TCACCACCTACGTCACAATCC-3' 
and reverse primer s'-AAAGATCCTCGCAGGCACAC-j'. 
For nested PCR, forward primer 5'-CAATCCTCATTGGGGACTTTC-3' and reverse 
primer 5'-GCATTGTGGACAGGAAGAGG-3') were employed. PCR products were 
purified from agarose gels and subsequently sequenced with the forward and 
reverse primer used in the nested PCR as described above. 
Minigene construction and analysis 
A plasmid containing the genomic region encompassing exons 3 to 5 of ^HO inserted 
at the EcoRI/Sall sites in the pCI-NEO vector was used for in vivo splicing assays.'4 
The plasmid was digested with EcoNI and PflMI (New England Biolabs, Beverly, 
Mass., USA), according to the manufacturer's protocol, resulting in the removal of 
exon 4 and part of the flanking intronic sequences. Subsequently, a fragment 
containing TMCi exon 19 and approximately 600 base pairs of flanking intronic 
sequences on each side were amplified from genomic DNA of a patient carrying the 
c.i763+3A>G mutation and of a wild-type control, and also digested with EcoNI and 
PflMI. The primer sequences are listed in supplemental table 1. Purification of 
digested PCR products and plasmids was performed after size separation of the 
digests on agarose gels with NucleoSpin Extract II columns (Macherey-Nagel, 
Düren, Germany) according to the manufacturer's protocol. Subsequently, the 
fragments and plasmids were ligated by using the Rapid DNA Ligation Kit (Roche, 
Mannheim, Germany). 
HEK273T cells (80% confluency) in a 6-well plate were transfected with ι pg of 
plasmid DNA in duplicate, using Effectene Transfection Reagent (Oiagen Benelux 
BV) according to the manufacturer's protocol. After transfection, the cells were 
incubated for 24 hours at 37°C and RNA isolation was performed using the 
NucleoSpin RNA II kit (Machery Nagel) according to the manufacturer's protocol. 
RNA was reverse transcribed into cDNA according to standard procedures using 
random hexamer primers. The RHO and TMCi exons were amplified from the cDNA 
with forward primer 5'- cggaggtcaacaacgagtct-3' and reverse primer s'-aggtg-
taggggatgggaga c-3'. which are located in KHOexon 3 and exon 5, respectively. PCR 
fragments were sequenced as described.'3 
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Audiometry and data analysis 
Pure tone and speech audiometry were performed in a sound-shielded room, 
according to the International Organization for Standardization (ISO) norms.15 '6 The 
threshold was fixed at an arbitrary value of 130 dB hearing level (HL) when 
measurements were out of scale. The individual 95,h percentile threshold values of 
presbyacusis (P95) were derived in relation to the participant's gender and age at 
each frequency, using the ISO 7029 method.'7 Individuals were considered to be 
clinically affected when the best ear showed air conduction thresholds beyond the 
P95 for at least 2 frequencies. Bone conduction thresholds were also measured to 
exclude conductive or mixed hearing impairment. 
To describe the level of hearing impairment, the CENDEAF (European Thematic 
Network on Genetic Deafness) criteria were used: mild = 20-40 dB; moderate = 
41-70 dB; severe = 71-95 dB, and profound = > 95 dB.'8 
Binaural mean pure tone thresholds (air conduction level in decibels hearing level) 
were calculated and plotted for each frequency for each individual. 
Speech audiometry was performed in a quiet environment using standard 
monosyllabic Dutch word lists. Maximum monaural phoneme recognition scores 
were derived from individual performance versus intensity plots. Phoneme 
recognition scores (averaged over both ears) were plotted against age and the 
binaural mean pure-tone average at the frequencies of 1,2 and 4 kHz (PTAlp2i4|(Hz)·'9 
Vestibular examination and data analysis 
All 3 mutation carriers underwent vestibular examination at ages of 46 - 55 years. 
The horizontal vestibulo-ocular reflex (VOR) was evaluated in the dark with the 
eyes open, using electronystagmography and computer analysis. Saccades, 
smooth-pursuit eye movements and optokinetic nystagmus responses were 
evaluated, as well as gaze-evoked and spontaneous nystagmus. Vestibular 
stimulation included velocity steps of goVs and caloric tests, as described 
previously.20 2' One of the affected individuals (Vlhg) also underwent vestibular 
examination elsewhere, which included caloric testing and sinusoidal rotation at 
0.1 Hz and joVs maximum velocity. 
Evaluation of the effect of Cochlear Implantation on phoneme recognition 
Pre- and postimplant performance was tested by open-set word testing, using a 
meaningful monosyllabic word list. The words were presented through a 
loudspeaker at a fixed distance of im from the patient at a normal conversational 
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level of 70 dB sound pressure level (SPL). Subject responses were scored as 
percentage of correct phonemes. The reference groups were composed of 
postlingually implanted adults, and their test results, after 1 year of use, were 
analyzed. The first group (n=7o), implanted with a CII/HR90K device of Advanced 
Bionics, showed a mean phoneme score of 64% (SD 23%). The second group (n = 65), 
implanted with a Nucleus 24RCA of Cochlear, showed a mean phoneme score of 
72% (SD 18%)." 
Results 
The pedigree of family W06-792 (fig. 1) shows 3 clinically affected members in 1 
sibship; a distant consanguinity had previously been traced by a genealogical 
search.9 All 3 affected individuals were diagnosed with progressive sensorineural 
hearing loss. The parents and the other siblings had normal hearing. 
There was no evidence of any nongenetic cause of the hearing impairment, and a 
syndromic type of hearing impairment was excluded because no other physical 
(urine analysis, neurological, ophthalmological and hematological examination) 
abnormalities were found.9 This was confirmed by a recent update of the medical 
history. No substantial noise exposure was reported. The 3 affected individuals had 
noticed first symptoms of hearing impairment at ages of 4, 7 and 11 years (Vlhg, 
Vll:6 and Vll:7, respectively), while the first audiometrie tests were performed 2 to 
5 years later. Otoscopy did not reveal any anomalies. All 3 affected persons made 
use of a conventional hearing aid before the age of 20 years. Tinnitus was not 
reported by any of them. 
Mapping of the genetic defect to the DFNB7/11 locus 
To find the locus carrying the genetic defect that causes the hearing loss in family 
W06-792, a 250K SNP array was used to genotype the 3 affected individuals. The 
genotypes were analyzed for homozygous regions shared by all affected individuals 
since the pedigree suggests recessive inheritance and the parents are distantly 
related. The 3 affected individuals shared only 1 homozygous region on chromosome 
9 (71.4 - 72.7 Mb) flanked by SNP_A-i86i230 and SNP_A-42i6934. VNTR marker 
analysis confirmed a segregation of this region with the disease: only the 3 affected 
individuals were homozygous for this region, whereas both parents and all the 
nonaffected siblings showed different haplotypes (data not shown), with a 
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maximum 2-point LOD-scoreof 2.14for marker D9S1876. Nine known genes resided 
within the homozygous region, among which was TMO, which is associated wi th 
autosomal recessive (DFNB7/11) and dominant (DFNA36) nonsyndromic hearing 
impairment.6 
Mutation analysis of TMO 
For 1 affected family member (Vll:6), the coding region and the intron-exon 
boundaries of the TMO gene were analyzed for the presence of a mutation by DNA 
sequencing. A homozygous A-to-G transition was detected in intron 19 close to the 
boundary of exon 19 (c.i763+3A>G), as shown in figure 2A. 
A unique S0W96I restriction site is created by the mutat ion. To verify segregation of 
the mutat ion in the family, a restriction digestion of the PCR fragment containing 
exon 19 and flanking DNA was performed wi th S0W96I. In the 3 affected individuals, 
both mutant alleles were digested, in the parents 1 of their alleles. The unaffected 
siblings were either heterozygous carriers or had 2 wild-type alleles (data not 
shown for privacy reasons). 
In 177 Dutch control individuals, 1 heterozygous carrier of the c.i763+3A>G change 
was identified, but the change was not found in a homozygous state in any of the 
control individuals. Furthermore, this mutation was not present in any of the 80 
Dutch probands wi th (presumably) recessive hearing loss, indicating that it is not a 
frequent cause of hearing impairment in the Dutch population. The mutation 
detected in family W06-792 has not previously been reported (table 1, figure 2D). 
Effect of splice site mutation on splicing 
Several splice site prediction programs (http://www.fruit l fy.org/seq_tools/spl ice. 
html and http://www.cbs.dtu.dk/services/NetGene2/) predicted the actual splice 
donor site to be lost by the mutation. In addition, a weak alternative splice donor 
site was predicted to be present 47 base pairs downstream in intron 19. To determine 
TMO splicing in vivo, RNA was isolated from blood of 1 of the affected individuals 
followed by RT-PCR analysis of TMO RNA. The nested PCR on the cDNA for exons 
18-20 of TMO resulted in a PCR product wi th an increased size in 1 affected individual 
as compared to that in a control sample, implying the use of a different splice site in 
these individuals (Figure 2B). Sequence analysis of this PCR fragment showed that 
exon 19 was extended wi th 47 base pairs of intron 19 (Figure 2C). By additional 
experiments wi th all 3 affected individuals, we found both the correctly spliced and 
aberrantly spliced TMO mRNA in the blood of these patients, while in controls, only 
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Fig. 2 A) Partial sequence of the TMCi gene showing the splice site mutation 
c.i763+3A>G in an affected family member (Vl:6) and in a control 
individual. B) Nested RT-PCR on lymphocyte RNA of an affected individual 
(Vl:6) and an unrelated control individual, using primers located in exons 
18 and 20 of TMCi. In the affected individual, a PCR product of 383 bp was 
present, while in the control sample, a smaller band of 336 bp was 
detected. C) Sequence analysis of the 383-bp PCR product presented in 
figure 2B. Due to the mutation, a cryptic splice site was used resulting in 
the addition of 47 nucleotides to exon 19 of the mutant TMC transcript. 
D) Overview of previously described TMC mutations causing DFNA36 or 
DFNB7/11. Rectangles represent the exons of the TMCi gene, with the 
protein-coding part indicated in black. Mutations are presented below the 
gene. Protein-truncating and splice site mutations are depicted in black, 
while missense changes are presented in purple. The 2 missense changes 
causing DFNA36 (D572N and D572H) are depicted in green. 
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the correctly spliced mRNA was detected. To further determine the effect of the 
c.i763+3A>G mutation on splicing, we employed a minigene approach, which 
showed correct splicing of the wild-type TMO exon 19, while the c.i763+3A>G 
mutation completely abolished the normal splicing signal. 
The 47 base pairs extension of exon 19 causes a frameshift, a premature stopcodon 
in exon 20 and the incorporation of 81 aberrant amino acids (p.W588WfsX8i) in the 
protein. Protein domain prediction by SMART (http://smart.embl-heidelberg.de) 
revealed that the TMC domain and the most C-terminal transmembrane region are 
absent from the predicted mutant protein. This may cause either nonsense-mediat-
ed degradation of TMCi mRNA or reduced protein stability. Alternatively, the 8i 
aberrant amino acids may cause the mutant TMCi protein to acquire different 
functional properties. 
Audiometrie analysis 
Pure tone thresholds versus age 
Fig. 3 shows the audiograms of the 3 affected individuals. The hearing losses were 
symmetrical (data not shown). Hearing impairment started in the high frequencies. 
The thresholds deteriorated rapidly with increasing age, and hearing impairment 
progressed to (overall) severe-to-profound, and ultimately to residual hearing (fig. 3). 
The audiograms of the heterozygous mutation carriers showed normal hearing. 
Fig.3 Longitudinal binaural mean air conduction threshold data of the 3 affected 
individuals (W06-792). 
VII: 9 F 
Age (years) is shown by symbol. M = male; F = female; Some measurements have been omitted for clarity. 
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Table I TMO mutations described in DFNA36 and DFNB7/11 families. 
Ethnic origin 
DFNA36 
North-America 
North-America 
DFN 87/11 
The Netherlands 
Pakistan 
Turkey 
Pakistan, Tunesia, 
Lebanon, Jordan, 
Iran, Turkey 
Pakistan, Iran 
India 
Pakistan 
Turkey 
Turkey 
Turkey 
Pakistan 
Sequence variant 
cDNA (NMJ38691) 
C.1714G>C 
C.1714C>A 
c.i763+3A>G 
c.i_i6del 
c.64+2T>A 
c.iooC>T 
C.236 -HG>T/A 
c.295del 
c.536-8T>A 
c.767delT 
c.776A>G 
c.82iC>T 
c.830A>G 
Protein 
P.D572H 
P.D572N 
p.W588WfsX8i 
n.d 
n.d. 
P.R34X 
n.d. 
p.K99KfsX2 
n.d. 
p.F255F/sXi4 
P.Y259C 
P.P274L 
P.Y277C 
Onset 
Postlingual 
Postlingual 
Postlingual 
Prelingual 
Congenital / 
Prelingual 
Prelingual 
Prelingual 
Prelingual 
Prelingual 
Prelingual 
Prelingual 
Prelingual 
Prelingual 
Phenotype 
Profound 
2nd decade: high frequencies, 
4,h-5'h decade: all frequencie; 
Severe-Profound 
is ' decade: mid and high 
frequencies 
2"d decade: all frequencies 
Profound 
is l decade: h ighfreq. s 
2"d-3,d decade: al l f req 
Severe-Profound 
Severe-Profound 
Severe-Profound 
Severe-Profound 
Severe-Profound 
Profound 
Severe-Profound 
Profound 
Profound 
Severe-Profound 
Reference 
[Kitajiri, 2007a] 
[Hilgert, 2009; Kurima, 2002; 
Makishima, 2004] 
present study 
[Kurima , 2002] 
[Sirmaci,2009] 
[Kitaj i r i , 2007b; Kurima , 2002; 
Tlili, 20o8,Sirmaci, 2009; Yang 
T, 2002] 
[Kitajiri, 2007] [Hilgert, 2008] 
[Kurima, 2002] 
[Kurima, 2002; Santos, 2005a] 
[Hilger, 2008] 
[Kalay, 2005] 
[Kalay, 2005] 
[Santos, 2005a] 
Pakistan 
Turkey 
Pakistan 
Sudan, Tunesia, 
Lebanon, Jordan 
Turkey 
Turkey 
Turkey 
Turkey, Pakistan 
Pakistan 
Pakistan 
Pakistan 
Tunisia 
Greece 
India 
Pakistan 
Turkey 
Pakistan 
Sudan 
Turkey 
c.884+iG>A 
c. io83jo87del 
c.iii4G>A 
C.1165OT 
c.ii66G>A 
c.i330G>A 
C.1333OT 
C.1334G>A 
ci534C>T 
c.i54iC>T 
c.i543T>C 
c.i764G>A 
c.i8ioC>T 
c.i96oA>G 
c.2004T>G 
c.203oT>C 
c.2035G>A 
c.2i29+5G>A 
c.i695_228odel 
n.d. 
ρ l362l/sX5 
P.V372M 
ρ R389X 
p R389Q 
Ρ G444R 
P.R445C 
Ρ R445H 
P.R512X 
ρ P514L 
P-C515R 
pW588X 
P.R604X 
ρ M654V 
pS668R 
Ρ.Ι677Τ 
ρ Ε679Κ 
n.d 
n.d. 
Prelingual 
Prelingual 
Prelingual 
Prelingual 
Prelmgual 
Congenital / 
Prelmgual 
Congenital / 
Prelingual 
Prelmgual 
Prelingual 
Prelingual 
Prelingual 
Prelingual 
Prelmgual 
Prelingual 
Prelingual 
Prelingual 
Prelingual 
Prelingual 
Congenital / 
Prelingual 
Severe-Profound 
Profound 
Severe-Profound 
Profound 
Severe-Profound 
Severe-Profound 
Severe-Profound 
Profound 
Severe-Profound 
Severe-Profound 
Severe-Profound 
Profound 
Profound 
Severe-Profound 
Severe-Profound 
Severe-Profound 
Severe-Profound 
Not reported 
Seve re-Profound 
[Kurima, 2002] 
[Kalay, 2005] 
[Santos, 2005a] 
[Hilgert, 2008; Meyer, 2005; 
Tli l i ,20o8] 
[Hilgert, 2008] 
[Sirmaci, 2009] 
[Sirmaci, 2009] 
[Kalay, 2005; Santos, 2005] 
[Kurima, 2002] 
[Kitaj i r i , 2007] 
[Kitajiri, 2007] 
[Tlili, 2008] 
[Hilgert, 2008] 
[Kurima, 2002] 
[Kitajiri, 2007; Santos, 2005] 
[Sirmaci, 2009] 
[Santos, 2005] 
[Hilgert, 2008; Meyer, 2005; 
Tlili, 2008] 
[Sirmaci, 2009] 
η d = not determined 
CHAPTER 3 ι 
In fig. 4, the binaural mean threshold data from the patients are separately plotted 
against age for each frequency. The initial slope was estimated by visually f i t t i n g a 
slope tangent into each frequency panel of the data panel up to the age of 30 year. 
Readings of the thresholds f rom the graphs at the ages of 10, 20,30,40 and 50 years 
were separately derived for each frequency from the plots shown in fig. 4. These 
were used to construct age-related typical audiograms (ARTA).23 The ARTA for the 
present DFNB7/11 family are shown together wi th the ARTA derived for the DFNA36 
traits reported by Makishima et al. and Kitajiri et al.2 4 in f ig. 5. Similar readings of the 
graphs have been applied by us to their published threshold data. 
The present DFNB7/11 trait showed considerable progression, especially during the 
first 3 decades of life, as reflected by estimated annual threshold deterioration 
(ATD) values in the range of 2.5-5 dB/year (fig. 4). Although this progression was 
generally higher than the progression shown by thep.D572H DFNA36 trait described 
by Kitajiri et al.2 4 (data not shown), it was generally lower than the progression 
reported by Makishima et al.25 for the P.D572N DFNA36 trait, as is reflected by the 
ARTA shown in f ig. 5. 
Speech recognition scores 
The onset age of the deterioration in speech recognition (90% score) may have 
occurred in the first decade, and the score deteriorated by about 2-3 % per year up 
to the age of about 30 years (fig. 6, left panel). It may be questioned whether person 
Vll:6 ever attained a score of 90% or higher. 
The onset level (90% score) was at best in the range at a PTA,
 2 4 Ι,ΗΖ of 20-30 dB HL 
in individuals Vll:7 and Vlhg. The score deteriorated by about 0.8-1% per dB HL in 
these persons. In patient Vll:6, the score may have deteriorated at an age of < 11 
years by about 2-3% per dB HL (fig. 6 right panel). For the sake of comparison, this 
figure includes an indication of the P50 for presbyacusis, which was obtained from 
the data pertaining to 45 patients w i t h only presbyacusis that were covered in the 
report by De Leenheer et al.2 6 The data for persons Vll:7 and Vlhg were very close to 
the Psoforthe presbyacusis patients. This is similar for person VII:6, except for the 
outlying value of this person's first measurement. 
Vestibular examination 
No vestibular symptoms appeared to be present in the patients (data not shown). 
Vestibular function was tested in all 3 affected individuals and was found to be 
normal at ages of 46 - 55 years. 
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Fig. 4 Longitudinal analysis of binaural mean air conduction thresholds in 
affected individuals' (dB HL) versus age. 
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Fig· 5 Age-related typical audiograms (ARTA) derived for the present DFNB7/11 
family with a c.i763+3A>G mutation in TMO. For comparison, the ARTA 
pertaining to the DFNA36 families are shown.6 i ' , ! 5. 
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Fig. 6 Binaural mean phoneme recognition scores (percent correct) plotted 
against age (left) and binaural mean PTA1|2 4 ^HZ (right). 
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The dashed line in the right panel represents the binaural mean P50 phoneme score plotted against the 
binaural mean PTA,
 2 4 k H ! f o r t h e 4 5 patients with only presbyacusis that were covered in the report by De 
Leenheer et a l ." 
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Evaluation of effect of Cochlear Implantation on phoneme recognition 
The affected individuals have recently been selected for cochlear implantation (CI). 
Computerized tomography of the temporal bone was performed as part of the 
preoperative CI selection procedure. It showed a normal configuration of the 
temporal bone, and normal middle and inner ear structures in all 3 individuals. 
Two patients underwent cochlear implantation in our hospital, and the cochlear 
implant was uneventfully and completely inserted into the right side in both cases. 
Individual Vll:6 was implanted wi th a Nucleus Freedom of Cochlear and person Vlhy 
with a CII/HR90K device of Advanced Bionics. Individual Vlhg was implanted in 
another University Medical Centre wi th a Nucleus 24RCA of Cochlear and complete 
insertion was reported. 
Person Vll:6 was tested 3 months after the activation of the speech processor and, 
at 70 dB SPL, showed a 65% phoneme score wi th the cochlear implant. This is 
equivalent to a word score of about 37%. Before implantation, aided speech 
reception thresholds w i t h a conventional aid on the right had been tested and no 
speech reception had been found at 70 dB SPL, and the maximum speech reception 
(phonemes) of about 30% was found at 90 dB SPL. Individual Vll:7 was tested after 
6 months of use and, at 70 dB SPL, showed 88% speech reception wi th the cochlear 
implant, which is equivalent to a word score of about 74%. Before implantation, 
aided thresholds wi th a conventional aid on the right had been tested and a speech 
reception of 10% had been found at 70 dB SPL; the maximum speech reception 
(phonemes) of about 25% was found at 90 dB SPL. Person Vlkg was tested after 12 
months of use and showed a speech reception of 50% (phonemes) at 70 dB SPL, and 
a word score of about 27% was found. Before implantation, no speech reception 
(phonemes) had been found at 120 dB SPL. 
The results in all 3 patients are with in the normal range of those of our 2 reference 
groups (12 months of use)22; moreover, final results are expected be even better 
since person Vll:6 and Vll:7 were evaluated after 3 months and 6 months of use, 
respectively. 
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Discussion 
This report describes a Dutch family whose hearing impairment is caused by a novel 
mutation in the known deafness gene T/MO Mutations m this gene have previously 
been described to cause autosomal dominant progressive hearing loss (DFNA36) as 
well as severe-to-profound prelmgual hearing loss inherited in an autosomal 
recessive manner (DFNBy/ii) Interestingly, the sensorineural hearing impairment 
m this family was progressive but inherited in an autosomal recessive pattern 
TMO is predicted to encode a multiple membrane-spanning protein whose 
topologie organization resembles that of ion channels, pumps or transporters,68 
but its precise function remains unknown In the murine cochlea, Tma is strongly 
expressed in both outer and inner hair cells m early stages of development6 : 7 This 
expression pattern suggests that Tma plays a role in the normal function of the 
cochlear hair cells rather than m the early embryonic development of these cells 6 
Besides m the cochlear hair cells, Tma is also expressed m the vestibular neuro-
sensory epithelium 28 
To unravel the physiological role of Tmci in more detail, others have extensively 
studied the characteristics of two mouse models for hearing impairment caused by a 
defect m Tma6 27 The Beethoven (Bth) mouse mutant carries a heterozygous mutation 
m Tma, resulting m the substitution of a lysine for a methionine residue (p M412K) In 
Tma8""* mice, progressive hair-cell degeneration, mainly affecting the inner hair cells, 
started from postnatal day 20 onwards, and these mice are therefore considered to be 
a model for progressive hearing loss resembling DFNA36 Before degeneration 
initiated, the hair cells seemed to function normallyJ7 The deafness (dn) mice carry a 
deletion of almost 17 kb genomic DNA, encompassing exon 14 of the Tma gene which 
is predicted to result m a frameshift and premature termination of the Tmci protein 
The dn mouse is considered to be a model for recessive hearing impairment DFNB7/11 
6
 In homozygous Tma'1"M" mice, cochlear hair cells develop normally, but cochlear 
responses are completely lacking29 3' Besides early hair cell degeneration of the organ 
of Corti, occasionally a degeneration of the vestibular saccular macule is observed m 
the Tmadn'd" mice io days after birth so 3' Despite this observation, the phenotype of 
both mutant mice (Tma''n/d" and TmaBthu) does not seem to be associated with 
vestibular deficits6 ;7 '' Taken together, the studies performed on the Beethoven and 
deafness mice support a role for Tma in the inner and outer hair cells, either in proper 
trafficking of other membrane proteins m these cells or m regulating the differentia-
tion of immature hair cells into fully functional auditory receptors ^ 
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Whereas a clear auditory phenotype was present in heterozygous Tmcf""* mice, 
heterozygous Tmcy'^mice did not show any obvious defects.32 These data indicate 
that the Ρ.ΛΛ412Κ mutation in the Beethoven mice has a dominant-negative or a 
gain-of-function effect rather than causing haplo-insufficiency. This is further 
supported by the fact that Tmci is thought to act as a multimene entity whose 
function may be disturbed by the incorporation of mutant subunits.32 In addition, 
genetic modifiers may influence the phenotype associated wi th the Tma""' allele 
since at least one quantitative trait locus has been mapped that influences the 
phenotype associated wi th the Tmcim allele in a series of experiments crossing 
Beethoven mice w i t h several other mouse strains.28 In contrast to the Tma8'h allele, 
the TmcT*" allele seems to be a true functional null allele. 
In humans, only 3 DFNA36 families have been reported so far. The hearing loss in 
these families is postlingual wi th an onset in the first or second decade of life and 
progression to profound deafness. 6 ' 2 4 ' 2 5 " Intriguingly, the affected individuals of 
these families all carry a missense mutation in TMO w i th the same amino acid 
substituted (aspartic acid at position 572), indicating a critical and specific role for 
this amino acid in the normal function and pathology of TMO. 
More than 50 DFNB7/11 families have been reported that originated from Pakistan, 
Sudan, Turkey, Iran, Lebanon/Jordan, Tunesia, India and Greece (table 1) w i t h more 
than 30 different mutations in the TMO gene.6 5 4 4 ' Some of the mutations recurred 
in different families, suggesting a founder effect.6 î6 All reported DFNB7/11 families 
thus far presented wi th a congenital or prelingual severe-to-profound hearing 
loss,6 a"4' affecting all frequencies.39 In the present family, hearing loss was noticed 
in the is , to 2nd decade of life,9 started at the high frequencies and rapidly progressed 
to residual hearing levels ('corner audiogram') already in the 2nd decade. From the 
2nd decade onwards, hearing aids were necessary for the patients for proper 
communication. The phoneme recognition scores were very similar to those in 
presbyacusis patients. This seems to favour a primary involvement of outer hair 
cells42, but does not exclude an involvement of inner hair cells.43 Overall, the type of 
hearing impairment shown by the present DFNB7/11 family resembled the 
progressive type of hearing loss described in the 3 DFNA36 traits rather than the 
profound-to-severe type of hearing impairment that has been reported for the 
previously outlined DFNB7/n traits. Generally, recessively inherited forms of hearing 
impairment are not progressive although, in addition to the DFNB7/11 family described 
here, also DFNB8, DFNB13, DFNB30, DFNB59, DFNB77 and several mutations in 
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DFNBi are reported to cause progressive hearing loss.44 5° Beside TMCi, also MYO3A 
(DFNB30), PJVK (DFNB59) and LOXHDi (DFNB77) are expressed in hair cells, 
suggesting that intrinsic defects in hair cell function might be responsible for 
progressive recessive hearing loss.4 4·4 9·5 0 
The mutation c.i763+3A>C in the present DFNB7/11 family was shown to alter TMCi 
splicing in at least part of the transcripts, and thereby leads to the addition of 47 
base pairs in the RNA after exon 19, resulting in a frameshift and a premature stop 
codon after the addition of 81 codons. This mutation would regularly be considered 
a TMC null allele, like many other mutations previously described to cause DFNB7/11. 
Why would yet another null allele cause a different type of hearing impairment 
compared to other protein-truncating TMCi mutations? A likely explanation is that 
the mutation does not completely abolish normal splicing of TMCi mRNA in the 
inner ear, which is supported by the finding of both the normally and aberrantly 
spliced TMCi mNRA in lymphocytes of the patients. As such, a certain amount of 
normal TMCi protein might still be present in the cochlear hair cells, sufficient for 
hearing at young age, and thus the mutation would be hypomorphic, as has been 
described for a synonymous change in exon 7 of the Cdh23 gene in mice.5' This 
variant results in skipping of exon 7 and leads to susceptibility to age-related 
hearing loss rather than causing the severe-to-profound hearing loss observed in 
both mice and humans carrying other recessive mutations in Cdhz^/CDHzj. An 
alternative explanation for the progressive hearing loss as a result of the c.i763+3A>C 
mutation in the present DFNB7/11 family could be that the mutant TMCi transcript 
is not completely degraded via nonsense-mediated decay and that the remaining 
truncated protein, including the 81 aberrant amino acids, still has some residual 
function sufficient for hearing at young age. 
In summary, in this report we describe a DFNB7/11 family wi th a novel mutation in 
TMCi. Hearing impairment developed postlingually in the high frequencies and 
progressed towards severe to profound in the 2nd decade of life, affecting all 
frequencies. Remarkably, this type of hearing loss has not previously been described 
for recessive hearing loss caused by many different mutations in TMCi. Notably, the 
progressive phenotype in this family was more similar to the phenotypes described 
for dominant TMCi mutations (DFNA36). As such, this report contributes to geno-
type-phenotype correlations that may be essential for understanding pathology of 
hearing impairment caused by mutations in TMCi. 
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Supplemental table ι 
Primer sequences used to amplify and sequence all exons and intron-exon boundaries 
of the human TMO gene and primers for used for minigene construction. 
Primers for PCR and sequence analysis of TMO 
Exon Forward primer Reverse primer 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
M 
15 
16 
17 
18 
19 
2 0 
21 
22-23 
24 
-ccagcatggaacattcacag-3' 5 
-agttcaagtccagcctgacc-3' 5 
-ggggaagctcaaactgtgac-3· 5 
-tgcattccttggctattcttg-3' 5 
-ttcaacccctttgacctgag-3' 5 
-atcgtgctcattttggcaag-s' 5 
-gtgaaccacaatggaaatg-3' 5 
-tcaggaaggcaaacactactg-3' 5 
-gcagacctggtaaattcaaatg-3' 5 
-gctgccagagagacatttcc-3' 5 
-aaaaaggaccaatgcctcac-3' 5 
-catggagacccaaagagtcc-3' 5 
-aatcaacatggcagctgaaac-3' 5 
-ttgcttctccacttcaacactc-3' 5 
-tacttgccatcgtttgttgg-3' 5 
-ccaaaattctggcaaaaagc-3' 5 
-gccttgtttctggattgtc-3' 5 
-ttgcagtcttcaagccaatac-3' 5 
-aattgaaaccctagccatgc-3' 5 
-tctggttgaaagtggcag-3' 5 
-tgaggtcaaagtgtcagcaag-3, 5 
-gcttaatgttcattcccatgc-3' 5 
5'-gatttctggccacctcattc-3' 5 
-ccaactgctttcctccattc-3' 
-agttcaagtccagcctgacc-3' 
-cattcacagccctgtcctg-3' 
-aaacccaggcctcattctg-3' 
-aaagggaaagccccaaaag-3· 
-ggtagctcaagtccacaagagg-3· 
-gcatcatcagattaaggctctct-3' 
-gcttccaatttataatcattagccc-3' 
-cccctttagaaaagaaccagtg-3' 
-ccagaaactgacaaaggcatc-3' 
-catgggcaccattttgaag-3' 
-attcagcctgacccaggag-3' 
-tccaatccccaaattaatcc-3' 
-ttggtaggcagaaaccatgag-3' 
-aagggcaggataggggatag-3' 
-gagatttcaaaggcatttctgg-3' 
-ttcagagccagcacacag-3' 
-tccccctctgtgagaaacac-3' 
-gctttgcaaaacagagagacac-3' 
-ggatctcatttccaccaacc-3' 
-gcagaacccttagggagagtg-s' 
-ttgtggaatgactcgctcac-3' 
-gtggttggggagacaggtag-s' 
Primers for minigene Construction 
Exon Forward primer Reverse primer 
19 5'- ggccatggtctggtcacccgcatataaagtatgac-3'* 5'- gcctctccgaggaagatatgacaacccttcacac-3'' 
"This forward primer includes a PflMI site at its 5' end, highlighted by underlined nucleotides. 
This reverse primers includes a EcoNI site at 5'end, highlighted by underlined nucleotides.' 
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Abstract 
The Nathalie syndrome (OMIM 255990) comprises a combination of features that 
does not resemble any other known syndrome and is as such an independent, rare 
entity. It is characterized by sensorineural hearing impairment, juvenile cataract, 
spinal muscular atrophy, skeletal abnormalities, retardation of growth, under­
developed secondary gender characteristics, and cardiomyopathy. Worldwide, only 
one family with this syndrome is known. An update of the clinical follow-up in this 
family and the results of autopsy are given. Audiometry showed a downsloping 
configuration that corresponded to the findings at histopathological examination 
of the cochlea: a diffuseatrophy of the organ of Corti, severe and diffuse atrophy of 
the stria vascularis and moderate loss of cochlear neurons in all turns. Another new 
striking feature is that individuals with the Nathalie syndrome have a shortened life 
expectancy with a risk of sudden death or death from heart failure resulting from 
(dilated) cardiomyopathy. 
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Introduction 
In 1975, Cremers et al. reported four siblings in a family of Dutch and Ukrainian 
descent (Fig.i). They presented with sensorineural hearing impairment and cataract 
formation as the most prominent clinical features. In addition, further physical 
examination also showed spinal muscular atrophy, skeletal abnormalities, 
retardation of growth, underdeveloped secondary sexual characteristics and 
cardiac conduction abnormalities. This condition was called "Nathalie syndrome" 
after the oldest affected child.' The assumed pattern of inheritance was autosomal 
recessive.'* 
Fig. 1 Part of the pedigree of the Dutch family w i t h the Nathalie syndrome. 
0—ι—O 
12 
111 II 2 X l l 3 II4 II 5 II6 II7 
Squares represent men, circles w o m e n . Solid symbol, clinically a f f e c t e d ; Open symfco/.clinically unaffected; 
slash, deceased indiv idual ; The proband is marked w i t h an arrow. The generation is indicated in the symbol 
legend. 
At that t ime, the oldest one of the four patients described was 20 years old. The 
clinical features of the four siblings reported then are summarized in Table 1. To our 
knowledge, this is the only family reported w i t h this syndrome. Long-term follow-up 
data could provide an opportunity to learn more about the natural history of this 
syndrome and could possibly provide new insights into prognosis and pathophysi­
ology. During the 36 years since our first publication on the Nathalie syndrome, 
three of the four affected siblings have unfortunately passed away. 
In this report we provide follow-up data on the affected siblings in this family wi th 
Nathalie syndrome. In addition, the outcome of a histological study on the temporal 
bones donated by one of the patients is described and related to the clinical 
presentation of hearing impairment. 
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Patient and methods 
Clinical follow up 
Informed consent was obtained from the participating individual Ihy. The mother of 
the children signed the informed consent to retrieve medical information about 
individual 11:4. The study was approved by the local medical ethics committee 
(Commissie Wetenschappelijk Onderzoek bij Mensen, project number 9504-0521). 
The ENT and cardiac medical files of the second affected child (case 11:4) could be 
retrieved. Several audiograms were available between the ages of 17 and 48 and 
age-related typical audiograms (ARTA) were derived for the present individual 
fol lowing an existing method (Fig.2).3 A graphic presentation of her hearing loss 
over t ime is presented and related to the histological data from the inner ears. 
The only patient still alive, the fourth affected child (case Ihy), was invited for 
clinical visits and we obtained a history, clinical examination, a recent audiogram, 
ocular examination, chest X-ray, functional lung examination, electrocardiogram, 
echocardiogram, cardiac MRI, and laboratory examination. 
Blood samples have been taken from three family members (Ihy, 11:5 and 1:2). 
No medical data are available from patients 11:3 and 11:6 except from what their 
sister (case Ihy) was able to convey. 
Autopsy and histopathology 
The second affected child (Fig.i, individual 11:4) died at the age of 49 years. She had 
donated her body for medical research and autopsy was performed. The temporal 
bones were removed at Nijmegen (the Netherlands) approximately 6 hours post 
mortem. Both temporal bones were brought to the Massachusetts Eye and Ear 
Infirmary, Boston, for histological examination. They were fixed in formalin and 
prepared for light microscopy using the standard EDTA decalcification and celloidin-
embedding technique, followed by serial sectioning at a thickness of 20 microns 
and every io , h section was stained wi th hematoxylin and eosin.'1 
A quantitative analysis was performed and audio-cytocochleograms for the right 
and left ears were prepared. The audiometrie data had been collected at the age of 
48 years. The cytocochleograms show graphic reconstruction of the cochlea 
performed in each ear according to the method described by Schuknecht." Neuronal 
counts of the patient at age 49 were compared to age-matched controls as well as 
compared to normal newborns. 
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Results 
Follow up 
Cose 7. The oldest affected child Nathalie, the index case (Fig.i, individual 11:3) died 
at the age of 22 years, most probably due to acute heart failure. A summary of the 
data described in the original report is presented in Table 1. She died only one year 
following publication and unfortunately data on follow up and in particular cardiac 
follow up during this year are not available. 
Table 1 Clinical characteristics of the affected family members as published in 
1975 and the age and cause of death. 
Age 
Sensorineural hearing 
impairment 
Cataract 
Muscular atrophy 
Osteochondropathy 
Growth retardation 
ECC abnormalities / 
palpitations 
Underdevelopment 
of secondary sexual 
characteristics 
Low weight at birth 
Age of death 
Cause of death 
Case 1(11:3) 
20 
+ 
+ 
+ 
Perthes' 
disease 
+ 
+ 
+ 
+ 
22 
Acute heart 
failure 
Case 2 (11:4) 
19 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
49 
Heart 
failure wi th 
ventricular 
f ibri l lation 
Case 3 (II: 
16 
+ 
+ 
+ 
6) 
Scheuermann's 
disease 
+/-
+ 
+ 
37 
Sudden death 
Case 4 (11:7) 
8 
+ 
+ 
+ 
Perthes' 
disease 
na 
+ 
na 
+ 
Alive 
Alive 
na, not available. 
Case 2. The second affected child (Fig 1, individual 11:4) was examined at the age of 
20 years. The results were described in the original paper ' and are summarized in 
Table 1. 
Audiometrie assessment at age 20 showed a bilateral symmetric threshold, sloping 
downwards from 40 to 110 dB with a maximum phoneme recognition score of 
approximately 60% bilaterally. The hearing loss progressed by about 25 dB over the 
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ensuing three decades (Fig.2). The high frequencies were most severely affected. 
Vestibular function was tested before the age of 20 and was normal.' 
Fig. 2 Personal age-related typical audiograms (ARTA) derived for the present 
case (11:4) wi th Nathalie syndrome. 
8 kHz 
Italics indicate age (years) m decade steps 
At the age of 45, she was diagnosed wi th dilated cardiomyopathy and treated wi th 
medication (angiotensin II inhibitor and diuretics). However, heart failure became 
manifest despite medical treatment. The ECG at 49 years of age, two days before 
death showed sinus rhythm with a frequency of 100 beats per minute, a left axis 
deviation and normal conduction intervals (PR interval 0.16 sec, ORS duration 0.10 
sec, QT interval 0.32 sec, QTc interval 0.382 sec). There were no signs of left ventricular 
hypertrophy. There was hardly any R-wave propagation and normal ST-T segments. 
Echocardiography revealed a dilated left ventricle wi th a poor contraction pattern, 
mild mitral valve insufficiency and diastolic dysfunction. During terminal hospital-
ization for heart failure, she suffered from severe hypotension and renal insufficiency 
and eventually died from ventricular fibrillation. 
Case 3. The third affected patient (Fig 1, individual 11:6) was examined at the age of 
16 years. The results were described in the original paper ' and are summarized in 
Table 1. Unfortunately he died suddenly during sleep at the age of 37 years. His sister 
(case 11:7) was able to communicate that he had had no complaints until three years 
before his death. Those three years he complained of fatigue and an unwell feeling 
not further described and for which no special medical examination was performed. 
He did not use any medication. No autopsy was performed. 
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Case 4. The fourth affected patient (Fig 1, individual II7) was still alive. Her previously 
described data at the age of 8 years are summarized in Table 1.' She underwent 
cholecystectomy at the age of 35. She had the university degree Master in 
Psychology and at the t ime of wri t ing this manuscript she worked as a teacher at a 
college for higher professional education for normal hearing students in The 
Netherlands. She was not under any medical care and we invited her for an 
out-patient clinic visit at the age of 43 years. 
Audiometrie assessment showed a bilateral symmetric threshold, sloping down-
wards from 45 to 110-120 dB at i-4kHz; higher frequencies could not be measured. 
Speech discrimination was approximately 60% bilaterally. 
Cataract surgery had been performed bilaterally when she was 8 years old, followed 
by bilateral surgery for after-cataract, and retinal detachment surgery of the right 
eye. Post-surgical aphakia had been corrected wi th contact lenses (+17 diopters). 
Visual acuity had not decreased in the postoperative period. Corrected visual acuity 
was i /6o in the right eye and 0.8 in the left eye. Peripheral visual fields were normal 
in both eyes. External ocular examination showed strabismus, wi th mild exotropia 
and hypertropia of the right eye. There was no nystagmus. Slitlamp examination 
revealed bilateral aphakia. Right eye fundus examination showed retinal 
pigmentation and fibrosis in the posterior pole and peripheral indentation 
associated wi th retinal detachment surgery. Intraocular pressures were 8 mm Hg in 
the right eye and 16 mm Hg in the left eye. 
She suffered from dyspnoea d'effort, comparable wi th NYHA class 3 (dyspnoea wi th 
mild exertion). She also described paroxysmal palpitations wi thout syncope or 
dizziness, which sometimes lasted for several days. There was no orthopnoea, 
nocturia, oedema or chest pain. Furthermore, she complained of movement 
restrictions in her shoulder and pelvis. Menarche occurred at the age of 12 and 
menopause at the age of 40. Physical examination showed saturation in room air 
measured between 93-95% and a blood pressure of 174/84 and 156/79 measured on 
the right and left arm, respectively. There was hypoplasia of the shoulder and pelvis 
musculature and generalized muscle atrophy in arms and legs. A chest X- ray 
showed no dilated heart or signs of volume overload and normal lungs. Functional 
lung examination showed no restricted or obstructed lung function. The electro-
cardiogram showed sinus rhythm wi th a frequency of 50 beats/minute, left axis 
deviation, normal conduction velocities, normal R-wave propagation and normal 
repolarisation. There were frequent monomorphic ventricular extra systoles. Also a 
24-hours Holter electrocardiogram recording showed frequent ventricular extra 
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Fig. 3 Histopathological findings in the inner ear. 
Top left shows mid-modiolar section of cochlea, demonstrating a missing organ of Corti in the basal turn 
along with diffuse and severe atrophy of the stria vascularis. Top right panel shows a view of the scala 
media from the upper basal turn. Note that the organ of Corti is not completely missing; it is represented 
by a mound of cells without any discernible hair cells. Bottom left shows a high power of the organ of 
Corti from the upper middle turn. An inner hair cell is present, while outer hair cells are not. Bottom right 
shows an intact crista of the lateral semicircular canal. 
systoles (3% of the time) without signs of ventricular tachycardia. The echo­
cardiogram showed no abnormalities with a normal ventricular function and 
diameter. Cardiac MRI showed normal morphometry of the ventricles and atria, and 
a normal ejection fraction (left ventricle 65% and right ventricle 55%). 
Subendocardial delayed enhancement was seen at the base of the inferolateral 
wall, which might be a sign of Fabry disease. However, laboratory examination 
showed normal leucocyte alpha-galactosidase activity, making Fabry disease less 
likely. Further laboratory evaluation showed no abnormalities except from LH and 
FSH values in the postmenopausal range and a slightly elevated CK. No abnormality 
of the N-linked glycolysation was shown by transferrin isoelectric focussing. 
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Bone densitometry showed lumbal spine and right femur neck osteoporosis. In 
conclusion, there were in particular no signs of cardiac conduction abnormalities, 
cardiomyopathy or impaired cardiac function. Medical treatment was started for 
frequent premature ventricular contractions and for hypertension. 
Autopsy and histopathology 
Autopsy 
Autopsy was performed on the second affected patient (Figi, case 11:4) and showed 
a very slight woman (length i6o cm and weight 41 kg) wi th muscular atrophy. There 
were underdeveloped mammae, which contained ducti but no lobuli. The other 
external sexual characteristics were normal and there was a normal distribution of 
body hair growth. The uterus and ovaria did not show any abnormalities. 
Macroscopy of the heart (840 grams) showed dilated cardiomyopathy wi th four 
chamber hypertrophy (myocardial muscle thickness left ventricle 14 mm and right 
ventricle 5 mm). No valvular abnormalities and no significant coronary artery 
disease were seen (maximum stenosis of 30%). Lung, liver and spleen showed 
extensive congestion. The liver was small and the spleen relatively large. There was 
atherosclerosis of the abdominal and thoracic aorta and the subclavian artery. 
Cerebral autopsy was essentially normal. 
Histopathology of the temporal bones 
Both temporal bones were nearly identical and are therefore described together. 
Tissue sections showed good histological preservation and preparation. The external 
auditory canals, tympanic membranes, all ossicles and mastoids appeared normal. 
Both middle ears contained scattered bands of mucosa and connective tissue, but no 
active inflammation or infection. The petrous apices were not pneumatized and were 
filled with fat ty bone marrow. The otic capsules appeared normal. 
The bony and membranous labyrinths were fully developed. The cochleae showed 
the normal 2"2 turns wi thout any pathological endolymphatic hydrops. The most 
notable finding was marked atrophy of the organs of Corti which were completely 
missing in the basal turns. In the middle turns, the organs of Corti were represented 
by a mound of cells and as one proceeded apically, pillar cells and supporting cells 
became evident. However, all outer hair cells were missing in the middle and apical 
turns in both ears. Inner hair cells could be identified in some sections in the upper 
middle and apical turns. The striae vasculares showed complete atrophy in much of 
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the cochleae and only small islands of stria were present in scattered locations on 
both sides. The cochlear neurons showed moderate atrophy in all turns on both 
sides. The total cochlear neuronal cell counts were 11,952 on the right (corresponding 
to a 57% loss compared to age-matched counts and 66% loss compared to normal 
neonatal counts) and 13,158 on the left (53% loss versus age-matched counts and 
63% loss versus normal neonates). Blood vessels supplying both inner ears appeared 
normal. Quantitative analyses of hair cells, stria and neurons in both ears are 
depicted as cytocochleograms in the accompanying figure 4. 
Fig. 4 Cytocochleograms of the right ear (circles) and left ear (crosses) showing 
graphic reconstruction of the cochlea performed in each ear according to 
the method described by Schuknecht.[Schuknecht, 1993]. 
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Missing or abnormal elements are shown in black. Inner hair cells (IHC) and outer hair cells (OHC) were 
noted as being absent or present. Vertical axes of cytocochleogram boxes for the stria vascularis and 
cochlear neurons show percentage of loss. Neuronal counts are displayed when compared to age-matched 
controls as wel l as compared to normal newborns. The audiometrie data was collected at age 48. The 
patient died at age 49. 
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The vestibular sense organs on both sides were normal, including the maculae of the 
utricle and saccule, and the cristae of all semicircular canals. The endolymphatic ducts 
and sacs appeared unremarkable. The internal auditory canals (lACs) were somewhat 
long and narrow on both sides (an anatomical variant). On the right, the cochleo-
vestibular nerve was present in the IAC, and Scarpa's (vestibular) ganglion showed a good 
population of cells, probably normal for age. On the left, the eighth nerve had been 
avulsed out of the IAC. The facial nerves appeared to be unremarkable on both sides. 
In summary, the major histopathological correlate of this patient's hearing loss was 
loss of the organ of Corti and the stria vascularis. There was also a moderate loss of 
cochlear neurons, some of which may have been due to retrograde neural 
degeneration as a result of atrophy of the organ of Corti. The normal vestibular 
sense organs corresponded wi th normal vestibular function as tested during life. 
Discussion 
In this report, the available clinical fol low-up data of four patients wi th Nathalie 
syndrome is described. This is a rare autosomal recessive syndrome. When it was 
first described in 1975, the syndrome was characterized by the combination of 
sensorineural hearing loss (SNHL), cataract, muscular atrophy, skeletal abnormalities, 
retardation of growth, underdeveloped secondary sexual characteristics, and 
cardiac abnormalities. To our knowledge this is the only family wi th this specific 
combination of symptoms.2 
Thirty-six years of fol low up taught us that these patients are at risk to develop 
cardiomyopathy and have a shortened life expectancy wi th a risk of sudden death 
or death from heart failure. Contrary to the first description of symptoms in 1975, 
we could not confirm cardiac conduction abnormalities in the recent available ECGs 
of two of the affected individuals (cases 11:4 and 11:7). However, the only patient still 
alive was suffering frequent premature ventricular contractions wi thout signs of 
ventricular tachycardia and had hypertension. She had no signs of impaired cardiac 
function. In addition she happened to have an early menopause wi th co-existing 
osteoporosis. 
This is the first report describing the histopathology of the inner ear in the Nathalie 
syndrome. 
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Histological examination of the temporal bones showed that the bony and 
membranous labyrinths on both sides were fully developed. The inner ear 
abnormalities consisted of diffuse atrophy of the organ of Corti, severe and diffuse 
atrophy of the stria vascularis, and moderate loss of cochlear neurons. There was a 
clear base-to-apex gradient for the lesion involving the organ of Corti: the most 
prominent atrophy was detected in the base and diminished towards the apex. This 
pattern of atrophy of the organ of Corti corresponded to the downsloping 
audiogram configuration constituting "residual hearing", based on the basilar 
membrane's sono-topography. The loss of cochlear neurons may have been due, in 
part, to retrograde neural degeneration as a result of atrophy of the organ of Corti. 
The normal vestibular sense organs corresponded w i t h normal vestibular function 
as tested during life. 
The underlying cause of the Nathalie syndrome is unknown. One of the most 
prominent symptoms is sensorineural hearing loss. Another new striking feature is 
that three of four affected individuals died at a young age from heart failure or 
sudden death. The original paper ' describes a cardiac conduction abnormality of 
short PO interval wi thout pre-excitation, which we could not confirm by recent 
ECGs. However, frequent premature ventricular contractions were seen in one 
individual (Case Ihy) wi thout signs of ventricular tachycardia. 
Autopsy in one of the three deceased individuals revealed dilated cardiomyopathy. 
The combination of sensorineural hearing loss and dilated cardiomyopathy has 
been described before by Schönberger et al.5 Two kindreds were reported that 
presented wi th autosomal-dominant sensorineural hearing loss and dilated 
cardiomyopathy. They had no other disorders. In late adolescence a moderate-to-
severe hearing loss was evident and after the fourth decade ventricular dysfunction 
produced progressive congestive heart failure.5 A deletion in the transcriptional 
coactivator EYA4 was found to cause this disease.6 The ΕΥΑ family of transcriptional 
coactivators (ΕΥΑΊ-4) is part of a regulatory network of proteins that interact to 
facil itate normal embryonic development. Wayne et al. have suggested that EYA4 is 
also important postdevelopmentally for continued function of the mature organ of 
Corti.7 Mutations that affect the 'Eyes absent 4' (EYA4) protein are known to cause 
nonsyndromic autosomal hearing loss at the DFNA10 locus.7 9 
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A pedigree co-segregating progressive SNHL and hypertrophic cardiomyopathy has 
been described by Mohiddin et al.10 They identified a mutation in the myosin VI 
gene (MY06). Myosin VI is expressed in the human heart" and in the cuticular plate 
of hair cells'2 '< and contributes to a broad range of cytoskeletal and cellular moti l i ty 
functions. Mutations in MY06 are known to cause DFNA22,5, a dominantly inherited 
and progressive SNHL, and the autosomal recessive congenital profound deafness 
DFNB37.'6 Mohiddin et al reported that the hearing loss started in the first decade, 
was progressive and affected all frequencies to varying degrees wi th a variety of 
audiometrie configurations. The cardiac symptoms were mild or absent in most 
affected family members and they suggested that the cardiac manifestations 
might have escaped detection in other pedigrees wi th MY06-associated SNHL. In 
addition, only certain MY06 mutations might be associated wi th cardiomyopathy 
or penetrance of the cardiomyopathy is age related.'0 
Another prominent feature in the Nathalie syndrome is cataract that presents in 
childhood. Individual Ihy had bilateral cataract surgery at the age of 8 years and 
showed postoperative aphakia of both eyes, that had been adequately corrected 
with a contact lens for the left eye. Although the anatomic result was satisfactory, 
the patient's low visual acuity of the right eye was in accordance wi th retinal 
scarring in the macular region. The left eye had near normal visual acuity, wi thout 
nystagmus, which excludes that the cataracts were congenital. The patient and the 
history of affected family members show that the cataract in Nathalie syndrome 
should be classified as juvenile cataract. Cataract in association wi th cardiomyopathy 
and premature death is a well-known feature of a syndrome wi th congenital 
cataract, hypertrophic cardiomyopathy, mitochondrial myopathy, and lactic 
acidosis. However, in this syndrome, the cataracts are congenital and the patients 
are visually handicapped and wi thout significant hearing loss.'7 
Features such as cataract, cardiomyopathy, or deafness have been reported in 
congenital disorders of glycolysation.'8 '9 However, a glycolysation disorder couldn't 
be confirmed in this family (individual Ihy). 
The additional features of the Nathalie syndrome, i.e. muscular atrophy, skeletal 
abnormalities, retardation of growth and underdeveloped secondary sexual char-
acteristics, are well known to be part of many genetic deafness syndromes as 
reported in the overview by Tonello et al. ; 
ISS 
CHAPTER 4 1 
The genetic defect associated wi th the Nathalie syndrome is unknown. The rarity of 
the syndrome and the small size of the family (with only four affected individuals) 
hamper the identification of the locus and the gene involved. However, DNA of 
three family members, including the patient are available for future studies. 
Although consanguinity of the parents was very unlikely since they originate from 
different countries, The Netherlands and the Ukrain, so we performed homozygosity 
mapping for individuals Ihy and 11:5 wi th high density Single Nucleotide Poly-
morphism arrays as described.20 This revealed no significant homozygous regions in 
the patient that were not shared by the unaffected sister. Also, the number and size 
of the homozygous regions did not provide any indication for a common ancestor of 
the parents. Based on the findings in the above mentioned syndromes, one may 
speculate about a causative gene wi th a function related to that of EYA4 or MY06. 
Mutations in these genes can result in cardiomyopathy and sensorineural hearing 
loss. For Nathalie syndrome, one might think about a gene that regulates EYA4, a 
gene that is regulated by EYA4 or a protein that is transported by myosin VI. It wil l 
be valuable to continue the follow-up in this family to generate a more detailed 
clinical picture that can guide genotyping in the future. 
Conclusion 
This report describes the clinical features and the histopathological findings of the 
temporal bone of an individual affected by the Nathalie syndrome. This syndrome 
comprises a combination of characteristics that does not resemble any other known 
syndrome and thus establishes an independent, rare entity. The associated genotype 
is as yet unknown. 
156 
NATHALIE SYNDROME 
References 
ι Cremers CWRJ, Ter Haar BC, Van Rens TJ The Nathalie syndrome A new hereditary syndrome Clin 
Genet 1975,8 330-40 
2 Tonello HV, Reardon W, Corlm RJ Hereditary Hearing Loss and Its Syndromes Oxford Monographs on 
Medical Genetics no 50 ed Oxford Oxford University Press, 2004 
3 Huygen PLM, Pennmgs RJE, Cremers CWRJ Characterizing and distinguishing progressive phenotypes 
in nonsyndromic autosomal dominant hearing impairment Audiol Med 2003,1 37-46 
4 Schuknecht HF Pathology of the Ear 2"d ed Philadelphia Lea & Febiger, 1993 
5 Schonberger J, Levy H, Grumg E et al Dilated cardiomyopathy and sensorineural hearing loss a 
heritable syndrome that maps to 6q23-24 Circulation 2000,101 1812-8 
6 Schonberger J, Wang L, Shin JT et al M u t a t i o n in the transcriptional coactivator EYA4 causes dilated 
cardiomyopathy and sensorineural hearing loss Nat Genet 2005,37 418-22 
7 Wayne S, Robertson NG, Declau F et al Mutat ions in the transcriptional activator EYA4 cause late-onset 
deafness at the DFNA10 locus Hum Mol Genet 2001,10 195-200 
8 Makishima T, Madeo AC, Brewer CC et al Nonsyndromic hearing loss DFNA10 and a novel mutat ion of 
EYA4 evidence for correlation of normal cardiac phenotype w i t h truncat ing mutations of the Eya 
domain Am J Med Genet 2007,143A 1592-8 
9 Hildebrand MS, Coman D, Yang Τ et al A novel splice site mutat ion in EYA4 causes DFNA10 hearing loss 
Am J Med Genet 2oo7,i43A 1599-604 
10 Mohiddm SA, Ahmed ZM, Griffith AJ et al Novel association of hypertrophic cardiomyopathy, sensorineural 
deafness, and a mutation in unconventional myosin VI (MY06) J Med Genet 2004,41 309-14 
11 Avraham KB, Hasson T, Sobe Τ et al Characterization of unconventional MY06, the human homologue 
of the gene responsible for deafness m Snell's waltzer mice Hum Mol Genet 1997,6 1225 31 
12 Avraham KB, Hasson T, Steel KP et al The mouse Snell's waltzer deafness gene encodes an unconventional 
myosin required for structural integrity of inner ear hair cells Nat Genet 1995,11 369 75 
13 Hasson T, Gillespie PG, Garcia JA et al Unconventional myosins in inner-ear sensory epitheha J Cell Biol 
1997.137 1287 307 
14 Self T, Sobe T, Copeland NG, Jenkins NA, Avraham KB, Steel KP Role of myosin VI in the dif ferent iat ion 
of cochlear hair cells Dev Biol 1999,214 331 41 
15 Melchionda S, Ahituv N, Bisceglia L et al MY06, the human homologue of the gene responsible for 
deafness m Snell's waltzer mice, is mutated m autosomal dominant nonsyndromic hearing loss Am J 
Hum Genet 2001,69 635-40 
16 Ahmed ZM, Morell RJ, Riazuddm S et al Mutat ions of MY06 are associated w i t h recessive deafness, 
DFNB37 Am J Hum Genet 2003,72 1315-22 
17 Cruysberg JRM, Sengers RCA, Pmckers A, Kubat K, van Haelst UJGM Features of a syndrome w i t h 
congenital cataract and hypertrophic cardiomyopathy Am J Ophthalmol 1986,102 740 9 
18 Morava E, WeversRA.Cantagrel V e t a l A novel cerebello ocular syndrome w i t h abnormal glycosylation 
due to abnormalit ies in dohchol metabolism Brain 2010,133 3210-20 
19 Lefeber DJ, Morava E, Jaeken J How to f ind and diagnose a CDG due to defective N-glycosylation J 
Inherit Metab Dis 2011,34 849-52 
20 Schraders M, Lee K, Oostrik J et al Homozygosity mapping reveals mutations of GRXCRi as a cause of 
autosomal recessive nonsyndromic hearing impairment Am J Hum Genet 2010,86 138-47 
IS? 

Discussion and conclusions 

DISCUSSION AND CONCLUSIONS 
Discussion 
The aim of this thesis was to contribute to the knowledge on phenotype-genotype 
correlations in hereditary hearing impairment. The studies delineate clinical and 
genetic aspects of nonsyndromic autosomal dominant hearing impairment types 
DFNA2, DFNA8/12, DFNA15 and DFNA20/26, nonsyndromic autosomal recessive 
hearing impairment DFNB7/11 and Nathalie syndrome. 
Since the mid nineties of the last century many types of hereditary nonsyndromic 
hearing impairment have been described based on gene linkage outcomes. These 
include autosomal dominant as well as autosomal recessive inherited types. With 
the use of genetic linkage and mutation analysis former syndromic and nonsyndromic 
types of hearing impairment could be split up into different types or merged to one 
type of hearing loss when the underlying genetic cause appeared to be identical. 
Chapter 2 characterizes clinical and genetic aspects in 4 different types of non-
syndromic autosomal dominant hearing impairment. 
In chapter 2.1 we present the audiograms and age-related typical audiogram (ARTA) 
of a new DFNA2 family. In addition, ARTAs for previously reported DFNA2 families 
were composed. We show that in families with hearing impairment that are too 
small for genome wide linkage analysis the audioprofile can guide in selecting 
potentially interesting loci for linkage analysis or genes for mutation analysis. The 
audioprofile can be retrieved by constructing ARTA' * or, as shown in this study, by 
use of the computer program AudioGene V3.0, which has been developed for 
automatic audioprofile analysis.3 Both methods create an audioprofile based on 
audiograms of affected individuals. In the family we describe (family Dutch VI) in 
our study the audioprofile suggested linkage to the Di:NA2/KCNQ4 locus. DFNA2 is 
characterized by a symmetric, predominantly high-frequency sensorineural hearing 
loss (SNHL) that is progressive across all frequencies. In all affected family members 
(Dutch VI), the c.82iT>A (p.Leu274His) mutation was detected. 
Two mouse kcnq4 models exist: a kcnq4 knockout mouse {kcnq4 ' ) and a knock-in of 
a dominant negative mutation (G286S) identified in human DFNA2.4 
In mice, kcnq4 is expressed in both inner and outer hair cells5, a selective and 
progressive degeneration of outer hair cells and progressive hearing loss was found 
in both mouse models.4 6 
161 
CHAPTER 5 
In Iowa (USA) a gene therapy study is performed in one of these mouse models 
(presentation RJH Smith, May 7,h Nijmegen, The Netherlands). Targeting and down-
regulation of theKCN04 gene offers the theoretical potential of altering the disease 
phenotype of DFNA2. Of all 19 DFNA2 families known worldwide, 6 have been 
identified in the department of Otorhinolaryngology of the Radboud University 
Nijmegen Medical Centre. This clinic might also play a role in the future to evaluate 
treatment options for DFNA2. 
In chapter 2.2, a Dutch DFNA8/12 family with a novel TECTA mutat ion (c.533iC>A) is 
described. DFNA8/12 can present as a mid-frequency (cookie-bite) hearing 
impairment when the mutation affects the Zona Pellucida (ZP) domain, entactin 
domain or the Zonadhesin (ZA) domain (i.e. vWFDi and vWFDi) of a-tectorin. When 
the ZA domain is affected it can also present as an high-frequency hearing 
impairment.716 
The novel mutat ion we described is predicted to affect splicing of TECTA RNA and is 
predicted to result in deletion of part of a-tectorin. The affected family members 
showed a prelingual, non-progressive, flat-threshold type of hearing impairment. 
This phenotype was fairly similar to the phenotypes previously described in TECTA 
mutations that affect the ZP domain. In addition, we demonstrated that this novel 
mutation in TECTA, which is thought to result in an intracochlear conductive hearing 
loss, provided protection againstthesensorineural hearing losscalled 'presbyacusis'. 
Also, DFNA13 (COLnAz) is characterized as a mid-frequency hearing impairment and 
the effect of the known mutations on hearing are described as a cochlear conductive 
loss.1720 Mice deficient in Colhaz exhibit hearing loss and also show an altered 
structure of the tectorial membrane18, as do mice wi th mutations in Teda.2'24 
Speech recognition scores are usually good in mid-frequency hearing impairment, 
therefore, the hearing impairment can easily go unnoticed. 
Rehabilitation of individuals wi th this specific mid-frequency hearing impairment 
audiogram configuration can be a challenge. A regular hearing aid is usually 
indicated in sensorineural hearing loss and can be fitted behind the ear or in the ear 
canal. The disadvantage of a traditional hearing aid is that the low-frequencies are 
more stimulated due to the occlusion effect of an earmold; in DFNA8/12 the low-
frequencies are usually spared. 
162 
DISCUSSION AND CONCLUSIONS 
In DFNA8/12 the structure of the tectorial membrane is affected that results in an 
intracochlear conductive hearing loss. This specific type of hearing impairment 
might be aided by an active middle ear implant that substitutes the speaker of a 
traditional hearing aid with a direct driver to the ossicles or the round window. This 
implant can offer a treatment option for patients wi th sensorineural25 j8, conductive, 
or mixed hearing loss.29 It can be programmed according to the hearing needs of the 
patient. The Vibrant Soundbridge is an example of an active middle ear implant and 
mainly amplifies the frequency range 500 to 2000Hz.30 3' However, until now it is 
mainly indicated when conventional hearing aids are not possible to wear, for 
example due to otitis externa. The best result w i th this device were found in hearing 
loss which is not too severe and when the audiogram has a flat or mildly sloping 
configuration.3' Nevertheless, technical innovations in the middle ear implants 
could specify the frequency ranges that are amplified and possibly make this device 
more suitable for midfrequency hearing loss, which would be promising for 
DFNA8/12 affected individuals. 
In chapter 2.3 we report on a second Dutch DFNA15 family (Dutch II) wi th a novel 
POU4F3 mutat ion, L223P. DFNA15 is characterized as a progressive sensorineural 
hearing impairment, wi th a subjective onset age varying from early adulthood to 
mid-life, in some individuals an onset in childhood is reported.'2 " The audiometrie 
configuration ranges from a flat, or midfrequency hearing impairment to a sloping 
curve.32,34 
Audiometrie analysis in this second Dutch family showed a high-frequency hearing 
impairment wi th an early-adult to mid-life onset. The clinical characteristics in this 
family were fairly similar to those in the two previously described DFNA15 families 
from Israel and The Netherlands, but the level of hearing impairment was milder.32 34 
The fourth report on DFNA15 originates from Korea, the audiogram had a 
down-sloping configuration with residual hearing in the low frequencies.35 
DFNAis is a cochleovestibular disorder since hypofunction of the labyrinth was 
found in the first Dutch family.32 " '6 However, vestibular function tests revealed no 
substantial vestibular dysfunction in this second Dutch family. 
The ARTA of DFNA15/L223P (family Dutch II) has a similar configuration as the ARTA 
for presbyacusis, w i th progression mainly for the high frequencies. In this DFNA15 
family, presbyacusis seems to have occurred precociously. The first presbyacusis 
gene identified is TFCP2L3 (alias GRHL2)}1 This gene is also associated wi th 
nonsyndromic autosomal dominant hearing impairment DFNA28 and encodes a 
163 
CHAPTbR 5 
transcription factor.'6 In mice, Tfcp2l3 is expressed in several epithelial tissues 
including epithelial cells lining the endolymph-containing scala media. Its function 
remains elusive, but the observation that TTO^ij-related hearing loss starts at a 
later age suggests that the protein plays an essential role in epithelial cell 
maintenance.'8 
The identification of genes regulated by POU4F3, which encodes a transcription 
factor might well provide excellent candidate genes for presbyacusis. The 
phenotypic changes in DFNA15 may be caused by other downstream molecules of 
POU4F3 that are essential for the survival and/or differentiation of inner hair cells in 
the cochlea and hair cells in the vestibulum. One of the genes regulated by Pou4f3 
is G/77.39 In G/77 mutant mice (Cfii ' ), loss of expression of Cfii resulted in degeneration 
of only the outer hair cells.39 4C This loss of outer hair cells specifically, results in 
reduced sensitivity and frequency selectivity of the cochlea, which is also found in 
presbyacusis. 
In chapter 2.4 the cochleovestibular findings of a Dutch DFNA20/26 family wi th a 
novel missense mutation (D51N) in the ACTCi gene are described. The ACTGi gene 
encodes γ-actin. In the cochlea, stereocilia of the hair cells are the most prominent 
structures containing γ-actin. It has been suggested that mutations in γ-actin cause 
hearing loss mainly by impairing the function and/or viability of hair cells.4145 
Families wi th different ACTCi mutations show variations in audiogram configuration 
and type (linear/nonlinear) and rate of threshold deterioration. In such a situation, 
the audioprofile or ARTA can make a certain type of DFNA more or less probable and 
can guide analysis for the most probable underlying genetic defect. 
The clinical features in this Dutch family were largely consistent wi th previous 
reports on DFNA20/26: downsloping audiograms at all the frequencies, w i t h 
predominant involvement of the mid and high frequencies. The hearing impairment 
had a postlingual onset, progressed to severe-profound hearing levels, and 
ultimately resulted in residual hearing (corner audiogram). Speech recognition 
scores became problematically low (maximum phoneme score of less than 50%) 
from about 60 years onward. All affected family members made use of a 
conventional hearing aid. The postlingual onset of hearing impairment, the 
progression to residual hearing and the risk of hair cell degeneration might make 
individuals wi th DFNA20/26 suitable candidates for cochlear implantation (CI). The 
electrodes inserted in the cochlea stimulate different tonotopic areas along the 
cochlea by producing electric pulses that spread to the auditory nerve fibers and 
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can thus provide auditory input when the organ of Corti is non-functional. Two 
affected individuals of the Dutch family have been implanted wi th a CI. In one 
individual, a maximum phoneme score of 71% at 70 dB SPL was measured one year 
after implantation. Before implantation a hearing aid was used and the maximum 
score was 18% at ösdB SPL. In the other individual, the CI was combined wi th a 
hearing aid in the same ear (electric acoustic stimulation). This is indicated when 
the hearing in the low frequencies is spared and still can be acoustically supported 
by a hearing aid. The mid and high frequencies are electrically stimulated wi th an 
CI.46 A year after implantation, a mean phoneme score of 93% at 70 dB SPL was 
measured. Before implantation, the maximum phoneme score wi th hearing aid was 
66% at 75 dB SPL. Thus, despite the progression of the hearing impairment to 
residual hearing and the concomitant difficulties in communication, the future 
perspectives for hearing in these individuals might be promising. 
Chapter 3.1 reports on a Dutch DFNB7/11 family wi th a novel mutation in TMO 
(c.i763+3A>G). Hearing impairment developed postlingually in the high frequencies, 
and progressed towards severe to profound in the 2nd decade of life, affecting all 
frequencies and resulting in residual hearing ('corner audiogram'). Remarkably, the 
sensorineural hearing impairment in this family was progressive but inherited in an 
autosomal recessive pattern. The phenotype in this family was more similar to the 
phenotypes described for dominant TMCi mutations (DFNA36). 
In mice, Tma is expressed in the inner and outer hair cells of the cochlea and the 
hair cells in the vestibular labyrinth. The precise function of TMCi is not known yet. 
Mice wi th a defect in Tma showed either first a normal function of hair cells but 
postnatal progressive hair cell degeneration, mainly affecting inner hair cells 
(7mc7e"'Afmice, model for DFNA36) 47 48 or had normally developed cochlear hair 
cells, but lacking cochlear responses (Tma"""1" mice, model for DFNB?/!!).495 ' 
Affected individuals of the Dutch DFNB7/n family wi th the c.i763+3A>G mutat ion 
still has some hearing function at younger age, in contrast to previously described 
DFNB7/11 families. We suggested that a certain amount of normal TMCi protein still 
might be present in the cochlear hair cells or the resulting truncated protein has 
some residual function, sufficient for hearing at younger age. However, the hearing 
impairment progressed rapidly and the affected family members needed a 
conventional hearing aid before the age of 20 years. From the age of 40 to 50 years, 
there was only residual hearing and conventional hearing aids were not sufficient 
anymore for proper communication. Fortunately, residual hearing can be aided by a 
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cochlear implant (CI) device. The first results in these family members were 
promising already after 3 to 6 months after implantation compared to the reference 
group who were tested after 12 months. The final phoneme scores in this family one 
year after implantation were 50%, 70% and 88% at 70 dB SPL. Since speech 
recognition in CI users improves over t ime, the final result might even be better, 
however, most progression in seen in the first year after implantation.52 The family 
members developed hearing impairment postlingually, so they had already 
developed language which can support in the CI rehabilitation afterwards. 
Interestingly, in DFNB8/10 families wi th a comparable phenotype, the best speech 
reception was reached after implantation wi th a CI: a mean phoneme score of 
84,1% at 70 dB SPL was measured. Affected individuals showed a progressive 
hearing impairment, which has a prelingual or postlingual onset and in general 
affected the high frequencies first, eventually resulting in a flat audiogram 
configuration." 
Chapter 4.1 describes the clinical fol low-up on the affected siblings in a family wi th 
Nathalie syndrome. This syndrome was first described in 1975.54 
It comprises a combination of features that does not resemble any other known 
syndrome and is as such an independent, rare entity. It is characterized by sensorineural 
hearing impairment, cataract formation, spinal muscular atrophy, skeletal abnormalities, 
retardation of growth, underdeveloped secondary gender characteristics and cardio-
myopathy. Follow up shows that the affected family members are at risk to develop 
cardiomyopathy and have a risk of sudden death or death from heart failure; 3 out 
of the 4 affected individuals had passed away. 
In addition, the histopathological findings of the temporal bone of one of the 
deceased affected individuals are described. It showed diffuse atrophy of the organ 
of Corti, severe and diffuse atrophy of the stria vascularis and moderate loss of 
cochlear neurons in all turns. These findings confirm that the hearing loss in this 
syndrome results from atrophy in the inner ear; the pattern of atrophy of the organ 
of Corti corresponded to the downsloping audiogram configuration. In general, his-
topathological findings of the temporal bone in hearing disorders are crucial to 
understand the disease and its treatment. It can stimulate investigation into the 
fundamental nature of how hearing and balance organs function. Unfortunately, 
only a few temporal bone histopathology laboratories have remained worldwide, 
which restricts future research in this f ie ld." 
166 
DISCUSSION AND CONCLUSIONS 
The genotype associated with the Nathalie syndrome is unknown. Blood samples of 
three family members have been taken recently and DNA is available for future genetic 
analysis. Until now, the identification of a mutant gene is impeded by the rarity of the 
syndrome and the small size of the family. Only four individuals are affected and of only 
one affected individual a blood sample is available, which makes linkage analysis 
impossible. However, whole genome sequencing may reveal the underlying genetic 
defect. In other syndromes in which a part of the features are comparable, i.e. 
sensorineural hearing loss and dilated or hypertrophic cardiomyopathy, mutations in 
EYA4 and MY06 were found.5658 Based on these findings one may speculate about a 
gene with a comparable function that result in cardiomyopathy and sensorineural 
hearing loss. For example, a gene regulated by EYA4 or a protein that is transported by 
MY06. It will be valuable to continue the follow-up in this family to generate a more 
detailed clinical picture that can guide genotyping in the future. 
General considerations and future perspectives 
Hearing impairment shows a wide variation in the phenotypic presentation, w i th 
differences in age of onset, severity, progression and audiometrie configuration. 
Based on the clinical findings or audioprofile, it is often possible to make an initial 
guess at the most probable underlying genetic defect and this can guide genetic 
analysis.2 The DFNA or DFNB audioprofile can be created by the use of ARTA2 or by 
accessing the specially developed program AudioGene on the Internet (h t tp : / / 
audiogene.eng.uiowa.edu/) to perform automatic audioprofile analysis of the 
family's (audiological) phenotype.3 59 Cenotype-phenotype correlation studies on 
hearing impaired families reveal insight in the natural course of these types of 
hearing loss and can help in genetic counseling of patients and their fami lies. In the 
past years, many deafness-causing genes have been identified. These findings are 
critical in understanding the molecular mechanism of auditory function and its 
loss. The genes known to be involved in nonsyndromic hearing impairment encode 
a large diversity of proteins wi th various functions. Also, the unraveling of the 
human genome sequence and the use of deaf mouse models have been crucial for 
the discovery of auditory genes. 
Hearing impairment is the most common sensory disorder, however, treatment 
today is limited to hearing aids, middle ear implants and cochlear implants. These 
devices support hearing but do not completely restore our ability to hear. 
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Alternative biological therapies are being developed, based on the knowledge on 
genes for hearing impairment and their function. Several general approaches are 
being considered for therapeutic intervention in hearing impairment: prevention of 
cell death, manipulation of expressed genes by gene therapy methods, inhibition of 
negative regulators and stem cell therapy. 
The mammalian inner ear is unable or almost unable to regenerate cells wi th 
auditory functions or supporting cells; the number of hair cells we are born wi th is 
our lifetime supply. Hair cells differentiate during development and do not divide 
anymore, so prevention of their loss is necessary. In the cochlea, the most sensible 
cells are the outer hair cells.60 ' ' Anti-apoptotic agents such as caspase 3 inhibitors 
have been studied in drug-induced hearing loss and have been shown to promote 
hair cell survival. Whether these agents also prevent hearing loss after cell death 
due to genetic disease remains to be determined.60,6 ' In addition, in pou4fs knockout 
mice, hair cells also degenerate during late embryonic development via apoptosis 
so a final common pathway of hearing loss resulting f rom ageing, drug ototoxicity 
and genetic defects might be apoptosis.60 Recent studies have shown that survival 
of hair cells in Pou4f3 knockout mice can be promoted by treating the embryonic 
cochlea wi th a general caspase inhibitor.62 
Gene therapy consists of the introduction of normal genes into somatic or stem 
cells to treat a specific disease. In inner ear gene therapy, DNA constructs are 
transferred into the cochlea w i th the aims of protecting inner ear anatomy and 
protecting the regeneration of sensory hair cells, neurons and other cell types. 
The structure of the cochlea is small and enclosed, which challenges the delivery of 
genes wi thout causing damage. Different gene transfer vectors have been 
developed to deliver therapeutic genes. Non-viral vectors, like liposomes have the 
advantage of being non-immunogenic. Of the viral vectors, adenoviral vectors are 
most widely used for cochlear gene transfer. They infect dividing and non-dividing 
cells, but do not integrate into the genome which leads to transient expression. The 
major disadvantage of viral vectors is that they can induce an immune response 
which is toxic to the recipient cell.60,61 Some studies demonstrated limited hair cell 
damage or protection by using immunosuppression treatment.63 64 Another type of 
viral vectors are adeno-associated virus vectors. These vectors induce a less potent 
immune response, integrate into non-dividing cells and lead to stable integration.60 
In addition, the success of gene therapy also depends on the ability of the gene 
delivery system to selectively deliver therapeutic genes to a sufficient number of 
168 
DISCUSSION AND CONCLUSIONS 
target cells, generating expression levels that influence the disease state. The use of 
tissue-specific promotors and/or enhancers makes this possible.60 
Genes studied for gene therapy in hearing impairment are for example genes that 
regulate hair cell differentiation. The aim is to introduce genes into the cochlea to 
induce non-sensory cells or damaged hair cells to transdifferentiate into functional 
hair cells. In non-mammalian vertebrates, lost hair cells can be replaced by newly 
generated hair cells. One of the inner ear genes that participate in early steps of hair 
cell differentiation is Atofa, a transcription factor.6"6 ' This gene has been introduced 
into the cochlea using adenoviruses in drug-induced deaf guinea pigs. New hair 
cells appeared wi th functional properties. This is the first functional restoration of 
a damaged mammalian hearing organ at the cellular level. It has been speculated 
that the new hair cells were derived from supporting cells or f rom other nonsensory 
cells close to the organ of Corti, which indicates transdifferentiation.65 However, the 
presence of differentiated supporting cells in the organ of Corti is necessary for this 
type of intervention.66 
The other focus of gene therapy in hearing impairment is on cell-cycle regulation 
genes. Several genes and proteins have been identified that are involved in 
regulation of cell proliferation (Ink4d, Kipi, Rb). These proteins (CKIs) inhibit the 
cyclin-dependent kinase activity which controls signals that drive cells into the 
S-phase (synthesis-phase, duplication of chromosomes) of the cell cyclus. The CKIs 
suppress S-phase entry. Ongoing cell proliferation in the organ of Corti occurs in 
mice in which the p27k|i"gene is silenced.67 Such genes might be used in regeneration 
of hair cells in the inner ear. The risk of suppressing cell cycle inhibitors is the 
formation of malignancy as a result of unregulated cell proliferation.60•'" 
Research on stem cell therapy also has some promising results. Stem cells can be 
generated by using adult organs (induced pluripotent stem cells). Neural and inner 
ear stem cells were shown to have the ability to differentiate into different inner 
ear cell types in vitro and in vivo.6"70 There might be a possibility to induce these 
cells to differentiate into sensory hair cells to rescue or restore hearing impairment.60 
Likewise, from embryonic stem cells, pluripotent cells derived f rom the inner cell 
mass of the blastocyst, inner ear progenitors have been derived in vitro.107' These 
were implanted in the inner ear of chick embryos and generated hair cells in vivo.6" 
Nevertheless, it has not been proven that these haircell-like cells can become fully 
functional and integrate into the auditory epithelium. The appropriate neural 
connections have to be formed to restore hearing.60·''Moreover, care should be 
taken to prevent stem cells from growing into tumors. 
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Further therapeutic options are interventions that block the expression of specific 
genes thereby preventing damage mediated by toxic molecules or the dominant-
negative mechanism of action of selected mutant proteins.72·73 
In autosomal dominant disease, the molecular mechanisms can be broadly classified as 
either loss-of-function (the phenotype reflects the consequence of haploinsufficiency) 
or gain-of-function mutations (a transcribed protein interferes in a negative way with 
normal function of the native protein or has a toxic effect on its own). Types of deafness 
in which gain-of-function mutations are observed include DFNA2 {KCNO4), DFNA3 
(CJB2) and DFNA5 (DFNAs). Targeting and down-regulating these specific genes offers 
the theoretical potential of altering a disease phenotype. RNA interference-mediated 
(RNAi) gene silencing reduces expression of target genes, this is a physiological 
phenomenon."·73 Targeted down-regulation of genes may be possible using adeno-as-
sociated or adenoviral vectors to deliver specific constructs to specific cells in the inner 
ear. For example, the expression of the R75W allele variant of the CJB2 gene (DFNA3) has 
been silenced, which restored hearing loss in a genetic mouse model.72 
The above mentioned therapeutic strategies for hearing impairment are promising 
for restoring hereditary hearing impairment. Unfortunately, at this moment clinical 
application in patients is not possible yet. For the application of gene-specific or 
mutation-specific therapy in the future, it is necessary to identify the genetic 
defects that underlie the hearing impairment in affected individuals. At present, 
the knowledge on these genetic defects is used for counseling of patients and their 
families. 
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SUMMARY S A M L N V A l l l N t j 
Summary 
In chapter ι of this thesis a general introduction to hereditary hearing impairment 
and an up to date review on DFNA2, DFNA8/12, DFNA15, DFNA20/26, DFNBy/n and 
Nathalie syndrome are provided. 
Chapter 2.1 describes the audiograms and age-related typical audiogram (ARTA) of 
a Dutch DFNA2 family (Dutch VI). DFNA2 is characterized by a symmetric, 
predominantly high-frequency sensorineural hearing loss (SNHL) that is progressive 
across all frequencies. Family Dutch VI was too small for genome wide linkage 
analysis. Their audioprofile was retrieved by constructing ARTA and by use of the 
computer program AudioCene V3.0, which has been developed for automatic 
audioprofile analysis. Based on the audioprofile linkage to the DPNA2/KCNO4 locus 
was suggested. Inali affected family members (Dutch VI), the c.82iT>A (p.Leu274His) 
mutation was detected. 
Chapter 2.2 concerned a Dutch DFNA8/12 family wi th a novel TECTA mutat ion 
(c.533iC>A).This novel mutation is predicted to affect splicing of TECTA RNA and is 
predicted to result in deletion of part of a-tectorin. The affected family members 
showed a prelingual, non-progressive, flat-threshold type of hearing impairment. 
This phenotype was fairly similar to the phenotypes previously described in TECTA 
mutations that affect the ZP domain. This novel mutation in TECTA is thought to 
result in an intracochlear conductive hearing loss. The study showed that this 
mutation might provide some protection against the sensorineural hearing loss 
called 'presbyacusis'. 
Chapter 2.3 reports on the cochleovestibular characteristics of a Dutch DFNAis family 
with a novel POU4F3 mutation, L223P. Audiometrie analysis generally showed a high-
frequency hearing impairment. An early-adult to mid-life onset was most common, in 
some individuals an onset in childhood was reported. The clinical characteristics were 
fairly similar to those in the t w o previously described DFNA15 families (L289F, 884del8) 
but the level of hearing impairment was milder. In contrast to the DFNA15/L289F 
family, no substantial vestibular dysfunction was detected in the L223P mutation 
carriers. The ARTA of the DFNA15/L223P family had a similar configuration as the ARTA 
for presbyacusis, with progression mainly at the high frequencies. In this DFNA15 
family, presbyacusis seems to have occurred 14 years precociously. 
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Chapter 2.4 addressed the audiometrie and vestibular findings of a Dutch DFNA20/ 
26 family wi th a novel missense mutation (D51N) in the4CTC7 gene. The audiograms 
had a downsloping configuration, w i th predominant involvement of the mid and 
high frequencies. The hearing impairment had a postlingual onset, progressed with 
about 1.1 to 2.1 decibels/year to severe-profound hearing levels, and ultimately 
resulted in residual hearing (corner audiogram). Speech recognition scores became 
problematically low (maximum phoneme score of less than 50%) from about 60 
years onward. Vestibular function tests revealed no dysfunction. The clinical 
features in this family were largely consistent wi th previous reports on DFNA20/26. 
ARTA constructed for seven DFNA20/26 families showed variation in age at onset, 
rate of progression and frequency range across the carriers of the different mutations. 
In chapter 3.1 the genotype and phenotype of a Dutch DFNB7/11 family are presented. 
A novel mutation in TMCi (c.i763+3A>C) was found, one of the 6 transmembrane 
domains and the actual TMC channel domain are predicted to be absent in the 
mutant protein. In contrast to previously described DFNB7/11 families, affected 
individuals of the Dutch DFNB7/11 family (c.i763+3A>C) still had some hearing 
function at younger age. Hearing impairment developed postlingually in the high 
frequencies, and progressed towards severe to profound in the 2nd decade of life, 
affecting all frequencies and resulting in residual hearing ('corner audiogram'). The 
phenotype in this family was more similar to the phenotypes described for dominant 
TMCi mutations (DFNA36). The residual hearing of the Dutch family members was 
aided by a cochlear implant (CI) device. The phoneme scores 3 to 6 months after 
implantation varied from 50% to 88% at 70 dB SPL. Vestibular function tests revealed 
no abnormalities. 
In chapter 4.1 a clinical fol low-up of a family wi th the Nathalie syndrome is provided. 
The syndrome comprises sensorineural hearing impairment, cataract formation, 
spinal muscular atrophy, skeletal abnormalities, retardation of growth, under-
developed secondary gender characteristics and cardiomyopathy. It does not 
resemble any other known syndrome and is as such an independent, rare entity. 
Follow up showed that the affected family members were at risk to develop 
cardiomyopathy and had a risk of sudden death or death from heart failure. Histo-
pathological findings of the temporal bone of one of the deceased affected 
individuals showed diffuse atrophy of the organ of Corti, severe and diffuse atrophy 
of the stria vascularis and moderate loss of cochlear neurons in all turns. These 
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findings confirmed that the hearing loss in this syndrome results from atrophy in 
the inner ear; the pattern of atrophy of the organ of Corti corresponded to the 
downsloping audiogram configuration. 
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Samenvatting 
Hoofdstuk ι van dit proefschrift betreft een algemene introductie over erfelijke 
slechthorendheid. Een overzicht wordt gegeven van DFNA2, DFNA8/12, DFNA15, 
DFNA20/26, DFNB7/11 en het Nathalie syndroom. 
Hoofdstuk 2.1 beschrijft de audiogrammen en ARTA (age-related typical audiogram) 
van een Nederlandse DFNA2 familie (Dutch VI). DFNA2 wordt gekenmerkt door een 
progressief symmetrisch perceptief gehoorsverlies dat zich met name in de hoge 
frequenties manifesteert. De Nederlandse familie was te klein om genoom wijde 
linkage analyse toe te passen. Door ARTA te construeren en met behulp van het 
computer programma AudioCene V3.0, dat het audioprof iel automatisch analyseert, 
is het audioprofiel van deze familie verkregen. Op basis van dit audioprofiel werd 
linkage aan het DFNA2/KCNQ4 locus vermoed. In alle aangedane familieleden, is de 
mutatie c.82iT>A (p.Leu274His) in het KCNO4 gen gevonden. 
Hoofdstuk 2.2 belicht een Nederlandse DFNA8/12 familie met een nieuwe mutatie 
in het TECTA gen (c.533iC>A).Van deze nieuwe mutatie wordt voorspeld dat deze 
het splitsen van TECTA RNA beïnvloedt en resulteert in de deletie van een deel van 
a-tectorin. De aangedane familieleden presenteerden zich met een prelinguaal, 
niet progressief, vlak gehoorsverlies. Dit fenotype was grotendeels gelijk aan de 
eerder beschreven fenotypes geassocieerd met TECTA mutaties in het ZP domein. 
Van deze nieuwe mutatie in TECTA wordt gedacht dat het resulteert in een 
intracochleair conductief gehoorsverlies. Het onderzoek gaf aanwijzingen dat deze 
mutatie mogelijk bescherming biedt tegen presbyacusis. 
Hoofdstuk 2.3 presenteert de cochleovestibulaire kenmerken van een Nederlandse 
DFNA15 familie met een nieuwe mutatie in het POU4F3 gen (L223P). Audiometrische 
analyse liet over het algemeen een gehoorsverlies in de hoge frequenties zien. Een 
afname van het gehoor begon meestal in de (jong) volwassenheid, enkele 
individuen gaven aan dat het gehoorsverlies in de kindertijd had aangevangen. De 
klinische karakteristieken waren vergelijkbaar met die in de twee eerder beschreven 
DFNA15 families (L289F, 884del8) maar het gehoorsverlies was milder. In 
tegenstelling to t de DFNA15/L289F familie is er in de L223P mutation dragers geen 
substantiële vestibulaire dysf unctie gemeten. De ARTA van de DFNA15/L223P familie 
had een zelfde configuratie als de ARTA voor presbyacusis, met voornamelijk 
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progressie inde hoge frequenties. Het lijkt alsof in deze DFNA15 familie presbyacusis 
14 jaar te vroeg is opgetreden. 
Hoofdstuk 2.4 zet de audiometrische en vestibulaire bevindingen uiteen van een 
Nederlandse DFNA20/26 familie met een nieuwe missense mutatie (D51N) in het 
ACTGi gen. Het gehoorsverlies kenmerkt zich door een aflopende audiometrische 
configuratie, waarbij met name de gehoorsdrempels voor de midden en hoge 
frequenties zijn toegenomen. Het gehoorsverlies begint postlinguaal en is neemt 
toe met circa 1.1 tot 2.1 decibel/jaar tot een ernstig gehoorsverlies, dit resulteert 
uiteindelijk in een restgehoor. Vanaf 60 jaar werd de spraakherkenning moeizaam 
(maximale phoneem score van minder dan 50%). Evenwichtsonderzoeken toonden 
geen dysfunctie. De klinische kenmerken in deze familie kwamen grotendeels 
overeen met eerdere DFNA20/26 publicaties. De ARTA van zeven reeds bekende 
DFNA20/26 families lieten een variatie zien tussen de dragers van de verschillende 
mutaties qua beginleeftijd, mate van progressie en aangedane frequenties. 
Hoofdstuk 3.1 beschrijft het genotype en fenotype van een Nederlandse DFNBy/ii 
familie met een nieuwe mutatie in het TMO gen (c.i763+3A>C). Het wordt voorspeld 
dat in het gemuteerde eiwit één van de 6 transmembraan domeinen en het TMC 
kanaal domein afwezig zijn. In tegenstelling tot eerder beschreven DFNBy/n 
families, was er bij de aangedane personen in de Nederlandse DFNB7/11 familie 
(c.i763+3A>G) nog sprake van een functioneel gehoor op jonge leeftijd. Het 
gehoorsverlies ontwikkelde zich postlinguaal en nam in de 2e decade toe in de hoge 
frequenties to t een ernstig verlies, waarbij uiteindelijk alle frequenties aangedaan 
waren en resulteerde in een restgehoor. Het fenotype in deze familie leek op de 
fenotypes die zijn beschreven bij dominante TMO mutaties (DFNA36). Het 
restgehoor van de Nederlandse DFNB7/11 familieleden werd ondersteund met 
behulp van een cochleair implantaat (Cl). De phoneem scores, gemeten 3 tot 6 
maanden na implantatie, varieerden van 50% tot 88% bij 70 dB SPL Evenwichts-
onderzoek liet geen afwijkingen zien. 
In hoofdstuk 4.1 wordt de klinische follow-up van een familie met het Nathalie 
syndroom beschreven. Dit syndroom wordt gekenmerkt door een perceptief 
gehoorsverlies, cataract, spinale spieratrofie, skelet afwijkingen, groei retardatie, 
onderontwikkeling van secundaire geslachtskenmerken en cardiomyopathie. Het 
vertoont geen gelijkenis met reeds bekende syndromen en is als zodanig een aparte 
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en zeldzame entiteit. Follow up liet zien dat de aangedane familieleden een risico 
liepen op het ontwikkelen van cardiomyopathie en een kans hadden op plots 
overlijden danwei een kans hadden op overlijden als gevolg van hartfalen. Histopa-
thologie van het os temporale van een van de overleden aangedane personen liet 
diffuse atrofie van het orgaan van Corti, ernstige en diffuse atrofie van de stria 
vascularis en een matig verlies van cochleaire neuronen in alle windingen zien. Deze 
bevindingen bevestigden dat het gehoorsverlies in dit syndroom het gevolg is van 
atrofie in het binnenoor; het atrofie patroon van het orgaan van Corti kwam 
overeen met de aflopende audiometrische configuratie. 
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DANKWOORD 
Dankwoord 
Het meest gelezen hoofdstuk van dit proefschrift, het dankwoord! Promoveren 
doe je zeker niet alleen, zonder de begeleiding, inzet en medewerking van heel veel 
mensen was ik nooit op deze pagina beland. 
Ten eerste ben ik veel dank verschuldigd aan alle familieleden van de verschillende 
families die vri jwil l ig en gelukkig ook vaak enthousiast hebben deelgenomen aan 
de onderzoeken. Jullie kwamen daarvoor zelfs op een zaterdag vanuit het hele land 
naar Nijmegen voor 'de familiedag', wat vaak een mooie combinatie opleverde van 
onderzoek en een familiereünie. Zonder jullie deelname zou dit boekje niet met 
deze resultaten gevuld zijn. 
Van alle personen die hebben bijgedragen wil ik er een aantal persoonlijk bedanken. 
Allereerst mijn promotor, professor Cremers. Onze eerste gesprekken kan ik mij nog 
goed herinneren, u schetste mij de inhoud van dit boekje, dat klonk mij op dat 
moment nog vrij utopisch in de oren. De namen van de typen slechthorendheid 
waren mij nog onbekend, evenals het opzetten van dit type onderzoek en het 
tijdsbestek waarin dat zou plaatsvinden. Uw enthousiasme heeft aanstekelijk 
gewerkt! U wist mij elke keer weer te verbazen over de snelheid waarmee u een 
stuk gecorrigeerd had en overleg was altijd en overal mogelijk: een internet 
verbinding werd zelfs last minute op een vakantie eiland geregeld. Op momenten 
dat ik zelf door de bomen het bos even niet meer zag schetste u het verdere traject 
helder en verdwenen alle beren op de weg als sneeuw voor de zon. Uw inzet en 
begeleiding is bewonderenswaardig, veel dank! 
Vervolgens natuurlijk dank aan mijn tweede promotor, professor Kremer. Beste 
Hannie, j i j hebt me wegwijs gemaakt in de wereld van de antropogenetica. Het 
duizelde me dikwijls van de genetische termen en begrippen. Je wierp een kritische 
blik op de manuscripten en wist ze zo aan te scherpen. Dank voor de goede en 
prettige begeleiding! 
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Dr. Huygen, beste Patrick, je kennis van het binnenoor & evenwichtsorgaan en je 
fysisch/wiskundige blik daarop is erg waardevol geweest. In alle drukte wist je altijd 
wel tijd vrij te maken voor overleg en het stuk vanuit een ander perspectief te 
beoordelen wat soms tot verrassende wendingen leidde. Met het opzetten van de 
samenwerking met Iowa is een nieuw tijdperk aangebroken, ik hoop dat je nog lang 
je unieke kwaliteiten en creativiteit daarin kwijt kan! 
Ook gaat mijn dank uit naar de medewerkers van de afdeling antropogenetica, Rob 
Collin, Margit Schraders en Jaap Oostrik voor de analyses van de genetische data de 
verwerking daarvan, het samen schrijven aan de artikelen en de prettige samenwerking. 
Saskia van de Velde-Visser, dank voor de goede organisatie van de logistiek rondom 
de bloedmonsters. 
Leden van de manuscriptcommissie, prof. dr. de Groot, prof. dr. Brunner en prof. dr. 
De Leenheer, hartelijk dank dat u het manuscript heeft willen beoordelen. 
Graag bedank ik ook de staf van de Keel-, Neus-, en Oorheelkunde van het UMC 
St Radboud voor het in mij gestelde vertrouwen en voor de kans die jullie me 
hebben gegeven mijn opleiding in Nijmegen te volgen en dat te combineren met 
dit promotieonderzoek. 
Alle (oud) arts-assistenten van de KNO: Niels, Brechtje, Ronald, Anne, Myrthe, 
Liselotte, Stijn, Rutger, Bart, Godelieve, Olivier, Sylvia, George, Robert Jan, Ferdinand, 
lise, Jan-Willem, Véronique, Stijn, Louise, Hans, Jimmie, Maarten, Erik, Arthur, 
Richard, Hubert, Joost, Rabia, Annemarie, Eline, Caroline, Ingrid, Rik, Henrieke, Anne, 
Saskia en Lisette dank voor jullie steun en gezelligheid op het werk maar vooral ook 
daarbuiten. Voor mij als 'niet-Nijmeegse' hebben jullie voor een warm onthaal 
gezorgd waardoor ik me snel thuis voelde! Het is uniek te mogen werken in zo'n 
leuke groep waarin de 'serieuze' werkgerelateerde zaken zo mooi samengaan met 
de gezellige feestjes, borrels en diners die we daarnaast beleven en in hoge mate 
bijdragen aan de leuke tijd hier! 
Dames van het audiologisch centrum, dank voor jullie bereidheid op de zaterdagen 
en soms zelfs in andere oorden de metingen te willen verrichten. Dank aan de KNO 
poli verpleegkundigen voor de bloedafnames die voor dit onderzoek nodig waren. 
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Lieve vrienden en familie, hopelijk is er niet al te veel tijd ten koste gegaan van jullie. 
Dank voor alle gezellige momenten die we samen beleven ! Dit biedt goed tegenwicht in 
tijden van onderzoeks "bloed, zweet, en tranen", ook al is het met dat bloed gelukkig 
wel meegevallen, behoudens de buisjes die nodig waren voor het genetisch onderzoek. 
Liebe Familie Frenzel, Hanna und Peter, wir treffen uns meistens „international": 
vom Schlittschuhfahren am Bodensee über Segeln in Friesland bis Burger-Essen in 
California. Lieben Dank das ich offen in der Familie aufgenommen wurde! 
Lieve Annelies, we startten samen onze geneeskundige carrière in de collegebanken 
in Groningen. Sinds die tijd hebben we veel beleefd samen, zowel in goede als in 
minder goede tijden kan ik bij je terecht. Je benteen zeer waardevolle vriendin! Wat 
fijn dat jij paranimf zal zijn bij mijn promotie! 
Lieve Francine, lief zusje, je benteen goed maatje van me met wie ik liefen leed kan 
delen. Wat mooi dat ook jij het 'artsen-pad' bent ingeslagen, misschien is dit ook 
genetisch bepaald? Ik ben ervan overtuigd dat je een goede doe zult worden. 
Fantastisch dat jij als 'kleine' schwes nu als paranimf bij mijn promotie zal staan. 
Dat stond natuurlijk al als een paal boven water toen ik met dit onderzoek begon ! 
Lieve Maurits, na ons gelijktijdige vertrek uit het veilige thuishonk hebben we 
het voor elkaar gekregen om afwisselend een langere periode in het buitenland te 
vertoeven, gelukkig bestaat er Skype en Easyjet! Broertje, dank voor het brainstormen 
voor het ontwerp van de kaft van dit boekje maar natuurlijk vooral dank voor alle 
leuke dingen die we samen hebben beleefd en zeker nog gaan beleven, waar ter 
wereld dan ook! 
Lieve beppe, wat vind ik het fijn en bijzonder, dat u, mijn oma, bij mijn promotie 
bent! Ik heb veel van u geleerd, maar de zin "Buter, brea en griene tsiis, wa't dat net 
sizze kin, is gjin oprjochte Fries" blijft toch een klein struikelblok. 
Lieve pap en mam, dank voor de liefdevolle opvoeding en jullie onvoorwaardelijke 
steun en vertrouwen. Jullie hebben me altijd gestimuleerd mijn mogelijkheden te 
benutten en net dat stapje extra te zetten, dat heeft geleid tot wie en waar ik nu 
ben. Jullie zijn fantastische ouders en ik hoop dat jullie dat nog lang zullen blijven! 
Met trots draag ik dit boekje op aan jullie. 
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Lieber Tim, was angefangen hat in Südafrika, ist seitdem gewachsen bis etwas 
unbeschreibliches Schönes. Dein Überraschungsbesuch, damals in Kapstadt hat sich 
als ein super Idee ergeben. Unglaublich das wir zusammen schon so viel dürften 
erleben und so weit gekommen sind. Ohne deiner Unterstützung, zuhörender Ohr 
und Hilfe war das schreiben dieses Doktorarbeit viel schwieriger gewesen. Lieben 
Dank für dein Verständnis, dass auch in unsere Wochenenden zusammen die 
kostbare Zeit manchmal an dieser Forschung verschenkt worden ist. Und jetzt ist 
es fertig! Ich geniesse es Dich in der Nähe zu haben. Lieben Dank für alles und Danke 
das du bist wer du bist. Ich Liebe dich! Demnächst fängt ein neues Kapitel an. 
Verweile doch, du bist so schön! (Coethe) 
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Anne-Martine de Heer werd op 19 april 1981 geboren te Apeldoorn. In 1999 haalde 
zij haar eindexamen aan het Stedelijk Gymnasium Apeldoorn en startte zij met de 
studie Geneeskunde aan de Rijksuniversiteit Groningen. In 2003 volgde een onder-
zoeksstage van 6 maanden naar het Mucoepidermoid carcinoom van de speeksel-
klieren bij de afdeling Pathologie in het Groote Schuur Ziekenhuis te Kaapstad, 
Zuid-Afrika. Tijdens haar co-schappen in het Medisch Spectrum Twente te Enschede 
groeide haar enthousiasme voor de Keel-, Neus- en Oorheelkunde. In 2006 ving zij 
aan met een onderzoek aan de afdeling KNO van de University of California San 
Francisco (UCSF) naar de tumormarker CD44 in het Plaveiselcelcarcinoom. Dit werd 
gevolgd door een keuze co-schap KNO in het UMC St Radboud te Nijmegen. Eind 
2006 behaalde zij haar artsexamen. In het daarop volgende jaar startte zij aan als 
arts-onderzoeker bij de afdeling KNO in het UMC St Radboud en deed zij onder 
leiding van prof. dr. C.W.R.J. Cremers en prof. dr. H. Kremer onderzoek naar erfelijke 
slechthorendheid wat uiteindelijk heeft geleid tot het tot stand komen van dit 
proefschrift. Sinds 2007 is zij in opleiding tot KNO-arts in het UMC St Radboud, haar 
perifere stages van de KNO opleiding werden gelopen in het CWZ te Nijmegen en 
Rijnstate ziekenhuis te Arnhem. 
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ACTGi gamma-actm 1 gene 
ARTA age-related typical audiogram 
ATD annual threshold deterioration 
AUNA locus for auditory neuropathy 
dB decibels 
cDNA complementary deoxyribonucleic acid 
CI cochlear implant 
CK creatine kinase 
cM centiMorgan 
DNA deoxyribonucleic acid 
DFN X-lmked non-syndromic hearing loss 
DFNA autosomal dommantly inherited sensorineural hearing loss 
DFNB autosomal recessively inherited sensorineural hearing loss 
DFNY Y-lmked inherited sensorineural hearing loss 
DFNM modifier gene locus for hearing impairment 
ECC electrocardiography 
ENT ear-nose-throat 
FSH follicle-stimulating hormone 
Cfn growth factor independence! 
HL hearing level 
Hz hertz 
IAC internal auditory canal 
IHC inner hair cell 
ISO international organization for standardization 
KCNQ4 member 4 of the voltage-gated potassium channel gene family 
kHz kilo hertz 
LH luteinizing hormone 
LOH loss-of-heterozygosity 
MRI magnetic resonance imaging 
mRNA messenger ribonucleic acid 
NYHA New York heart association 
OHC outer hair cell 
PCR polymerase chain reaction 
PTA pure tone average 
POU4F3 gene encoding POU3F4, a member of the POU family of transcription factors 
RNA ribonucleic acid 
RNAi ribonucleic acid interference 
RT PCR reverse transcriptase polymerase chain reaction 
SD standard deviation 
SNHL sensorineural hearing loss 
SNP smgle-nucleotide polymorphism 
SPL sound pressure level 
STS sequence tagged-site marker analysis 
Τ time constant 
TECTA gene encoding alpha-tectorm 
TMG transmembrane channel-like 1 gene 
VNTR variable number tandem repeat 
VOR vestibule ocular reflex 
vWF von Willebrand factor 
y year 
ZA zonadhesm 
ZP zona pellucida 
195 

LIST OF PUBLICATIONS 
List of Publications 
Collin RW, de Heer AM, Oostrik J, Pauw RJ, Plantmga RF, Huygen PL, Admiraal R, de Brouwer AP, Strom TM, 
Cremers CW, Kremer H Mid-frequency DFNA8/12 hearing loss caused by a synonymous TECTA mutat ion 
that affects an exomc splice enhancer. Eur J Hum Genet 2008 Dec;i6(i2)-i430-6 
de Heer AR, Bouman H, Gerritsen MJ, Ingels KJ, Kaanders JH, Takes RP. Regionale metastasen van plaveisel-
celcarcmoom van de huid in het hoofd-halsgebied. Ned Tijdschr Geneeskd 2008 Dec 6,152(491:2645-9. 
de Heer AR, Pauw RJ, Huygen PL, Collm RW, Kremer H, Cremers CW Flat threshold and mid-frequency hearing 
impairment m a Dutch DFNA8/12 family w i t h a novel mutat ion in TECTA Some evidence for protection of the 
inner ear. Audiol Neurootol. 2009,14(3) 153-62. 
de Heer AM, Huygen PL, Collin RW, Kremer H, Cremers CW Mild and variable audiometrie and vestibular 
features in a third DFNA15 fami ly w i th a novel mutat ion in POU4F3 Ann Otol Rhinol Laryngol 2009 
Apr,i i8(4) 313-20 
de Heer AM, Huygen PL, Collin RW, Oostrik J, Kremer H, Cremers CW. Audiometrie and vestibular features in 
a second Dutch DFNA20/26 family w i th a novel mutat ion in ACTG1 Ann Otol Rhinol Laryngol. 2009 
May,i i8(5)-382-90 
Wang SJ, Wong G, de Heer AM, Xia W, Bourguignon LY CD44 variant isoforms in head and neck squamous 
cell carcinoma progression. Laryngoscope 2009 Aug, i i9(8) . 1518-30 
de Heer AM, Collin RW, Huygen PL, Schraders M, Oostrik J, Rouwette M, Kunst HP, Kremer H, Cremers CW 
Progressive sensorineural hearing loss and normal vestibular funct ion in a Dutch DFNB7/11 family w i th a 
novel mutat ion in TMCi Audiol Neurootol 20i i ; i6(2) 93-105 
de Heer AM, Schraders M, Oostrik J, Hoefsloot L, Huygen PL, Cremers CW Audioprofi le-directed successful 
mutat ion analysis in a DFNA2/KCNQ4 (p Leu274His) family Ann Otol Rhinol Laryngol. 2011 Apr,i2o(4) 243 8 
de Heer AMR, Merchant SN, Kammeraad JAE, Cruysberg JRM, Huygen PLM, Cremers CWRJ Clinical Follow-up 
and Histopathology of the Temporal Bones in Nathalie Syndrome. Audiol Neurootol Accepted 2011 
ig? 

Wat de rups het einde noemt, noemt de rest van de wereld een vlinder. 
Lao-Tse 

Stellingen behorende bij het proefschrift 
Hereditary Hearing Impairment 
Clinical and Genetic Aspects of 
DFNA2, DFNA8/12, DFNA15, DFNA20/26, DFNB7/11 
and Nathalie syndrome 
1 Het programma AudioGene kan in kleine families met slechthorendheid een 
audioprofiel analyseren Dit kan richting geven aan het opsporen van het 
gemuteerde gen (dit proefschrift) 
2 Een defect m het tectonele membraan (DFNA8/12, TECTA) geeft een 'geleidmgs-
verhes' m het binnenoor (dit proefschrift) 
3 DFNA15 {POU4F3) kan zich manifesteren als een hoge tonen perceptief 
gehoorsverhes en overeenkomsten vertonen met 'vroegtijdige' presbyacusis 
(dit proefschrift) 
4 Autosomaal recessieve mutaties m het TMCi gen (DFNB7/11) kunnen zich 
presenteren met een progressieve postlinguale perceptieve slechthorendheid 
Qua fenotype lijkt dit erg op de fenotypes die beschreven worden voor de 
autosomaal dominante mutaties DFNA36 (TMCi) (dit proefschrift) 
5 De oorzaak van het perceptieve gehoorsverhes m het Nathalie syndroom is gelegen 
in het orgaan van Corti (dit proefschrift) 
6 Voor een slechthorende klinkt gentherapie als toekomstmuziek 
7 Een bmaurale hoortoestelaanpassmg bij kinderen vergroot sterk hun vermogen tot 
richtmghoren en draagt daardoor bij aan de verkeersveiligheid van het kind 
8 Nicht sehen können heißt, die Menschen von den Dingen trennen, nicht horen 
können heißt, die Menschen von den Menschen trennen (Als je niet kan zien, ben je 
gescheiden van de dingen, als je met kan horen, ben je gescheiden van de mensen) 
Immanuel Kant 
9 Geluk is iets wat zich verdubbelt als men het deelt {Albert Schweitzer) 
io Ervaring is watje krijgt, nadat je het nodig hebt 
n Dat dokter de Heer een vrouw is zorgt vandaag de dag - ondanks de vele 
vrouwelijke artsen- toch nog eens voor verwarring 
12 Van je proefschrift 'bevallen' is het afronden van een hoofdstuk, de bevalling van je 
kind vormt het begin van een nieuwe avontuurlijke 'roman' 


Today, in our society of fast communication, good 
hearing is very important. Hearing impairment is often 
caused by diseases of the inner ear, which can be of 
genetic and/or environmental origin. 
To develop therapeutic strategies for genetic inner ear 
hearing impairment it is necessary to gain knowledge 
of the genes involved in the development and functioning 
of the cochlea. The identification of genetic defects 
that underlie hearing impairment can help to unravel 
the function of these genes. To gain insight into the 
natural course of hereditary hearing loss and to identify 
the causative genetic defect genotype-phenotype 
correlation studies in affected families can be used. 
This thesis aims to provide further understanding of 
four types of nonsyndromic autosomal dominant hearing 
impairment (DFNA2, DFNA8/12, DFNAis and DFNA20/26), 
one type of nonsyndromic autosomal recessive hearing 
impairment (DFNB7/11) and Nathalie syndrome. 
